Cross reference for [Ontology Name] classes, properties and dataproperties back to ToC

This section provides details for each class and property defined by [Ontology Name].

Classes

Bacteriac back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Bacteria

A microscopic single-celled organism, lacking a nucleus, that multiplies by simple cell division or by spores.
has super-classes
Organism c

Bibliographic resourcec back to ToC or Class ToC

IRI: http://purl.org/dc/terms/BibliographicResource

A book, article, or other documentary resource
Is defined by
http://purl.org/dc/terms/
has super-classes
has sub-classes
Paper c

Diseasec back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Disease

Illness; sickness
has super-classes
Disorder c
has members
dis1 ni

Disorderc back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Disorder

A disruption to regular bodily structure and function.
has super-classes
has sub-classes
Disease c

Drugc back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Drug

A substance used in treating disorder
has super-classes
Treatment c
has members
10027278 ni, 10034073 ni, 100945367 ni, 10114 ni, 10121883 ni, 10129151 ni, 10133 ni, 10150497 ni, 10168 ni, 101700644 ni, 10173277 ni, 10177 ni, 1018 ni, 10182969 ni, 101835682 ni, 101886302 ni, 101886309 ni, 102004710 ni, 10206 ni, 10207 ni, 10219 ni, 102208345 ni, 10250777 ni, 10281 ni, 10288191 ni, 10324367 ni, 10334137 ni, 10343070 ni, 10364 ni, 10433813 ni, 10436839 ni, 10458788 ni, 10474335 ni, 104838 ni, 104850 ni, 10494 ni, 10531 ni, 10621 ni, 10700345 ni, 107704 ni, 107751 ni, 107771 ni, 107778 ni, 107876 ni, 10814212 ni, 1102 ni, 11024923 ni, 1110 ni, 11167602 ni, 11242315 ni, 11285588 ni, 11285792 ni, 11294368 ni, 1130 ni, 11313622 ni, 11317348 ni, 11404337 ni, 11494412 ni, 11511120 ni, 11520894 ni, 115237 ni, 115358 ni, 115368 ni, 11538455 ni, 11556711 ni, 11560842 ni, 11570805 ni, 11582982 ni, 11609955 ni, 11617 ni, 11629084 ni, 11667893 ni, 11671467 ni, 11707110 ni, 118502708 ni, 11856170 ni, 11857239 ni, 118598754 ni, 119171 ni, 11977753 ni, 11980904 ni, 11980943 ni, 11982272 ni, 12004512 ni, 12035 ni, 120716 ni, 120734 ni, 121304016 ni, 121427831 ni, 121855 ni, 122019 ni, 122068 ni, 122262 ni, 122281 ni, 122672 ni, 122850 ni, 12315492 ni, 123630 ni, 123694 ni, 123976 ni, 124221649 ni, 12629 ni, 126456119 ni, 126961334 ni, 126961335 ni, 128861 ni, 129138801 ni, 12947 ni, 129626603 ni, 130313 ni, 130786 ni, 131411 ni, 131536 ni, 131801119 ni, 132010322 ni, 132991317 ni, 133065662 ni, 133337 ni, 134160274 ni, 134780 ni, 135398508 ni, 135398510 ni, 135398513 ni, 135398658 ni, 135398671 ni, 135398740 ni, 135398742 ni, 135398743 ni, 135398744 ni, 135398748 ni, 135403648 ni, 135403795 ni, 135403798 ni, 135403821 ni, 135410875 ni, 135413536 ni, 135438004 ni, 135449332 ni, 135464322 ni, 135499583 ni, 135533054 ni, 135539077 ni, 135545472 ni, 135564632 ni, 135564749 ni, 135565589 ni, 135565674 ni, 136828302 ni, 136859177 ni, 136902555 ni, 137566 ni, 13789 ni, 138911323 ni, 14106343 ni, 1432799 ni, 14427423 ni, 145996610 ni, 146026181 ni, 14779700 ni, 148124 ni, 148192 ni, 148195 ni, 14982 ni, 15103 ni, 151170 ni, 152946 ni, 153241 ni, 15385516 ni, 154234 ni, 154257 ni, 154573793 ni, 154584292 ni, 154584298 ni, 154699466 ni, 1548943 ni, 15604015 ni, 156391 ni, 15664 ni, 15689808 ni, 158781 ni, 160024 ni, 16038120 ni, 16041424 ni, 160478 ni, 16063245 ni, 16076883 ni, 16130295 ni, 16134395 ni, 16134627 ni, 16220172 ni, 16222096 ni, 16315 ni, 163311 ni, 16362 ni, 163829 ni, 163884 ni, 16590 ni, 166548 ni, 16678941 ni, 16719221 ni, 16720766 ni, 16722836 ni, 16747388 ni, 16760340 ni, 16779 ni, 168849 ni, 169870 ni, 176077 ni, 176155 ni, 176870 ni, 176873 ni, 177384 ni, 17748 ni, 17755052 ni, 179651 ni, 18283 ni, 184311 ni, 185465 ni, 185617 ni, 185954 ni, 189308 ni, 192 ni, 193962 ni, 19649 ni, 197020 ni, 197081 ni, 20345 ni, 2081089 ni, 2083 ni, 208917 ni, 21138 ni, 21159455 ni, 21233 ni, 213039 ni, 213046 ni, 2132 ni, 2132298 ni, 2145 ni, 21577376 ni, 2162 ni, 216239 ni, 216322 ni, 216326 ni, 21637732 ni, 2164 ni, 2165 ni, 21704 ni, 21722930 ni, 219025 ni, 219104 ni, 22227931 ni, 222528 ni, 2244 ni, 2247 ni, 22571 ni, 2267 ni, 2280 ni, 2287236 ni, 2327 ni, 2351 ni, 2353 ni, 23649154 ni, 23652732 ni, 23662274 ni, 2375 ni, 238053 ni, 23958169 ni, 24199313 ni, 24424 ni, 24748573 ni, 2475 ni, 24766 ni, 24769759 ni, 2477 ni, 24772860 ni, 24798764 ni, 24823 ni, 24826799 ni, 24847767 ni, 24861960 ni, 24873435 ni, 24963252 ni, 24964624 ni, 25033539 ni, 25062766 ni, 25126798 ni, 25141092 ni, 25151504 ni, 25154714 ni, 25167777 ni, 25183872 ni, 2519 ni, 25236288 ni, 25260757 ni, 25262792 ni, 25262965 ni, 253602 ni, 2541 ni, 2577 ni, 2585 ni, 26501160 ni, 2662 ni, 2663 ni, 2678 ni, 2683 ni, 26987 ni, 27126377 ni, 2723601 ni, 2724385 ni, 2726 ni, 2733484 ni, 2733525 ni, 2749 ni, 275196 ni, 2754 ni, 2764 ni, 2783 ni, 2794 ni, 2801 ni, 285033 ni, 287180 ni, 2950 ni, 3000237 ni, 3001497 ni, 3005573 ni, 3010818 ni, 3011897 ni, 30323 ni, 3033832 ni, 3034034 ni, 3035728 ni, 3038499 ni, 3062316 ni, 3081361 ni, 3084407 ni, 3085092 ni, 3086451 ni, 3086576 ni, 31101 ni, 3117 ni, 31202 ni, 3121 ni, 31256 ni, 31307 ni, 3163969 ni, 31703 ni, 3190778 ni, 3191 ni, 3194 ni, 3219 ni, 3220 ni, 32756 ni, 3286789 ni, 332427 ni, 3334 ni, 3343 ni, 33572 ni, 33887 ni, 3396 ni, 3440 ni, 3447 ni, 3469 ni, 3475 ni, 3488 ni, 3501 ni, 3559 ni, 35802 ni, 3598 ni, 3611 ni, 3634 ni, 36462 ni, 3663 ni, 36811 ni, 370 ni, 3715 ni, 37393 ni, 37542 ni, 3793 ni, 38258 ni, 387447 ni, 3883 ni, 3899 ni, 39186 ni, 392622 ni, 3948 ni, 3961 ni, 400769 ni, 4008 ni, 4030 ni, 40326 ni, 40486 ni, 4054 ni, 4055 ni, 40854 ni, 4091 ni, 410087 ni, 4124851 ni, 4168 ni, 41684 ni, 41774 ni, 4212 ni, 42601552 ni, 42608235 ni, 4286 ni, 4368136 ni, 4369270 ni, 438692 ni, 439501 ni, 439533 ni, 44093 ni, 440936 ni, 441145 ni, 441207 ni, 441243 ni, 441300 ni, 441401 ni, 44153669 ni, 44182295 ni, 44187362 ni, 44205240 ni, 44217246 ni, 442428 ni, 442439 ni, 44247568 ni, 44257178 ni, 442884 ni, 443654 ni, 443869 ni, 444485 ni, 44462760 ni, 44465558 ni, 44479007 ni, 444795 ni, 445154 ni, 445643 ni, 446006 ni, 44603531 ni, 44606238 ni, 44606239 ni, 446155 ni, 446157 ni, 446378 ni, 446541 ni, 447043 ni, 4477 ni, 447715 ni, 448108 ni, 449241 ni, 45100495 ni, 45110509 ni, 45137165 ni, 451415 ni, 451417 ni, 451658 ni, 452548 ni, 45375808 ni, 45375953 ni, 454217 ni, 45485025 ni, 454937 ni, 457193 ni, 4594 ni, 46215462 ni, 46220502 ni, 4628 ni, 464205 ni, 468595 ni, 46907787 ni, 46908905 ni, 46912230 ni, 46934000 ni, 46943415 ni, 471161 ni, 471426 ni, 4735 ni, 4775 ni, 479503 ni, 483477 ni, 4893 ni, 492405 ni, 493570 ni, 4971 ni, 49800004 ni, 49803313 ni, 49806720 ni, 49836020 ni, 49843508 ni, 49849508 ni, 500902 ni, 50248 ni, 5035 ni, 503737 ni, 503982 ni, 5083 ni, 50918847 ni, 51358113 ni, 515964 ni, 51634 ni, 525328 ni, 525330 ni, 525331 ni, 5271805 ni, 5273567 ni, 5276890 ni, 5277135 ni, 5280343 ni, 5280445 ni, 5280453 ni, 5280459 ni, 5280544 ni, 5280633 ni, 5280637 ni, 5280795 ni, 5280805 ni, 5280863 ni, 5280965 ni, 5281040 ni, 5281081 ni, 5281104 ni, 5281232 ni, 5281599 ni, 5281600 ni, 5281605 ni, 5281607 ni, 5281609 ni, 5281616 ni, 5281654 ni, 5281672 ni, 5281673 ni, 5281691 ni, 5281694 ni, 5281701 ni, 5281703 ni, 5281718 ni, 5281773 ni, 5281855 ni, 5281881 ni, 5282398 ni, 5282411 ni, 5282452 ni, 5282745 ni, 5283731 ni, 5283734 ni, 5283748 ni, 5284360 ni, 5284373 ni, 5284596 ni, 5284613 ni, 5284616 ni, 5288783 ni, 5291 ni, 52938427 ni, 52947239 ni, 5311054 ni, 5311180 ni, 5311181 ni, 5311497 ni, 5311498 ni, 5312125 ni, 5315 ni, 5315459 ni, 5315472 ni, 5316606 ni, 5318517 ni, 5318997 ni, 5320053 ni, 5320863 ni, 5324346 ni, 5328940 ni, 5329 ni, 5329102 ni, 5330286 ni, 5333 ni, 53340666 ni, 5335621 ni, 53361968 ni, 53477715 ni, 5352855 ni, 5352907 ni, 5352909 ni, 5353365 ni, 5361 ni, 5362119 ni, 5362391 ni, 5362440 ni, 5366552 ni, 5388906 ni, 5388925 ni, 5388962 ni, 5403 ni, 5426 ni, 54445 ni, 54454 ni, 5452 ni, 54575456 ni, 5458428 ni, 5462224 ni, 5467 ni, 54670067 ni, 54671008 ni, 54671203 ni, 54675776 ni, 54675777 ni, 54675779 ni, 54682461 ni, 54686904 ni, 54687 ni, 5469424 ni, 54708748 ni, 54713659 ni, 54726191 ni, 54732242 ni, 5475 ni, 5475158 ni, 5479530 ni, 5479537 ni, 5479539 ni, 5481224 ni, 5481663 ni, 5483 ni, 5494422 ni, 5503 ni, 5566 ni, 5574 ni, 5584 ni, 5625 ni, 56841801 ni, 56843850 ni, 56845155 ni, 5702160 ni, 5702162 ni, 5702220 ni, 57030 ni, 57389999 ni, 57412325 ni, 5743 ni, 5754 ni, 5755 ni, 57697 ni, 57976227 ni, 58029842 ni, 5816 ni, 5819 ni, 58298316 ni, 58406357 ni, 59472121 ni, 5959 ni, 6014 ni, 6032 ni, 6041 ni, 6047 ni, 60657 ni, 60734 ni, 60795 ni, 60823 ni, 60825 ni, 60855 ni, 60877 ni, 6099 ni, 61253 ni, 6133 ni, 6166 ni, 61926 ni, 6197 ni, 6239 ni, 62434 ni, 6293 ni, 6303 ni, 6321416 ni, 6321424 ni, 6321425 ni, 6324659 ni, 636405 ni, 637511 ni, 637517 ni, 637563 ni, 637760 ni, 638024 ni, 638678 ni, 6398761 ni, 64139 ni, 64142 ni, 6436173 ni, 6436223 ni, 6437380 ni, 6438353 ni, 6438825 ni, 644019 ni, 6440352 ni, 644076 ni, 6442177 ni, 644241 ni, 6444318 ni, 6451164 ni, 6476696 ni, 6483648 ni, 64927 ni, 64945 ni, 64971 ni, 64982 ni, 65028 ni, 6505803 ni, 65064 ni, 65329 ni, 6536 ni, 65380 ni, 65399 ni, 65452 ni, 65628 ni, 65636 ni, 656580 ni, 65663 ni, 656630 ni, 656656 ni, 656668 ni, 657144 ni, 657181 ni, 657237 ni, 65814 ni, 65863 ni, 65866 ni, 65947 ni, 6604200 ni, 6604915 ni, 66069 ni, 661498 ni, 667490 ni, 66828839 ni, 67315776 ni, 67356 ni, 6741 ni, 68165256 ni, 6839 ni, 6852141 ni, 68539 ni, 68591 ni, 68595 ni, 68827 ni, 68871 ni, 68933 ni, 6917864 ni, 6918155 ni, 6918289 ni, 6918296 ni, 6918328 ni, 6918456 ni, 6918554 ni, 6918606 ni, 6918638 ni, 6918736 ni, 6918837 ni, 7028 ni, 70945511 ni, 71301 ni, 71342 ni, 71420 ni, 71433 ni, 71481097 ni, 71481119 ni, 71481187 ni, 71492799 ni, 71496458 ni, 71522234 ni, 71576678 ni, 71692 ni, 71713800 ni, 71739 ni, 71751812 ni, 72081 ni, 72193633 ni, 72271 ni, 72276 ni, 72307 ni, 72376 ni, 72378 ni, 72394 ni, 72430 ni, 7304 ni, 73078 ni, 73296 ni, 73364 ni, 73568 ni, 73659186 ni, 7405 ni, 7439 ni, 74989 ni, 75552 ni, 76372196 ni, 7673 ni, 77050711 ni, 772 ni, 77254 ni, 78357788 ni, 820777 ni, 8223 ni, 8328 ni, 8378 ni, 865855 ni, 86763204 ni, 89594 ni, 896 ni, 89670174 ni, 89741632 ni, 90311989 ni, 91532 ni, 91610 ni, 92095 ni, 92097 ni, 92305 ni, 92727 ni, 932 ni, 948801 ni, 95168 ni, 95478 ni, 9552079 ni, 95779 ni, 9578507 ni, 9589606 ni, 9661141 ni, 969516 ni, 97489240 ni, 9794222 ni, 9808998 ni, 9817231 ni, 9820475 ni, 9821849 ni, 9826520 ni, 9826528 ni, 9827968 ni, 9829523 ni, 9831415 ni, 9846339 ni, 9853053 ni, 9853654 ni, 9853710 ni, 9854012 ni, 9854219 ni, 9855027 ni, 9870652 ni, 9876378 ni, 9884685 ni, 9890209 ni, 9912771 ni, 9914081 ni, 9915743 ni, 9918381 ni, 99315 ni, 9936746 ni, 9939865 ni, 9954082 ni, 9956222 ni, 9960285 ni, 9963057 ni, 9966051 ni, 9988405 ni

Genec back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Gene

Identified gene from an organism
has super-classes
has members
i d1 ni, i d10 ni, i d100 ni, i d1000 ni, i d1001 ni, i d1002 ni, i d1003 ni, i d1004 ni, i d1005 ni, i d1006 ni, i d1007 ni, i d1008 ni, i d1009 ni, i d101 ni, i d1010 ni, i d1011 ni, i d1012 ni, i d1013 ni, i d1014 ni, i d1015 ni, i d1016 ni, i d1017 ni, i d1018 ni, i d1019 ni, i d102 ni, i d1020 ni, i d1021 ni, i d1022 ni, i d1023 ni, i d1024 ni, i d1025 ni, i d1026 ni, i d1027 ni, i d1028 ni, i d1029 ni, i d103 ni, i d1030 ni, i d1031 ni, i d1032 ni, i d1033 ni, i d1034 ni, i d1035 ni, i d1036 ni, i d1037 ni, i d1038 ni, i d1039 ni, i d104 ni, i d1040 ni, i d1041 ni, i d1042 ni, i d1043 ni, i d1044 ni, i d1045 ni, i d1046 ni, i d1047 ni, i d1048 ni, i d1049 ni, i d105 ni, i d1050 ni, i d1051 ni, i d1052 ni, i d1053 ni, i d1054 ni, i d1055 ni, i d1056 ni, i d1057 ni, i d1058 ni, i d1059 ni, i d106 ni, i d1060 ni, i d1061 ni, i d1062 ni, i d1063 ni, i d1064 ni, i d1065 ni, i d1066 ni, i d1067 ni, i d1068 ni, i d1069 ni, i d107 ni, i d1070 ni, i d1071 ni, i d1072 ni, i d1073 ni, i d1074 ni, i d1075 ni, i d1076 ni, i d1077 ni, i d1078 ni, i d1079 ni, i d108 ni, i d1080 ni, i d1081 ni, i d1082 ni, i d1083 ni, i d1084 ni, i d1085 ni, i d1086 ni, i d1087 ni, i d1088 ni, i d1089 ni, i d109 ni, i d1090 ni, i d1091 ni, i d1092 ni, i d1093 ni, i d1094 ni, i d1095 ni, i d1096 ni, i d1097 ni, i d1098 ni, i d1099 ni, i d11 ni, i d110 ni, i d1100 ni, i d1101 ni, i d1102 ni, i d1103 ni, i d1104 ni, i d1105 ni, i d1106 ni, i d1107 ni, i d1108 ni, i d1109 ni, i d111 ni, i d1110 ni, i d1111 ni, i d1112 ni, i d1113 ni, i d1114 ni, i d1115 ni, i d1116 ni, i d1117 ni, i d1118 ni, i d1119 ni, i d112 ni, i d1120 ni, i d1121 ni, i d1122 ni, i d1123 ni, i d1124 ni, i d1125 ni, i d1126 ni, i d1127 ni, i d1128 ni, i d1129 ni, i d113 ni, i d1130 ni, i d1131 ni, i d1132 ni, i d1133 ni, i d1134 ni, i d1135 ni, i d1136 ni, i d1137 ni, i d1138 ni, i d1139 ni, i d114 ni, i d1140 ni, i d1141 ni, i d1142 ni, i d1143 ni, i d1144 ni, i d1145 ni, i d1146 ni, i d1147 ni, i d1148 ni, i d1149 ni, i d115 ni, i d1150 ni, i d1151 ni, i d1152 ni, i d1153 ni, i d1154 ni, i d1155 ni, i d1156 ni, i d1157 ni, i d1158 ni, i d1159 ni, i d116 ni, i d1160 ni, i d1161 ni, i d1162 ni, i d1163 ni, i d1164 ni, i d1165 ni, i d1166 ni, i d1167 ni, i d1168 ni, i d1169 ni, i d117 ni, i d1170 ni, i d1171 ni, i d1172 ni, i d1173 ni, i d1174 ni, i d1175 ni, i d1176 ni, i d1177 ni, i d1178 ni, i d1179 ni, i d118 ni, i d1180 ni, i d1181 ni, i d1182 ni, i d1183 ni, i d1184 ni, i d1185 ni, i d1186 ni, i d1187 ni, i d1188 ni, i d1189 ni, i d119 ni, i d1190 ni, i d1191 ni, i d1192 ni, i d1193 ni, i d1194 ni, i d1195 ni, i d1196 ni, i d1197 ni, i d1198 ni, i d1199 ni, i d12 ni, i d120 ni, i d121 ni, i d122 ni, i d123 ni, i d124 ni, i d125 ni, i d126 ni, i d127 ni, i d128 ni, i d129 ni, i d13 ni, i d130 ni, i d131 ni, i d132 ni, i d133 ni, i d134 ni, i d135 ni, i d136 ni, i d137 ni, i d138 ni, i d139 ni, i d14 ni, i d140 ni, i d141 ni, i d142 ni, i d143 ni, i d144 ni, i d145 ni, i d146 ni, i d147 ni, i d148 ni, i d149 ni, i d15 ni, i d150 ni, i d151 ni, i d152 ni, i d153 ni, i d154 ni, i d155 ni, i d156 ni, i d157 ni, i d158 ni, i d159 ni, i d16 ni, i d160 ni, i d161 ni, i d162 ni, i d163 ni, i d164 ni, i d165 ni, i d166 ni, i d167 ni, i d168 ni, i d169 ni, i d17 ni, i d170 ni, i d171 ni, i d172 ni, i d173 ni, i d174 ni, i d175 ni, i d176 ni, i d177 ni, i d178 ni, i d179 ni, i d18 ni, i d180 ni, i d181 ni, i d182 ni, i d183 ni, i d184 ni, i d185 ni, i d186 ni, i d187 ni, i d188 ni, i d189 ni, i d19 ni, i d190 ni, i d191 ni, i d192 ni, i d193 ni, i d194 ni, i d195 ni, i d196 ni, i d197 ni, i d198 ni, i d199 ni, i d2 ni, i d20 ni, i d200 ni, i d201 ni, i d202 ni, i d203 ni, i d204 ni, i d205 ni, i d206 ni, i d207 ni, i d208 ni, i d209 ni, i d21 ni, i d210 ni, i d211 ni, i d212 ni, i d213 ni, i d214 ni, i d215 ni, i d216 ni, i d217 ni, i d218 ni, i d219 ni, i d22 ni, i d220 ni, i d221 ni, i d222 ni, i d223 ni, i d224 ni, i d225 ni, i d226 ni, i d227 ni, i d228 ni, i d229 ni, i d23 ni, i d230 ni, i d231 ni, i d232 ni, i d233 ni, i d234 ni, i d235 ni, i d236 ni, i d237 ni, i d238 ni, i d239 ni, i d24 ni, i d240 ni, i d241 ni, i d242 ni, i d243 ni, i d244 ni, i d245 ni, i d246 ni, i d247 ni, i d248 ni, i d249 ni, i d25 ni, i d250 ni, i d251 ni, i d252 ni, i d253 ni, i d254 ni, i d255 ni, i d256 ni, i d257 ni, i d258 ni, i d259 ni, i d26 ni, i d260 ni, i d261 ni, i d262 ni, i d263 ni, i d264 ni, i d265 ni, i d266 ni, i d267 ni, i d268 ni, i d269 ni, i d27 ni, i d270 ni, i d271 ni, i d272 ni, i d273 ni, i d274 ni, i d275 ni, i d276 ni, i d277 ni, i d278 ni, i d279 ni, i d28 ni, i d280 ni, i d281 ni, i d282 ni, i d283 ni, i d284 ni, i d285 ni, i d286 ni, i d287 ni, i d288 ni, i d289 ni, i d29 ni, i d290 ni, i d291 ni, i d292 ni, i d293 ni, i d294 ni, i d295 ni, i d296 ni, i d297 ni, i d298 ni, i d299 ni, i d3 ni, i d30 ni, i d300 ni, i d301 ni, i d302 ni, i d303 ni, i d304 ni, i d305 ni, i d306 ni, i d307 ni, i d308 ni, i d309 ni, i d31 ni, i d310 ni, i d311 ni, i d312 ni, i d313 ni, i d314 ni, i d315 ni, i d316 ni, i d317 ni, i d318 ni, i d319 ni, i d32 ni, i d320 ni, i d321 ni, i d322 ni, i d323 ni, i d324 ni, i d325 ni, i d326 ni, i d327 ni, i d328 ni, i d329 ni, i d33 ni, i d330 ni, i d331 ni, i d332 ni, i d333 ni, i d334 ni, i d335 ni, i d336 ni, i d337 ni, i d338 ni, i d339 ni, i d34 ni, i d340 ni, i d341 ni, i d342 ni, i d343 ni, i d344 ni, i d345 ni, i d346 ni, i d347 ni, i d348 ni, i d349 ni, i d35 ni, i d350 ni, i d351 ni, i d352 ni, i d353 ni, i d354 ni, i d355 ni, i d356 ni, i d357 ni, i d358 ni, i d359 ni, i d36 ni, i d360 ni, i d361 ni, i d362 ni, i d363 ni, i d364 ni, i d365 ni, i d366 ni, i d367 ni, i d368 ni, i d369 ni, i d37 ni, i d370 ni, i d371 ni, i d372 ni, i d373 ni, i d374 ni, i d375 ni, i d376 ni, i d377 ni, i d378 ni, i d379 ni, i d38 ni, i d380 ni, i d381 ni, i d382 ni, i d383 ni, i d384 ni, i d385 ni, i d386 ni, i d387 ni, i d388 ni, i d389 ni, i d39 ni, i d390 ni, i d391 ni, i d392 ni, i d393 ni, i d394 ni, i d395 ni, i d396 ni, i d397 ni, i d398 ni, i d399 ni, i d4 ni, i d40 ni, i d400 ni, i d401 ni, i d402 ni, i d403 ni, i d404 ni, i d405 ni, i d406 ni, i d407 ni, i d408 ni, i d409 ni, i d41 ni, i d410 ni, i d411 ni, i d412 ni, i d413 ni, i d414 ni, i d415 ni, i d416 ni, i d417 ni, i d418 ni, i d419 ni, i d42 ni, i d420 ni, i d421 ni, i d422 ni, i d423 ni, i d424 ni, i d425 ni, i d426 ni, i d427 ni, i d428 ni, i d429 ni, i d43 ni, i d430 ni, i d431 ni, i d432 ni, i d433 ni, i d434 ni, i d435 ni, i d436 ni, i d437 ni, i d438 ni, i d439 ni, i d44 ni, i d440 ni, i d441 ni, i d442 ni, i d443 ni, i d444 ni, i d445 ni, i d446 ni, i d447 ni, i d448 ni, i d449 ni, i d45 ni, i d450 ni, i d451 ni, i d452 ni, i d453 ni, i d454 ni, i d455 ni, i d456 ni, i d457 ni, i d458 ni, i d459 ni, i d46 ni, i d460 ni, i d461 ni, i d462 ni, i d463 ni, i d464 ni, i d465 ni, i d466 ni, i d467 ni, i d468 ni, i d469 ni, i d47 ni, i d470 ni, i d471 ni, i d472 ni, i d473 ni, i d474 ni, i d475 ni, i d476 ni, i d477 ni, i d478 ni, i d479 ni, i d48 ni, i d480 ni, i d481 ni, i d482 ni, i d483 ni, i d484 ni, i d485 ni, i d486 ni, i d487 ni, i d488 ni, i d489 ni, i d49 ni, i d490 ni, i d491 ni, i d492 ni, i d493 ni, i d494 ni, i d495 ni, i d496 ni, i d497 ni, i d498 ni, i d499 ni, i d5 ni, i d50 ni, i d500 ni, i d501 ni, i d502 ni, i d503 ni, i d504 ni, i d505 ni, i d506 ni, i d507 ni, i d508 ni, i d509 ni, i d51 ni, i d510 ni, i d511 ni, i d512 ni, i d513 ni, i d514 ni, i d515 ni, i d516 ni, i d517 ni, i d518 ni, i d519 ni, i d52 ni, i d520 ni, i d521 ni, i d522 ni, i d523 ni, i d524 ni, i d525 ni, i d526 ni, i d527 ni, i d528 ni, i d529 ni, i d53 ni, i d530 ni, i d531 ni, i d532 ni, i d533 ni, i d534 ni, i d535 ni, i d536 ni, i d537 ni, i d538 ni, i d539 ni, i d54 ni, i d540 ni, i d541 ni, i d542 ni, i d543 ni, i d544 ni, i d545 ni, i d546 ni, i d547 ni, i d548 ni, i d549 ni, i d55 ni, i d550 ni, i d551 ni, i d552 ni, i d553 ni, i d554 ni, i d555 ni, i d556 ni, i d557 ni, i d558 ni, i d559 ni, i d56 ni, i d560 ni, i d561 ni, i d562 ni, i d563 ni, i d564 ni, i d565 ni, i d566 ni, i d567 ni, i d568 ni, i d569 ni, i d57 ni, i d570 ni, i d571 ni, i d572 ni, i d573 ni, i d574 ni, i d575 ni, i d576 ni, i d577 ni, i d578 ni, i d579 ni, i d58 ni, i d580 ni, i d581 ni, i d582 ni, i d583 ni, i d584 ni, i d585 ni, i d586 ni, i d587 ni, i d588 ni, i d589 ni, i d59 ni, i d590 ni, i d591 ni, i d592 ni, i d593 ni, i d594 ni, i d595 ni, i d596 ni, i d597 ni, i d598 ni, i d599 ni, i d6 ni, i d60 ni, i d600 ni, i d601 ni, i d602 ni, i d603 ni, i d604 ni, i d605 ni, i d606 ni, i d607 ni, i d608 ni, i d609 ni, i d61 ni, i d610 ni, i d611 ni, i d612 ni, i d613 ni, i d614 ni, i d615 ni, i d616 ni, i d617 ni, i d618 ni, i d619 ni, i d62 ni, i d620 ni, i d621 ni, i d622 ni, i d623 ni, i d624 ni, i d625 ni, i d626 ni, i d627 ni, i d628 ni, i d629 ni, i d63 ni, i d630 ni, i d631 ni, i d632 ni, i d633 ni, i d634 ni, i d635 ni, i d636 ni, i d637 ni, i d638 ni, i d639 ni, i d64 ni, i d640 ni, i d641 ni, i d642 ni, i d643 ni, i d644 ni, i d645 ni, i d646 ni, i d647 ni, i d648 ni, i d649 ni, i d65 ni, i d650 ni, i d651 ni, i d652 ni, i d653 ni, i d654 ni, i d655 ni, i d656 ni, i d657 ni, i d658 ni, i d659 ni, i d66 ni, i d660 ni, i d661 ni, i d662 ni, i d663 ni, i d664 ni, i d665 ni, i d666 ni, i d667 ni, i d668 ni, i d669 ni, i d67 ni, i d670 ni, i d671 ni, i d672 ni, i d673 ni, i d674 ni, i d675 ni, i d676 ni, i d677 ni, i d678 ni, i d679 ni, i d68 ni, i d680 ni, i d681 ni, i d682 ni, i d683 ni, i d684 ni, i d685 ni, i d686 ni, i d687 ni, i d688 ni, i d689 ni, i d69 ni, i d690 ni, i d691 ni, i d692 ni, i d693 ni, i d694 ni, i d695 ni, i d696 ni, i d697 ni, i d698 ni, i d699 ni, i d7 ni, i d70 ni, i d700 ni, i d701 ni, i d702 ni, i d703 ni, i d704 ni, i d705 ni, i d706 ni, i d707 ni, i d708 ni, i d709 ni, i d71 ni, i d710 ni, i d711 ni, i d712 ni, i d713 ni, i d714 ni, i d715 ni, i d716 ni, i d717 ni, i d718 ni, i d719 ni, i d72 ni, i d720 ni, i d721 ni, i d722 ni, i d723 ni, i d724 ni, i d725 ni, i d726 ni, i d727 ni, i d728 ni, i d729 ni, i d73 ni, i d730 ni, i d731 ni, i d732 ni, i d733 ni, i d734 ni, i d735 ni, i d736 ni, i d737 ni, i d738 ni, i d739 ni, i d74 ni, i d740 ni, i d741 ni, i d742 ni, i d743 ni, i d744 ni, i d745 ni, i d746 ni, i d747 ni, i d748 ni, i d749 ni, i d75 ni, i d750 ni, i d751 ni, i d752 ni, i d753 ni, i d754 ni, i d755 ni, i d756 ni, i d757 ni, i d758 ni, i d759 ni, i d76 ni, i d760 ni, i d761 ni, i d762 ni, i d763 ni, i d764 ni, i d765 ni, i d766 ni, i d767 ni, i d768 ni, i d769 ni, i d77 ni, i d770 ni, i d771 ni, i d772 ni, i d773 ni, i d774 ni, i d775 ni, i d776 ni, i d777 ni, i d778 ni, i d779 ni, i d78 ni, i d780 ni, i d781 ni, i d782 ni, i d783 ni, i d784 ni, i d785 ni, i d786 ni, i d787 ni, i d788 ni, i d789 ni, i d79 ni, i d790 ni, i d791 ni, i d792 ni, i d793 ni, i d794 ni, i d795 ni, i d796 ni, i d797 ni, i d798 ni, i d799 ni, i d8 ni, i d80 ni, i d800 ni, i d801 ni, i d802 ni, i d803 ni, i d804 ni, i d805 ni, i d806 ni, i d807 ni, i d808 ni, i d809 ni, i d81 ni, i d810 ni, i d811 ni, i d812 ni, i d813 ni, i d814 ni, i d815 ni, i d816 ni, i d817 ni, i d818 ni, i d819 ni, i d82 ni, i d820 ni, i d821 ni, i d822 ni, i d823 ni, i d824 ni, i d825 ni, i d826 ni, i d827 ni, i d828 ni, i d829 ni, i d83 ni, i d830 ni, i d831 ni, i d832 ni, i d833 ni, i d834 ni, i d835 ni, i d836 ni, i d837 ni, i d838 ni, i d839 ni, i d84 ni, i d840 ni, i d841 ni, i d842 ni, i d843 ni, i d844 ni, i d845 ni, i d846 ni, i d847 ni, i d848 ni, i d849 ni, i d85 ni, i d850 ni, i d851 ni, i d852 ni, i d853 ni, i d854 ni, i d855 ni, i d856 ni, i d857 ni, i d858 ni, i d859 ni, i d86 ni, i d860 ni, i d861 ni, i d862 ni, i d863 ni, i d864 ni, i d865 ni, i d866 ni, i d867 ni, i d868 ni, i d869 ni, i d87 ni, i d870 ni, i d871 ni, i d872 ni, i d873 ni, i d874 ni, i d875 ni, i d876 ni, i d877 ni, i d878 ni, i d879 ni, i d88 ni, i d880 ni, i d881 ni, i d882 ni, i d883 ni, i d884 ni, i d885 ni, i d886 ni, i d887 ni, i d888 ni, i d889 ni, i d89 ni, i d890 ni, i d891 ni, i d892 ni, i d893 ni, i d894 ni, i d895 ni, i d896 ni, i d897 ni, i d898 ni, i d899 ni, i d9 ni, i d90 ni, i d900 ni, i d901 ni, i d902 ni, i d903 ni, i d904 ni, i d905 ni, i d906 ni, i d907 ni, i d908 ni, i d909 ni, i d91 ni, i d910 ni, i d911 ni, i d912 ni, i d913 ni, i d914 ni, i d915 ni, i d916 ni, i d917 ni, i d918 ni, i d919 ni, i d92 ni, i d920 ni, i d921 ni, i d922 ni, i d923 ni, i d924 ni, i d925 ni, i d926 ni, i d927 ni, i d928 ni, i d929 ni, i d93 ni, i d930 ni, i d931 ni, i d932 ni, i d933 ni, i d934 ni, i d935 ni, i d936 ni, i d937 ni, i d938 ni, i d939 ni, i d94 ni, i d940 ni, i d941 ni, i d942 ni, i d943 ni, i d944 ni, i d945 ni, i d946 ni, i d947 ni, i d948 ni, i d949 ni, i d95 ni, i d950 ni, i d951 ni, i d952 ni, i d953 ni, i d954 ni, i d955 ni, i d956 ni, i d957 ni, i d958 ni, i d959 ni, i d96 ni, i d960 ni, i d961 ni, i d962 ni, i d963 ni, i d964 ni, i d965 ni, i d966 ni, i d967 ni, i d968 ni, i d969 ni, i d97 ni, i d970 ni, i d971 ni, i d972 ni, i d973 ni, i d974 ni, i d975 ni, i d976 ni, i d977 ni, i d978 ni, i d979 ni, i d98 ni, i d980 ni, i d981 ni, i d982 ni, i d983 ni, i d984 ni, i d985 ni, i d986 ni, i d987 ni, i d988 ni, i d989 ni, i d99 ni, i d990 ni, i d991 ni, i d992 ni, i d993 ni, i d994 ni, i d995 ni, i d996 ni, i d997 ni, i d998 ni, i d999 ni

Genomec back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Genome

Full genome (fasta format) from an organism
has super-classes
has members
o r g s i d1 ni

Organismc back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Organism

A living being identify and classify by experts
has super-classes
has sub-classes
Bacteria c, Virus c

Paperc back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Paper

A document of the corpus, subject of bio-annotations
has super-classes
Bibliographic resource c
has members
10.1101/2021.01.13.21249779 ni, 10.1101/2021.01.16.21249956 ni, 10.1101/2021.01.19.21250111 ni, 10.1101/2021.01.19.21250126 ni, 10.1101/2021.01.19.21250132 ni, 10.1101/2021.01.20.21249656 ni, 10.1101/2021.01.20.21249888 ni, 10.1101/2021.01.20.21249905 ni, 10.1101/2021.01.20.21250158 ni, 10.1101/2021.01.20.427043 ni, 10.1101/2021.01.20.427541 ni, 10.1101/2021.01.21.20228569 ni, 10.1101/2021.01.21.20240887 ni, 10.1101/2021.01.21.20245795 ni, 10.1101/2021.01.21.21249640 ni, 10.1101/2021.01.21.21250117 ni, 10.1101/2021.01.21.21250228 ni, 10.1101/2021.01.21.21250230 ni, 10.1101/2021.01.21.21250231 ni, 10.1101/2021.01.21.21250237 ni, 10.1101/2021.01.21.21250240 ni, 10.1101/2021.01.21.21250243 ni, 10.1101/2021.01.21.21250258 ni, 10.1101/2021.01.21.21250261 ni, 10.1101/2021.01.21.21250264 ni, 10.1101/2021.01.21.21250266 ni, 10.1101/2021.01.21.21250268 ni, 10.1101/2021.01.21.21250273 ni, 10.1101/2021.01.21.427574 ni, 10.1101/2021.01.21.427579 ni, 10.1101/2021.01.21.427657 ni, 10.1101/2021.01.21.427676 ni, 10.1101/2021.01.22.21250283 ni, 10.1101/2021.01.22.21250289 ni

Paragraphc back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Paragraph

One of a series of subsections each usually devoted to one idea and each usually marked by the beginning of a new line, indentation, increased interlinear space, etc.
has super-classes

Proteinc back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Protein

A protein is a biomolecule comprised of amino acid residues joined together by peptide bonds
has super-classes
has members
a0 a6 b9 w i k4 ni, a0 a6 c0 q e n3 ni, a0 a6 f8 z1 d7 ni, a0 a6 f8 z994 ni, a0 a6 g7 c r90 ni, a0 a6 g7 k r d9 ni, a0 a6 g7 k2 f6 ni, a0 a6 g7 k2 s5 ni, a0 a6 g7 k2 v2 ni, a0 a6 g9 k d h5 ni, a0 a6 g9 z x a5 ni, a0 a6 g9 z x30 ni, a0 a6 g9 z x45 ni, a0 a6 g9 z y b8 ni, a0 a6 h0 c2 p8 ni, a0 a6 h0 c4 h2 ni, a0 a6 h0 c4 k2 ni, a0 a6 h0 c4 m2 ni, a0 a6 h0 c4 z4 ni, a0 a6 h0 c5 f7 ni, a0 a6 h0 c5 k7 ni, a0 a6 h0 c5 l9 ni, a0 a6 h0 c599 ni, a0 a6 h0 c6 j2 ni, a0 a6 h0 c6 k8 ni, a0 a6 h0 c680 ni, a0 a6 h0 c761 ni, a0 a6 h0 j g71 ni, a0 a6 h0 j m c1 ni, a0 a6 h0 j m d6 ni, a0 a6 h0 j n e9 ni, a0 a6 h0 j n q1 ni, a0 a6 h0 j n75 ni, a0 a6 h0 j p42 ni, a0 a6 h0 m b y8 ni, a0 a6 h0 m9 z2 ni, a0 a6 h0 q t k2 ni, a0 a6 h0 q t90 ni, a0 a6 h0 q u b7 ni, a0 a6 h0 z2 d7 ni, a0 a6 h1 p h i9 ni, a0 a6 h1 p h s8 ni, a0 a6 h1 p i g6 ni, a0 a6 h1 p i k0 ni, a0 a6 h1 p i k7 ni, a0 a6 h1 p i q8 ni, a0 a6 h1 p j l6 ni, a0 a6 h1 p j v4 ni, a0 a6 h1 p j z2 ni, a0 a6 h1 p k i7 ni, a0 a6 h1 p k90 ni, a0 a6 h1 p l k8 ni, a0 a6 h1 p l x6 ni, a0 a6 h1 p l25 ni, a0 a6 h1 p m n4 ni, a0 a6 h1 p n56 ni, a0 a6 h1 p n84 ni, a0 a6 h1 p q x1 ni, a0 a6 h1 t f g9 ni, a0 a6 h1 t f j7 ni, a0 a6 h1 t f p8 ni, a0 a6 h1 t f95 ni, a0 a6 h1 t g t0 ni, a0 a6 h1 t h f0 ni, a0 a6 h1 t h n6 ni, a0 a6 h1 t h t0 ni, a0 a6 h1 t j r7 ni, a0 a6 h1 x l n4 ni, a0 a6 h1 x m00 ni, a0 a6 h1 x m98 ni, a0 a6 h1 x n d5 ni, a0 a6 h1 x n k2 ni, a0 a6 h1 x n u0 ni, a0 a6 h1 x n68 ni, a0 a6 h1 x p f6 ni, a0 a6 h1 x p s2 ni, a0 a6 h1 x p u5 ni, a0 a6 h1 x p76 ni, a0 a6 h1 z3 h4 ni, a0 a6 h1 z310 ni, a0 a6 h1 z4 x5 ni, a0 a6 h2 e f f6 ni, a0 a6 h2 e g i5 ni, a0 a6 h2 e g u7 ni, a0 a6 h2 e i u5 ni, a0 a6 h2 e i78 ni, a0 a6 h2 e j69 ni, a0 a6 h2 l a h8 ni, a0 a6 h2 l a32 ni, a0 a6 h2 l c t9 ni, a0 a6 h2 l c v8 ni, a0 a6 h2 l6 i0 ni, a0 a6 h2 l673 ni, a0 a6 h2 l683 ni, a0 a6 h2 l7 p8 ni, a0 a6 h2 l8 b6 ni, a0 a6 h2 l8 h9 ni, a0 a6 h2 l8 p2 ni, a0 a6 m3 v w l1 ni, a0 a6 m3 w m j8 ni, a0 a6 m3 w p v3 ni, a0 a6 m3 y r24 ni, a0 a6 m4 b b q0 ni, a0 a6 m4 e n n1 ni, a0 a6 m4 e r w7 ni, a0 a6 m4 m y i3 ni, a0 a6 m4 n d c2 ni, a0 a6 m4 n d y0 ni, a0 a6 m4 n f71 ni, a0 a6 m4 n h q1 ni, a0 a6 m4 n j80 ni, a0 a6 m4 n0 v5 ni, a0 a6 m4 n1 v1 ni, a0 a6 m4 n2 n5 ni, a0 a6 m4 n2 w7 ni, a0 a6 m4 n341 ni, a0 a6 m4 n6 s0 ni, a0 a6 m4 n9 b1 ni, a0 a6 m5 k a w5 ni, a0 a6 m5 s x n6 ni, a0 a6 m6 b8 z3 ni, a0 a6 m8 d p u6 ni, a0 a6 m8 d y w3 ni, a0 a6 m8 d z80 ni, a0 a6 m8 e x u6 ni, a0 a6 m8 f b13 ni, a0 a6 m8 f5 v8 ni, a0 a6 m8 w f v2 ni, a0 a6 m8 w m m2 ni, a0 a6 m9 q c d0 ni, a0 a6 m9 t u q1 ni, a0 a6 n0 v q l9 ni, a0 a6 n0 v r n9 ni, a0 a6 n0 v r35 ni, a0 a6 n0 v r93 ni, a0 a6 n0 v t90 ni, a0 a6 n0 v u j4 ni, a0 a6 n0 v u49 ni, a0 a6 n0 v w i0 ni, a0 a6 n0 v w p2 ni, a0 a6 n0 v y m0 ni, a0 a6 n0 v y77 ni, a0 a6 n0 w0 n5 ni, a0 a6 n1 n c j1 ni, a0 a6 n1 n r r0 ni, a0 a6 n1 n1 b1 ni, a0 a6 n1 q955 ni, a0 a6 n1 w i29 ni, a0 a6 n1 w j27 ni, a0 a6 n1 w n h3 ni

Treatmentc back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Treatment

Medical care given to a patient for an illness or injury.
has super-classes
has sub-classes
Drug c

Virusc back to ToC or Class ToC

IRI: https://w3id.org/def/COV#Virus

Microorganism composed of genetic material protected by a protein envelope, which causes various diseases by introducing itself as a parasite into a cell to reproduce in it.
has super-classes
Organism c
has members
o r g s i d1 ni

Object Properties

causedByop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#causedBy

A relation between a disease/disorder and the organism that causes it.

Containsop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#contains

A relatiion between a whole and one of its parts

has genomeop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#hasGenome

A relation between an organism and the full genome in FASTA format.

has proteinop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#hasProtein

A relation between an organism and the protein it has.

hasGeneop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#hasGene

A relation between an organism and the identified genes that it has.

isMencionedop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#isMencioned

A relation between something and the resource where is mencioned.

isTreatedWithop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#isTreatedWith

A relation between a Disease and the treatment use to treat it.

Mentionsop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#mentions

A relation between a text (a paper, a paragraph or a sentece) and one of the entities it speaks of

producedByop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#producedBy

A relation between an organism and the substance produced.

produceDisorderop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#produceDisorder

A relation between an organism and the disorder it produces.
has super-properties
top object property

transcribedToop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#transcribedTo

A relation between a gene and the protein it is transcribed to.

treatsDisorderop back to ToC or Object Property ToC

IRI: https://w3id.org/def/COV#treatsDisorder

A relation between a drug/treatment and the disorder/disease it treats.

Data Properties

has common namedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasCommonName

has range
string

hasAbstractdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasAbstract

Abstract from a paper
has range
string

hasCategorydp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasCategory

Category of a paper.
has range
string

hasFunctiondp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasFunction

Function of a drug.
has range
string

hasISOpointdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasISOpoint

The isoelectric point is the pH at which a polyampholyte has zero net charge.
has range
string

hasIUPACNamedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasIUPACName

IUPAC official name of a drug.
has range
string

hasLatestDatabaseUpdatedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasLatestDatabaseUpdate

Latest update of the database that contains the treatment.
has range
date time

hasLatestPublicationDatedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasLatestPublicationDate

Latest publication date of a treatment.
has range
date time

hasLenghtdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasLenght

Lenght of the protein in aas.
has range
int

hasLicensedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasLicense

License of the paper.
has range
string

hasMassdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasMass

Mass of a protein.
has range
int

hasMFdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasMF

Molecular formula of a substance.
has range
int

hasMWdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasMW

Molecular weight of some substance.
has range
int

hasNamedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasName

Name of some class (principal name).
has range
string

hasNumberOfAuthorsdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasNumberOfAuthors

Number of authors of a resource.
has range
int

hasNumberOfReferencesdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasNumberOfReferences

Number of references.
has range
int

hasRealeaseDatedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasRealeaseDate

Realease date of some class.
has range
date time

hasResearchPhasedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasResearchPhase

Research phase of a drug.
has range
date time

hasSequencedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasSequence

Secuence of aminoacids of a protein. (empty)
has range
string

hasSitedp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasSite

Site of publication of a resource.
has range
string

hasStatusdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasStatus

Status of a process (drug development in this case).
has range
string

hasTitledp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasTitle

Title of a resource.
has range
string

hasTypeOfPublicationdp back to ToC or Data Property ToC

IRI: https://w3id.org/def/COV#hasTypeOfPublication

Type of publication of a resource.
has range
string

Named Individuals

10.1101/2021.01.13.21249779ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.13.21249779

belongs to
Paper c
has facts
hasAbstract dp "Large-scale deployment of safe and durably effective vaccines can halt the COVID-19 pandemic. However, the high vaccine efficacy reported by ongoing phase 3 placebo-controlled clinical trials is based on a median follow-up time of only about two months and thus does not pertain to long-term efficacy. To evaluate the duration of protection while allowing trial participants timely access to efficacious vaccine, investigators can sequentially cross placebo recipients to the vaccine arm according to priority groups. Here, we show how to estimate potentially time-varying placebo-controlled vaccine efficacy in this type of staggered vaccination of placebo recipients. In addition, we compare the performance of blinded and unblinded crossover designs in estimating long-term vaccine efficacy."
hasCategory dp "infectious diseases"
hasLicense dp "cc_no"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.13.21249779"
hasNumberOfAuthors dp "3"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "medRxiv"
hasTitle dp "Evaluating the Long-Term Efficacy of COVID-19 Vaccines"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.16.21249956ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.16.21249956

belongs to
Paper c
has facts
hasAbstract dp "Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients with diagnosis of COVID-19. We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients with a diagnosis of SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. A total of 50 studies were retrieved from the databases. Four articles were finally included in the data extraction, qualitative and quantitative synthesis of results. The meta-analysis suggests that there is no benefit of convalescent plasma compared to standard care or placebo in the reduction of the overall mortality and in the ventilation requirement; but there could be a benefit for the clinical improvement in patients treated with plasma. We can conclude that the convalescent plasma transfusion cannot reduce the mortality or ventilation requirement in hospitalized patients diagnosed with SARS-CoV-2 infection. More controlled clinical trials conducted with methodologies that ensure a low risk of bias are still needed."
hasCategory dp "epidemiology"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.16.21249956"
hasNumberOfAuthors dp "5"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.19.21250111ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.19.21250111

belongs to
Paper c
has facts
hasAbstract dp "Background: Healthcare workers' (HCWs') travel-related anxiety needs to be assessed in light of the emergence of SARS-CoV-2 mutations. Methods: An online, cross-sectional questionnaire among HCWs between December 21, 2020 to January 7, 2021. The outcome variables were HCWs' knowledge and awareness of the SARS-CoV-2 B.1.1.7 lineage, and its associated travel worry and Generalized Anxiety Disorder (GAD-7) score. Results: A total of 1,058 HCWs completed the survey; 66.5% were female, 59.0% were nurses. 9.0% indicated they had been previously diagnosed with COVID-19 themselves. Regarding the B.1.1.7 lineage, almost all (97.3%) were aware of its emergence, 73.8% were aware that it is more infectious, 78.0% thought it causes more severe disease, and only 50.0% knew that current COVID-19 vaccines are effective in preventing it. Despite this, 66.7% of HCWs were not registered to receive the vaccine. HCWs' most common source of information about the new variant was social media platforms (67%), and this subgroup was significantly more worried about travelling. Nurses were more worried than physicians (P=0.001); additionally, those who had not travelled in the previous 3 months and those who had not received or registered for the COVID-19 vaccine were also significantly more worried (P = 0.037 and P < 0.001, respectively). Conclusions: Most HCWs were aware of the emergence of SARS-CoV-2 B.1.1.7 variant and expressed substantial travel worries. Increased worry levels were found among HCWs who used social media as their main source of information, those with lower levels of COVID-19 vaccine uptake, and those with higher GAD-7 scores. Utilization of official social media platforms could improve accurate information dissemination among HCWs regarding the pandemic's evolving mutations. Targeted vaccine campaigns are warranted to assure HCWs about the efficacy of COVID-19 vaccines toward SARS-CoV-2 variants."
hasCategory dp "infectious diseases"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.19.21250111"
hasNumberOfAuthors dp "18"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "medRxiv"
hasTitle dp "SARS-CoV-2 B.1.1.7 lineage-related perceptions and travel worry among healthcare workers"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.19.21250126ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.19.21250126

belongs to
Paper c
has facts
hasAbstract dp "Introduction: Coronavirus disease 2019 (COVID-19) has caused an unprecedented health crisis around the world, not least because of its heterogeneous clinical presentation and course. The new information on the pandemic emerging daily has made it challenging for healthcare workers (HCWs) to stay current with the latest knowledge, which could influence their attitudes and practices during patient care. Methods: This study is a follow-up evaluation of changes in HCWs' knowledge, attitudes, and practices as well as anxiety levels regarding COVID-19 since the beginning of the pandemic. Data were collected through an anonymous, predesigned, self-administered questionnaire that was sent online to HCWs in Saudi Arabia. Results: The questionnaire was sent to 1500 HCWs, with a 63.8% response rate (N=957). The majority of respondents were female (83%), and the most common age group was 31-40 years (52.2%). Nurses constituted 86.3% of the respondents. HCWs reported higher anxiety during the COVID-19 pandemic which increased from 4.91{+/-}2.84 to 8.6{+/-}2.27 on an 11-point Likert scale compared to other viral outbreaks. HCWs believed that their own preparedness as well as that of their hospital's intensive care unit (ICU) or emergency room (ER) was higher during the COVID-19 pandemic than during the Middle East respiratory syndrome coronavirus pandemic (2012-2015). About 58% of HCWs attended one or more simulations concerning the management of COVID-19 patients in their ICU/ER, and nearly all had undergone N95 mask fit testing. The mean score of HCWs' knowledge of COVID-19 was 9.89/12. For most respondents (94.6%), the perception of being at increased risk of infection was the main cause of anxiety related to COVID-19; the mean score of anxiety over COVID-19 increased from 4.91{+/-}2.84 before to 8.6{+/-}2.27 during the pandemic in Saudi Arabia. Conclusions: HCWs' anxiety levels regarding COVID-19 have increased since a pandemic was declared. It is vital that healthcare facilities provide more emotional and psychological support for all HCWs."
hasAbstract dp "IntroductionCoronavirus disease 2019 (COVID-19) has caused an unprecedented health crisis around the world, not least because of its heterogeneous clinical presentation and course. The new information on the pandemic emerging daily has made it challenging for healthcare workers (HCWs) to stay current with the latest knowledge, which could influence their attitudes and practices during patient care. MethodsThis study is a follow-up evaluation of changes in HCWs knowledge, attitudes, and practices as well as anxiety levels regarding COVID-19 since the beginning of the pandemic. Data were collected through an anonymous, predesigned, self-administered questionnaire that was sent online to HCWs in Saudi Arabia. ResultsThe questionnaire was sent to 1500 HCWs, with a 63.8% response rate (N=957). The majority of respondents were female (83%), and the most common age group was 31-40 years (52.2%). Nurses constituted 86.3% of the respondents. HCWs reported higher anxiety during the COVID-19 pandemic which increased from 4.91{+/-}2.84 to 8.6{+/-}2.27 on an 11-point Likert scale compared to other viral outbreaks. HCWs believed that their own preparedness as well as that of their hospitals intensive care unit (ICU) or emergency room (ER) was higher during the COVID-19 pandemic than during the Middle East respiratory syndrome coronavirus pandemic (2012-2015). About 58% of HCWs attended one or more simulations concerning the management of COVID-19 patients in their ICU/ER, and nearly all had undergone N95 mask fit testing. The mean score of HCWs knowledge of COVID-19 was 9.89/12. For most respondents (94.6%), the perception of being at increased risk of infection was the main cause of anxiety related to COVID-19; the mean score of anxiety over COVID-19 increased from 4.91{+/-}2.84 before to 8.6{+/-}2.27 during the pandemic in Saudi Arabia. ConclusionsHCWs anxiety levels regarding COVID-19 have increased since a pandemic was declared. It is vital that healthcare facilities provide more emotional and psychological support for all HCWs."
hasCategory dp "infectious diseases"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.19.21250126"
hasNumberOfAuthors dp "20"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "medRxiv"
hasTitle dp "Changes in healthcare workers' knowledge, attitudes, practices, and stress during the COVID-19 pandemic"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.19.21250132ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.19.21250132

belongs to
Paper c
has facts
hasAbstract dp "Using publicly available data, we quantify the impact of mask adherence and mask mandates on COVID-19 outcomes. We show that mask mandates are associated with a statistically significant decrease in daily new cases (-3.24 per 100K), deaths (-0.19 per 100K), and the proportion of hospital admissions (-2.47%) due to COVID-19 between February 1 and September 27, 2020. These effects are large, corresponding to 13% of the highest recorded number of cases, 20% of deaths, and 7% of admission proportion. We also find that mask mandates are linked to a 23.4 percentage point increase in mask adherence in four diverse states, and that mask adherence is associated with improved COVID-19 outcomes. Lastly, using a large novel survey in 68 countries, we find that community mask adherence and attitudes towards masks are associated with a reduction in COVID-19 cases and deaths. Our results have relevant policy implications, indicating the need to maintain and encourage mask-wearing."
hasCategory dp "epidemiology"
hasLicense dp "cc_no"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.19.21250132"
hasNumberOfAuthors dp "9"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "medRxiv"
hasTitle dp "Association between COVID-19 Outcomes and Mask Mandates, Adherence, and Attitudes"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.20.21249656ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.20.21249656

belongs to
Paper c
has facts
hasAbstract dp "Objectives: Accurate and reliable criteria to rapidly estimate the probability of infection with the novel coronavirus-2 that causes the severe acute respiratory syndrome (SARS-CoV-2) and associated disease (COVID-19) remain an urgent unmet need, especially in emergency care. The objective was to derive and validate a clinical prediction rule for SARS-CoV-2 infection that uses simple criteria widely available at the point of care. Methods: Data came from the Registry data from the national REgistry of suspected COVID-19 in EmeRgency care (RECOVER network) comprising 116 hospitals from 25 states in the US. Clinical predictors and 30-day outcomes were abstracted from medical records of 19,850 emergency department (ED) patients tested for SARS-CoV-2. The criterion standard for diagnosis of SARS-CoV-2 required a positive molecular test from a swabbed sample or positive antibody testing within 30 days. The prediction rule was derived from a 50% random sample (n=9,925) using unadjusted analysis of 107 candidate variables as a screening step, followed by stepwise forward logistic regression on 72 variables. Results: Multivariable regression yielded a 13-variable score, which was simplified to 13-point rule: +1 point each for age>50 years, measured temperature>37.5 degrees C, oxygen saturation<95%, Black race, Hispanic or Latino ethnicity, household contact with known or suspected COVID-19, patient reported history of dry cough, anosmia/dysgeusia, myalgias or fever; and -1 point each for White race, no direct contact with infected person, or smoking. In the validation sample (n=9,975), the score produced an area under the receiver operating character curve of 0.80 (95% CI: 0.79-0.81), and this level of accuracy was retained across patients enrolled from the early spring to summer of 2020. In the simplified rule, a score of zero produced a sensitivity of 95.6% (94.8-96.3%), specificity of 20.0% (19.0-21.0%), likelihood ratio negative of 0.22 (0.19-0.26). Increasing points on the simplified rule predicted higher probability of infection (e.g., >75% probability with +5 or more points). Conclusion: Criteria that are available at the point of care can accurately predict the probability of SARS-CoV-2 infection. These criteria could assist with decision about isolation and testing at high throughput checkpoints."
hasCategory dp "emergency medicine"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.20.21249656"
hasNumberOfAuthors dp "2"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Clinical prediction rule for SARS-CoV-2 infection from 116 U.S. emergency departments"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.20.21249888ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.20.21249888

belongs to
Paper c
has facts
hasAbstract dp "Background The coronavirus COVID-19 pandemic has radically compromised healthcare for people living with chronic conditions such as diabetes. Government-imposed restrictions to contain the spread of the virus has forced people to suddenly adjust their lifestyle. This study aimed to capture the impact of the pandemic on people living with diabetes and the views of these individuals on ways in which the information, advice and support they are receiving could be improved. Research design and methods An online anonymous survey was distributed across the UK during the first lockdown and initial easing. The survey comprised questions about confidence in diabetes self-management, resources used to obtain information, advice and support, and opinions on how these could be improved. Open-ended captured subjective experiences. Results The survey was completed by 773 adults living with diabetes (69.2% type 1, 28.5% type 2). There was notable variability in the impact of the pandemic on confidence in self-management, with confidence having deteriorated most commonly in the ability to take care of own mental wellbeing (37.0% respondents) and improved most commonly in maintaining a healthy weight (21.1% respondents). 41.2% of respondents living alone reported not receiving any outside support. The quality of information, advice and support received from the healthcare team was rated poorly by 37.2%. Respondents sought greater communication and tailored advice from their care team, clear and consistent information from the government and news channels, and improved understanding of diabetes and its challenges from their personal networks and employers. Conclusion Adjusting to the COVID-19 pandemic has strained the mental health and wellbeing of people living with diabetes. Diabetes care teams must receive assistance to support these individuals without risking further inequalities in access to healthcare. Equipping personal networks and employers with knowledge on diabetes and skills to support self-management may reduce the burden on the NHS."
hasCategory dp "health policy"
hasLicense dp "cc_by_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.20.21249888"
hasNumberOfAuthors dp "5"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Exploring support needs of people living with diabetes during the coronavirus COVID-19 pandemic: insights from a UK survey."
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.20.21249905ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.20.21249905

belongs to
Paper c
has facts
hasAbstract dp "Background: Colleges and universities across the United States are developing and implementing data-driven prevention and containment measures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Identifying risk factors for SARS-CoV-2 seropositivity could help to direct these efforts. Objective: To estimate the associations between demographic factors and social behaviors and SARS-CoV-2 seropositivity and self-reported positive SARS-CoV-2 diagnostic test. Methods: In September 2020, we randomly sampled Indiana University Bloomington (IUB) undergraduate students. Participants completed a cross-sectional, online survey about demographics, SARS-CoV-2 testing history, relationship status, and risk behaviors. Additionally, during a subsequent appointment, participants were tested for SARS-CoV-2 antibodies using a fingerstick procedure and SARS-CoV-2 IgM/IgG rapid assay kit. We used unadjusted modified Poisson regression models to evaluate the associations between predictors of both SARS-CoV-2 seropositivity and self-reported positive SARS-CoV-2 infection history. Results: Overall, 1,076 students were included in the serological testing analysis, and 1,239 students were included in the SARS-CoV-2 infection history analysis. Current seroprevalence of SARS-CoV-2 was 4.6% (95% CI: 3.3%, 5.8%). Prevalence of self-reported SARS-CoV-2 infection history was 10.3% (95% CI: 8.6%, 12.0%). Greek membership, having multiple romantic partners, knowing someone in one's immediate environment with SARS-CoV-2 infection, drinking alcohol more than 1 day per week, and hanging out with more than 4 people when drinking alcohol increased both the likelihood of seropositivity and SARS-CoV-2 infection history. Conclusion: Our findings have implications for American colleges and universities and could be used to inform SARS-C0V-2 prevention and control strategies on such campuses."
hasCategory dp "epidemiology"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.20.21249905"
hasNumberOfAuthors dp "8"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "A cross-sectional analysis of demographic and behavioral risk factors of SARS-CoV-2 antibody positivity among a sample of U.S. college students"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.20.21250158ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.20.21250158

belongs to
Paper c
has facts
hasAbstract dp "Background High prevalence of SARS-CoV-2 virus in many northern hemisphere populations is causing extreme pressure on healthcare services and leading to high numbers of fatalities. Even though safe and effective vaccines are being deployed in many populations, the majority of those most at-risk of severe COVID-19 will not be protected until late spring, even in countries already at a more advanced stage of vaccine deployment. Methods The REal-time Assessment of Community Transmission study-1 (REACT-1) obtains throat and nose swabs from between 120,000 and 180,000 people in the community in England at approximately monthly intervals. Round 8a of REACT-1 mainly covers a period from 6th January 2021 to 15th January 2021. Swabs are tested for SARS-CoV-2 virus and patterns of swab-positivity are described over time, space and with respect to individual characteristics. We compare swab-positivity prevalence from REACT-1 with mobility data based on the GPS locations of individuals using the Facebook mobile phone app. We also compare results from round 8a with those from round 7 in which swabs were collected from 13th November to 24th November (round 7a) and 25th November to 3rd December 2020 (round 7b). Results In round 8a, we found 1,962 positives from 142,909 swabs giving a weighted prevalence of 1.58% (95% CI, 1.49%, 1.68%). Using a constant growth model, we found no strong evidence for either growth or decay averaged across the period; rather, based on data from a limited number of days, prevalence may have started to rise at the end of round 8a. Facebook mobility data showed a marked decrease in activity at the end of December 2020, followed by a rise at the start of the working year in January 2021. Between round 7b and round 8a, prevalence increased in all adult age groups, more than doubling to 0.94% (0.83%, 1.07%) in those aged 65 and over. Large household size, living in a deprived neighbourhood, and Black and Asian ethnicity were all associated with increased prevalence. Both healthcare and care home workers, and other key workers, had increased odds of swab-positivity compared to other workers. Conclusion During the initial 10 days of the third COVID-19 lockdown in England in January 2021, prevalence of SARS-CoV-2 was very high with no evidence of decline. Until prevalence in the community is reduced substantially, health services will remain under extreme pressure and the cumulative number of lives lost during this pandemic will continue to increase rapidly."
hasCategory dp "infectious diseases"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.20.21250158"
hasNumberOfAuthors dp "15"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "REACT-1 round 8 interim report: SARS-CoV-2 prevalence during the initial stages of the third national lockdown in England"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.20.427043ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.20.427043

belongs to
Paper c
has facts
hasAbstract dp "As the COVID-19 pandemic persists, new SARS-CoV-2 variants with potentially dangerous features have been identified by the scientific community. Variant B.1.1.7 lineage clade GR from Global Initiative on Sharing All Influenza Data (GISAID) was first detected in the UK, and it appears to possess an increased transmissibility. At the same time, South African authorities reported variant B.1.351, that shares several mutations with B.1.1.7, and might also present high transmissibility. Even more recently, a variant labeled P.1 with 17 non-synonymous mutations was detected in Brazil. In such a situation, it is paramount to rapidly develop specific molecular tests to uniquely identify, contain, and study new variants. Using a completely automated pipeline built around deep learning techniques, we design primer sets specific to variant B.1.1.7, B.1.351, and P.1, respectively. Starting from sequences openly available in the GISAID repository, our pipeline was able to deliver the primer sets in just under 16 hours for each case study. In-silico tests show that the sequences in the primer sets present high accuracy and do not appear in samples from different viruses, nor in other coronaviruses or SARS-CoV-2 variants. The presented methodology can be exploited to swiftly obtain primer sets for each independent new variant, that can later be a part of a multiplexed approach for the initial diagnosis of COVID-19 patients. Furthermore, since our approach delivers primers able to differentiate between variants, it can be used as a second step of a diagnosis in cases already positive to COVID-19, to identify individuals carrying variants with potentially threatening features."
hasCategory dp "bioinformatics"
hasLicense dp "cc_by_nc"
hasLink dp "https://biorxiv.org/cgi/content/short/2021.01.20.427043"
hasNumberOfAuthors dp "7"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "bioRxiv"
hasTitle dp "Design of Specific Primer Sets for the Detection of B.1.1.7, B.1.351 and P.1 SARS-CoV-2 Variants using Deep Learning"
hasTypeOfPublication dp "new results"

10.1101/2021.01.20.427541ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.20.427541

belongs to
Paper c
has facts
hasAbstract dp "Cell lines are the mainstay in understanding the biology of COVID-19 infection, but do not recapitulate many of the complexities of human infection. The use of human lung tissue is one solution for the study of such novel respiratory pathogens. We hypothesized that a cryopreserved bank of human lung tissue allows for the in vitro study of the inter-individual heterogeneity of host response to SARS-CoV-2 infection, thus providing a bridge between studies with cell lines and studies in animal models. We generated a cryobank of tissues from 16 donors, most of whom had risk factors for severe illness from COVID-19. Cryopreserved tissues preserved 90% of cell viability and contained heterogeneous populations of metabolically active epithelial, endothelial, and immune cell subsets of the human lung. Samples were readily infectible with HCoV-OC43 and SARS-CoV-2 coronavirus strains, and demonstrated comparable susceptibility to infection. In contrast, we observed a marked donor-dependent heterogeneity in the expression of IL-6, CXCL8 and IFN{beta} in response to SARS-CoV-2 infection. Treatment of tissues with dexamethasone and the experimental drug, N-hydroxycytidine, suppressed viral growth in all samples, whereas chloroquine and remdesivir had no detectable effect. Metformin and sirolimus, molecules with predicted antiviral activity, suppressed viral replication in tissues from a subset of donors. In summary, we developed a novel system for the in vitro study of human SARS-CoV-2 infection using primary human lung tissue from a library of donor tissues. This model may be useful for drug screening and for understanding basic mechanisms of COVID-19 pathogenesis."
hasCategory dp "microbiology"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://biorxiv.org/cgi/content/short/2021.01.20.427541"
hasNumberOfAuthors dp "13"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "bioRxiv"
hasTitle dp "In vitro infection of human lung tissue with SARS-CoV-2: Heterogeneity in host defense and therapeutic response"
hasTypeOfPublication dp "new results"

10.1101/2021.01.21.20228569ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.20228569

belongs to
Paper c
has facts
hasAbstract dp "Objective With much of the public around the world depending on fabric face masks to protect themselves and others, it is essential to understand how the protective ability of fabric masks can be enhanced. This study evaluated the protection offered by eighteen fabric masks designs. In addition, it assessed the benefit of including three design features: insert filters, surgical mask underlayers, and nose wires. Methods Quantitative fit tests were conducted on different masks and with some additional design features. An array of fabric masks were tested on a single participant to account for variability in face shapes. The effects of insert filters, surgical mask underlayers and nose wires were also assessed. Results As expected, the fabric masks offered low degrees of protection; however, alterations in design showed significant increase in their protective ability. The most effective designs were multi-layered masks that fit tightly to the face and lacked dead space between the user and mask. Also, low air-resistance insert filters and surgical mask underlays provided the greatest increase in protection. Conclusions Our findings indicate substantial heterogeneity in the protection offered by various fabric face masks. We also note some design features which may enhance the protection these masks offer."
hasCategory dp "public and global health"
hasLicense dp "cc_by_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.20228569"
hasNumberOfAuthors dp "5"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Improving Fabric Face Masks: Impact of Design Features on the Protection Offered by Fabric Face Masks"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.20240887ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.20240887

belongs to
Paper c
has facts
hasAbstract dp "Objectives This study reports preliminary findings on the prevalence of, and factors associated with, mental health and wellbeing outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Methods Preliminary cross-sectional data were analysed from a cohort study (n=4,378). Clinical and non-clinical staff of three London-based NHS Trusts (UK), including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of probable common mental disorders (CMDs), measured by the General Health Questionnaire (GHQ-12). Secondary outcomes are probable anxiety (GAD-7), depression (PHQ-9), Post-Traumatic Stress Disorder (PTSD) (PCL-6), suicidal ideation (CIS-R), and alcohol use (AUDIT). Moral injury is measured using the Moray Injury Event Scale (MIES). Results Analyses showed substantial levels of CMDs (58.9%, 95%CI 58.1 to 60.8), and of PTSD (30.2%, 95%CI 28.1 to 32.5) with lower levels of depression (27.3%, 95%CI 25.3 to 29.4), anxiety (23.2%, 95%CI 21.3 to 25.3), and alcohol misuse (10.5%, 95%CI, 9.2 to 11.9). Women, younger staff, and nurses tended to have poorer outcomes than other staff, except for alcohol misuse. Higher reported exposure to moral injury (distress resulting from violation of one's moral code) was strongly associated with increased levels of CMDs, anxiety, depression, PTSD symptoms, and alcohol misuse. Conclusions Our findings suggest that mental health support for healthcare workers should consider those demographics and occupations at highest risk. Rigorous longitudinal data are needed in order to respond to the potential long-term mental health impacts of the pandemic."
hasCategory dp "psychiatry and clinical psychology"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.20240887"
hasNumberOfAuthors dp "30"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "The psychosocial impact of the COVID-19 pandemic on 4,378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic."
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.20245795ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.20245795

belongs to
Paper c
has facts
hasAbstract dp "Background: The COVID-19 pandemic has raised serious concerns about the mental health impact of people directed and indirectly affected by the virus. Because this is a rapidly evolving situation, our goal was to explore potential risk factors and trends in feelings of anxiety and depression among the general population in Canada over the first five months of the pandemic. Methods: We completed on-line surveys of 3,127 unique individuals representative of the Canadian general population at 4 discreet periods every 6 weeks from April 15th to July 28th 2020. We assessed feelings of anxiety, depression and loss of interest with the interRAI self-reported mood scale using a multivariable generalized estimating equation model to examine factors associated with having a 5+ score on the scale (indicating potentially depressed mood). We also investigated potential longitudinal trends to examine temporal changes in mood scores. Results: More than 30% of participants felt highly anxious, depressed, and disinterested in everyday activities in the first survey (April), but this number decreased to about 20% over 4 months. Feeling lonely, younger age, feeling overwhelmed by one's health needs, having financial concerns, and living outside of Quebec were significantly associated with depressed mood. Interpretation: The prevalence of depressed mood during the pandemic was between 2 and 3 times the pre-pandemic rate (especially among young people), but it can change rapidly in response to social changes. Thus, monitoring of psychological distress among vulnerable groups that may benefit from additional supports should be a priority."
hasCategory dp "epidemiology"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.20245795"
hasNumberOfAuthors dp "6"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Longitudinal trends and risk factors for depressed mood among Canadian adults during the first wave of COVID-19"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21249640ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21249640

belongs to
Paper c
has facts
hasAbstract dp "Objectives: Near-source tracking of SARS-CoV-2 RNA in the sewage drains serving particular buildings may allow rapid identification of SARS-CoV-2 infection cases or local outbreaks. In this pilot study, we investigated whether this was the case for nursing homes (NH). Methods: The study involved five NH (from A to E) affiliated to the Clinico-Malvarrosa Health Department, Valencia (Spain). These were nursing or mixed nursing/care homes of different sizes, altogether providing care for 472 residents attended by a staff of 309. Near-source sewage samples were screened for presence of SARS-CoV-2 RNA by RT-qPCR at least 5 days per week during the study period. SARS-CoV-2 RNA testing in nasopharyngeal swabs from residents and staff was performed with the TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, Massachusetts, USA). Results: SARS-CoV-2 RNA was detected in wastewater samples from four of the five NH. SARS-CoV-2 infection cases were documented in three of these four NH. Of the two NH without SARS-CoV-2 infection cases, no SARS-CoV-2 RNA was detected in sewer samples from one facility, while it was repeatedly detected in samples from the other. Presence of SARS-CoV-2 RNA in sewage preceded identification of isolated cases among residents or staff or outbreak declaration in two NH, with lag times ranging from 5 to 19 days. Conclusion: Our study demonstrated that intermittent or persistent detection of SARS-CoV-2 RNA in NH sewers can provide an early warning of subsequent individual cases or outbreaks in these facilities."
hasCategory dp "infectious diseases"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21249640"
hasNumberOfAuthors dp "11"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250117ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250117

belongs to
Paper c
has facts
hasAbstract dp "Objective: We investigated whether patterns of work during COVID-19 pandemic altered by effort to contain the outbreak affected anxiety and depression. Methods: We conducted a cross-sectional online survey of 911 residents of Philadelphia, inquiring about their working lives during early months of the epidemic, symptoms of anxiety and depression, plus demographics, perceived sources of support, and general health. Results: Occupational contact with suspected COVID-19 cases was associated with anxiety. Concerns about return to work, childcare, lack of sick leave, and loss/reduction in work correlated with anxiety and depression, even when there was no evidence of occupational contact with infected persons; patterns differed by gender. Conclusions: Heightened anxiety and depression during COVID-19 pandemic can be due to widespread disruption of working lives, especially in non-essential low-income industries, on par with experience in healthcare."
hasCategory dp "occupational and environmental health"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250117"
hasNumberOfAuthors dp "2"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Symptoms of anxiety and depression in relation to work patterns during the first wave of the COVID-19 epidemic in Philadelphia PA: a cross-sectional survey"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250228ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250228

belongs to
Paper c
has facts
hasAbstract dp "Purpose: To analyze potential COVID-19 epidemic outcomes in New York City under different SARS-CoV-2 virus circulation scenarios and vaccine rollout policies from early Jan 2021 to end of June 2021. Key findings: In anticipation of the potential arrival and dominance of the more infectious SARS-CoV-2 variant: 1) Mass-vaccination would be critical to mitigating epidemic severity (26-52% reduction in infections, hospitalizations, and deaths, compared to no vaccination, provided the new UK variant supplants currently circulating variants). 2) Prioritizing key risk groups for earlier vaccination would lead to greater reductions in hospitalizations and deaths than infections. Thus, in general this would be a good strategy. 3) Current vaccination prioritization policy is suboptimal. To avert more hospitalizations and deaths, mass-vaccination of all individuals 65 years or older should be done as soon as possible. For groups listed in the same phase, 65+ year-olds should be given first priority ahead of others. 4) Available vaccine doses should be given to the next priority groups as soon as possible without awaiting hesitant up-stream groups. 5) While efficacy of vaccination off-protocol is unknown, provided immune response following a first vaccine dose persists, delaying the 2nd vaccine dose by ~1 month (i.e. administer the two doses 8 weeks apart) can substantially reduce infections, hospitalizations, and deaths compared to the 3-week apart regimen. Across all scenarios tested here, delaying the 2nd vaccine dose leads to the largest reduction in severe epidemic outcomes (e.g. hospitalizations and deaths). Therefore, to protect as many people as possible, this strategy should be considered if rapid increases in infections, hospitalization or deaths and/or shortages in vaccines were to occur."
hasCategory dp "public and global health"
hasLicense dp "cc_no"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250228"
hasNumberOfAuthors dp "3"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Simulating the impact of different vaccination policies on the COVID-19 pandemic in New York City"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250230ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250230

belongs to
Paper c
has facts
hasAbstract dp "Background: A rapid influx of patients to intensive care and infection control measures during the COVID-19 pandemic required the rapid development of innovative redeployment and training strategies. Methods: We conducted a systematic search of 9 databases including key terms related to intensive care AND training AND redeployment AND healthcare workers. Analysis consisted of a narrative synthesis of quantitative study outputs, and a framework-based thematic analysis of qualitative study outputs and grey literature. These results were then combined applying an interpretative synthesis. Results: Twenty papers were analysed. These took place primarily in the UK (N=8, 40%) and USA (N=5, 25%). Themes included in the results are Redeployment: Implementation strategies and learnings; Redeployed staff experience and strategies to address their needs; Redeployed staff learning needs; Training formats offered and training evaluations; and Future redeployment and training concerns. Some of the redeployment implementation and training strategies documented in this review are: Skills-based redeployment, buddy support systems, and agreeing on locally-specific principles, rather than strict procedures. Conclusion: The COVID-19 pandemic presented unique challenges to deliver training promptly while following infection control recommendations and develop flexible redeployment strategies. This study synthesises original approaches to tackle these challenges which are relevant to inform the development of targeted and adaptative training and redeployment plans."
hasCategory dp "intensive care and critical care medicine"
hasLicense dp "cc_by"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250230"
hasNumberOfAuthors dp "6"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Redeployment and training of healthcare professionals to Intensive Care during COVID-19: a systemic review"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250231ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250231

belongs to
Paper c
has facts
hasAbstract dp "The COVID-19 disease, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is a very contagious disease that has killed many people around the world. According to the World Health Organization (WHO) data, the spread of the disease appears to be slower in Africa. Although a number of studies have been published on the relationship between meteorological parameters and COVID-19 transmission, the effects of climate conditions on COVID-19 remain largely unexplored and without consensus following the main research finding over Africa (often based on a single country or city). Here, using available epidemiological data over 275 days (i.e., from March 1 to November 30, 2020) taken from the European Center for Disease Prevention and Control of the European Union database and daily data of surface air temperature and humidity from the National Center for Environmental Prediction (NCEP), this paper investigates the potential contributions of climate conditions on COVID-19 transmission over 16 countries selected from three bioclimatic regions of Africa (i.e., Sahel, Maghreb and Gulf of Guinea). On average, our main findings highlight statistically significant inverse correlations between COVID-19 cases and temperature over the Maghreb and the Gulf of Guinea regions, whereas positive correlations are found in the Sahel, especially over the central part including Niger and Mali. Correlations with specific humidity and water vapor parameters display significant and positive values over the Sahelian and the Gulf of Guinean countries and negative values over the Maghreb countries. In other word, results imply that the COVID-19 pandemic transmission is influenced differently across the three bioclimatic regions: i) cold and dry environmental conditions over the Maghreb; ii) warm and humid conditions over the Sahel iii) cold and humid conditions over the Gulf of Guinea. These findings could be useful for decision-makers who plan public health and control measures in affected African countries and would have substantial implications for directing respiratory disease surveillance activities. Keywords: COVID-19 pandemic, Climate conditions, Health, West Africa, North Africa"
hasCategory dp "occupational and environmental health"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250231"
hasNumberOfAuthors dp "8"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Potential contribution of climate conditions on COVID-19 pandemic transmission over West and North African countries"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250237ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250237

belongs to
Paper c
has facts
hasAbstract dp "An agent-based infectious disease modeling tool (CovidSIMVL) is employed in this paper to explore outcomes associated with MRNA two-dose vaccination regimens set out in Emergency Use Authorization (EUA) documents submitted by Pfizer and Moderna to the US Department of Health & Human Services. As well, the paper explores outcomes associated with a third "Hybrid" policy that reflects ranges of expected levels of protection according to Pfizer and Moderna EUA's, but entails a 35 day separation between first and second dose, which exceeds the 21 days set out in Pfizer documentation or the 28 days in Moderna documentation. Four CovidSIMVL parameters are varied in the course of 75 simulated clinical trials. Two relate directly to the vaccines and their impacts (duration between doses; degree of expected protection conferred by different vaccines following first or second dose). Two relate to the simulation contexts to which the vaccines are applied (degree of infectivity; duration of infectivity). The simulated trials demonstrate expected effects for timing of second dose, and for degree of protection associated with first and second dose of Pfizer and Moderna vaccines, and the effects are consistent with an assumed value of 75% for degree of protection after first and second doses for the Hybrid vaccine. However, the simulated trials suggest a more complex interaction between expected level of protection following first dose, timing of second dose and degree of infectivity. These results suggest that policy options should not be considered independent of the transmission dynamics that are manifested in the contexts in which the policies could be applied. CovidSIMVL embodies stochasticity in the mechanisms that govern viral transmission, and it treats the basic reproduction number (R0)as an emergent characteristic of transmission dynamics, not as a pre-set value that determines those dynamics. As such, results reported in this paper reflect outcomes that could happen, but do not necessarily reflect what is more or less likely to happen, given different configurations of parameters. The discussion section goes into some measure of detail regarding next steps that could be pursued to enhance the potential for agent-based models such as CovidSIMVL to inform exploration of possible vaccination policies, and to project outcomes that are possible or likely in local contexts, where stochasticity and heterogeneity of transmission must be featured in models that are intended to reflect local realism."
hasCategory dp "epidemiology"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250237"
hasNumberOfAuthors dp "2"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Agent-Based Simulation of Covid-19 Vaccination Policies in CovidSIMVL"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250240ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250240

belongs to
Paper c
has facts
hasAbstract dp "Intervention strategies for minimizing indoor SARS-CoV-2 transmission are often based on anecdotal evidence because there is little evidence-based research to support them. We developed a spatially-explicit agent-based model for simulating indoor respiratory pathogen transmission, and used it to compare effects of four interventions on reducing individual-level SARS-CoV-2 transmission risk by simulating a well-known case study. We found that imposing movement restrictions and efficacious mask usage appear to have the greatest effects on reducing infection risk, but multiple concurrent interventions are required to minimize the proportion of susceptible individuals infected. Social distancing had little effect on reducing transmission if individuals move during the gathering. Furthermore, our results suggest that there is potential for ventilation airflow to expose susceptible people to aerosolized pathogens even if they are relatively far from infectious individuals. Maximizing rates of aerosol removal is the key to successful transmission-risk reduction when using ventilation systems as intervention tools."
hasCategory dp "infectious diseases"
hasLicense dp "cc_by_nc"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250240"
hasNumberOfAuthors dp "2"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Assessing the efficacy of interventions to control indoor SARS-Cov-2 transmission: an agent-based modeling approach"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250243ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250243

belongs to
Paper c
has facts
hasAbstract dp "Introduction: The impact of policies on COVID-19 outcomes is one of the most important questions of our time. Unfortunately, there are substantial concerns about the strength and quality of the literature examining policy impacts. This study systematically assessed the currently published COVID-19 policy impact literature for a checklist of study design elements and methodological issues. Methods: We included studies that were primarily designed to estimate the quantitative impact of one or more implemented COVID-19 policies on direct SARS-CoV-2 and COVID-19 outcomes. After searching PubMed for peer-reviewed articles published on November 26 or earlier and screening, all studies were reviewed by three reviewers independently and in consensus. The review tool was based on review guidance for assessing COVID-19 health policy impact evaluation analyses, including first identifying the assumptions behind the methods used, followed by assessing graphical display of outcomes data, functional form for the outcomes, timing between policy and impact, concurrent changes to the outcomes, and an overall rating. Results: After 102 articles were identified as potentially meeting inclusion criteria, we identified 36 published articles that evaluated the quantitative impact of COVID-19 policies on direct COVID-19 outcomes. The majority (n=23/36) of studies in our sample examined the impact of stay-at-home requirements. Nine studies were set aside due to inappropriate study design (n=8 pre/post; n=1 cross-section), and 27 articles were given a full consensus assessment. 20/27 met criteria for graphical display of data, 5/27 for functional form, 19/27 for timing between policy implementation and impact, and only 3/27 for concurrent changes to the outcomes. Only 1/27 studies passed all of the above checks, and 4/27 were rated as overall appropriate. Including the 9 studies set aside, we found that only four (or by a stricter standard, only one) of the 36 identified published and peer-reviewed health policy impact evaluation studies passed a set of key design checks for identifying the causal impact of policies on COVID-19 outcomes. Discussion: The current literature directly evaluating the impact of COVID-19 policies largely fails to meet key design criteria for useful inference. This may be partially due to the circumstances for evaluation being particularly difficult, as well as a context with desire for rapid publication, the importance of the topic, and weak peer review processes. Importantly, weak evidence is non-informative and does not indicate how effective these policies were on COVID-19 outcomes."
hasCategory dp "health policy"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250243"
hasNumberOfAuthors dp "24"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation (PEACHPIE): A systematic strength of methods review"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250258ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250258

belongs to
Paper c
has facts
hasAbstract dp "Observational studies of the effectiveness of vaccines to prevent COVID-19 are needed to inform real-world use. These are now in planning amid the ongoing rollout of SARS-CoV-2 vaccines globally. While traditional case-control (TCC) and test-negative design (TND) studies feature prominently among strategies used to assess vaccine effectiveness, such studies may encounter important threats to validity. Here we review the theoretical basis for estimation of vaccine direct effects under TCC and TND frameworks, addressing specific natural history parameters of SARS-CoV-2 infection and COVID-19 relevant to these designs. Bias may be introduced by misclassification of cases and controls, particularly when clinical case criteria include common, non-specific indicators of COVID-19. When using diagnostic assays with high analytical sensitivity for SARS-CoV-2 detection, individuals testing positive may be counted as cases even if their symptoms are due to other causes. The TCC may be particularly prone to confounding due to associations of vaccination with healthcare-seeking behavior or risk of infection. The TND reduces but may not eliminate this confounding, for instance if individuals who receive vaccination seek care or testing for less-severe infection. These circumstances indicate the two study designs cannot be applied naively to datasets gathered through public health surveillance or administrative sources. We suggest practical strategies to reduce bias in vaccine effectiveness estimates at the study design and analysis stages."
hasCategory dp "epidemiology"
hasLicense dp "cc_no"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250258"
hasNumberOfAuthors dp "9"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250261ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250261

belongs to
Paper c
has facts
hasAbstract dp "Objectives: Obtaining body temperature is a quick and easy method to screen for acute infection such as COVID-19. Currently, the predictive value of body temperature for acute infection is inhibited by failure to account for other readily available variables that affect temperature values. In this proof-of-concept study, we sought to improve COVID-19 pretest probability estimation by incorporating covariates known to be associated with body temperature, including patient age, sex, comorbidities, month, time of day. Methods: For patients discharged from an academic hospital emergency department after testing for COVID-19 in March and April of 2020, we abstracted clinical data. We reviewed physician documentation to retrospectively generate estimates of pretest probability for COVID-19. Using patient COVID-19 PCR test results as a gold standard, we compared AUCs of logistic regression models predicting COVID-19 positivity that used: 1) body temperature alone; 2) body temperature and pretest probability; 3) body temperature, pretest probability, and body temperature-relevant covariates. Calibration plots and bootstrap validation were used to assess predictive performance for model #3. Results: Data from 117 patients were included. The models AUCs were: 1) 0.69 2) 0.72, and 3) 0.76, respectively. The absolute difference in AUC was 0.029 (95%CI -0.057 to 0.114, p=0.25) between model 2 and 1 and 0.038 (95%CI -0.021 to 0.097, p=0.10) between model 3 and 2. Conclusions: By incorporating covariates known to affect body temperature, we demonstrated improved pretest probability estimates of acute COVID-19 infection. Future work should be undertaken to further develop and validate our model in a larger, multi-institutional sample."
hasCategory dp "emergency medicine"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250261"
hasNumberOfAuthors dp "7"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Using body temperature and variables commonly available in the EHR to predict acute infection: A proof-of-concept study showing improved pretest probability estimates for acute COVID-19 infection among discharged emergency department patients"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250264ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250264

belongs to
Paper c
has facts
hasAbstract dp "Objective: to determine the statistical relationship between reported deaths and infections in the UK coronavirus outbreak Design: Publicly available UK government data is used to determine a relationship between reported cases and deaths, taking into account various UK regions, age profiles and prevalence of the variant of concern (VOC) B.1.1.7. Main Outcome Measures: Establishing a simple statistical relationship between detected cases and subsequent mortality. Results: Throughout October and November 2020, deaths in England are well described as 1/55th of detected cases from 12 days previously. After that, the relationship no longer holds and deaths are significantly higher. This is especially true in regions affected by the VOC B.1.1.7 Conclusions: In early December, some new factor emerged to increase the case-fatality rate in the UK."
hasCategory dp "epidemiology"
hasLicense dp "cc_by_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250264"
hasNumberOfAuthors dp "2"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Abrupt increase in the UK coronavirus death-case ratio in December 2020"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250266ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250266

belongs to
Paper c
has facts
hasAbstract dp "Background Though SARS-CoV-2 outbreaks have been documented in occupational settings and though there is speculation that essential workers face heightened risks for COVID-19, occupational differences in excess mortality have, to date, not been examined. Such information could point to opportunities for intervention, such as workplace modifications and prioritization of vaccine distribution. Methods and findings Using death records from the California Department of Public Health, we estimated excess mortality among Californians 18--65 years of age by occupational sector and occupation, with additional stratification of the sector analysis by race/ethnicity. During the COVID-19 pandemic, working age adults experienced a 22% increase in mortality compared to historical periods. Relative excess mortality was highest in food/agriculture workers (39% increase), transportation/logistics workers (28% increase), facilities (27%) and manufacturing workers (23% increase). Latino Californians experienced a 36% increase in mortality, with a 59% increase among Latino food/agriculture workers. Black Californians experienced a 28% increase in mortality, with a 36% increase for Black retail workers. Asian Californians experienced an 18% increase, with a 40% increase among Asian healthcare workers. Excess mortality among White working-age Californians increased by 6%, with a 16% increase among White food/agriculture workers. Conclusions Certain occupational sectors have been associated with high excess mortality during the pandemic, particularly among racial and ethnic groups also disproportionately affected by COVID-19. In-person essential work is a likely venue of transmission of coronavirus infection and must be addressed through strict enforcement of health orders in workplace settings and protection of in-person workers. Vaccine distribution prioritizing in-person essential workers will be important for reducing excess COVID mortality."
hasCategory dp "occupational and environmental health"
hasLicense dp "cc_no"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250266"
hasNumberOfAuthors dp "8"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Excess mortality associated with the COVID-19 pandemic among Californians 18-65 years of age, by occupational sector and occupation: March through October 2020"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250268ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250268

belongs to
Paper c
has facts
hasAbstract dp "We introduce an explicit function that describes virus-load curves on a patient-specific level. This function is based on simple and intuitive model parameters. It allows virus load analysis without solving a full virus load dynamic model. We validate our model on data from influenza A as well as SARS-CoV-2 infection data for Macaque monkeys and humans. Further, we compare the virus load function to an established target model of virus dynamics, which shows an excellent fit. Our virus-load function offers a new way to analyse patient virus load data, and it can be used as input to higher level models for the physiological effects of a virus infection, for models of tissue damage, and to estimate patient risks."
hasCategory dp "infectious diseases"
hasLicense dp "cc_no"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250268"
hasNumberOfAuthors dp "3"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Personalized Virus Load Curves of SARS-CoV-2 Infection"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.21250273ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.21250273

belongs to
Paper c
has facts
hasAbstract dp "The Elliott Wave principle is a time-honored, oft-used method for predicting variations in the financial markets. It is based on the notion that human emotions drive financial decisions. In the fight against COVID-19, human emotions are similarly decisive, for instance in that they determine one's willingness to be vaccinated, and/or to follow preventive measures including the wearing of masks, the application of social distancing protocols, and frequent handwashing. On this basis, we postulated that the Elliott Wave Principle may similarly be used to predict the future evolution of the COVID-19 pandemic. We demonstrated that this method reproduces the data pattern especially well for USA (daily new cases). Potential scenarios were then extrapolated, from the best-case corresponding to a rapid, full vaccination of the population, to the utterly disastrous case of slow vaccination, and poor adherence to preventive protocols."
hasCategory dp "infectious diseases"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.21.21250273"
hasNumberOfAuthors dp "10"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Do Pandemics Obey the Elliott Wave Principle of Financial Markets?"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.21.427574ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.427574

belongs to
Paper c
has facts
hasAbstract dp "We present an updated version of our automated computational pipeline, Infection Pathogen Detector IPD 2.0 with a SARS-CoV-2 module, to perform genomic analysis to understand the pathogenesis and virulence of the virus. Analysing the currently available 208911 SARS-CoV2 genome sequences (as accessed on 28 Dec 2020), we generate an extensive database of sample-wise variants and clade annotation, which forms the core of the SARS-CoV-2 analysis module of the analysis pipeline. A comparative account of lineage specific mutations in the newer SARS-CoV-2 strains emerging in the UK, South Africa and Brazil along with data reported from India identify overlapping and lineages specific acquired mutations suggesting a repetitive convergent and adaptive evolution. Thus, persistence of pandemic may lead to emergence of newer regional strains with improved fitness. IPD 2.0 also adopts the recent dynamic clade nomenclature and shows improvement in accuracy of clade assignment, processing time and portability, to its predecessor and thus could be a vital tool to help facilitate genomic surveillance in a population to identify variants involved in breakthrough infections."
hasCategory dp "bioinformatics"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://biorxiv.org/cgi/content/short/2021.01.21.427574"
hasNumberOfAuthors dp "4"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "bioRxiv"
hasTitle dp "Evolving Insights from SARS-CoV-2 Genome from 200K COVID-19 Patients"
hasTypeOfPublication dp "new results"

10.1101/2021.01.21.427579ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.427579

belongs to
Paper c
has facts
hasAbstract dp "The evolutionary process of genetic recombination has the potential to rapidly change the properties of a viral pathogen, and its presence is a crucial factor to consider in the development of treatments and vaccines. It can also significantly affect the results of phylogenetic analyses and the inference of evolutionary rates. The detection of recombination from samples of sequencing data is a very challenging problem, and is further complicated for SARS-CoV-2 by its relatively slow accumulation of genetic diversity. The extent to which recombination is ongoing for SARS-CoV-2 is not yet resolved. To address this, we use a parsimony-based method to reconstruct possible genealogical histories for samples of SARS-CoV-2 sequences, which enables the analysis of recombination events that could have generated the data. We propose a framework for disentangling the effects of recurrent mutation from recombination in the history of a sample, and hence provide a way of estimating the probability that ongoing recombination is present. We apply this to samples of sequencing data collected in England and in South Africa, and find compelling evidence of ongoing recombination."
hasCategory dp "evolutionary biology"
hasLicense dp "cc_by_nc_nd"
hasLink dp "https://biorxiv.org/cgi/content/short/2021.01.21.427579"
hasNumberOfAuthors dp "3"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "bioRxiv"
hasTitle dp "Evidence of ongoing recombination in SARS-CoV-2 through genealogical reconstruction"
hasTypeOfPublication dp "new results"

10.1101/2021.01.21.427657ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.427657

belongs to
Paper c
has facts
hasAbstract dp "SARS-CoV-2 has caused a global pandemic, and has taken over 1.7 million lives as of mid-December, 2020. Although great progress has been made in the development of effective countermeasures, with several pharmaceutical companies approved or poised to deliver vaccines to market, there is still an unmet need of essential antiviral drugs with therapeutic impact for the treatment of moderate-to-severe COVID-19. Towards this goal, a high-throughput assay was used to screen SARS-CoV-2 nsp15 uracil-dependent endonuclease (endoU) function against 13 thousand compounds from drug and lead repurposing compound libraries. While over 80% of initial hit compounds were pan-assay inhibitory compounds, three hits were confirmed as nsp15 endoU inhibitors in the 1-20 uM range in vitro. Furthermore, Exebryl-1, a beta-amyloid anti-aggregation molecule for Alzheimers therapy, was shown to have antiviral activity between 10 to 66 uM, in VERO, Caco-2, and Calu-3 cells. Although the inhibitory concentrations determined for Exebryl-1 exceed those recommended for therapeutic intervention, our findings show great promise for further optimization of Exebryl-1 as an nsp15 endoU inhibitor and as a SARS-CoV-2 antiviral."
hasCategory dp "microbiology"
hasLicense dp "cc_by_nd"
hasLink dp "https://biorxiv.org/cgi/content/short/2021.01.21.427657"
hasNumberOfAuthors dp "18"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "bioRxiv"
hasTitle dp "High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity."
hasTypeOfPublication dp "new results"

10.1101/2021.01.21.427676ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.21.427676

belongs to
Paper c
has facts
hasAbstract dp "We introduce an explicit function that describes virus-load curves on a patient-specific level. This function is based on simple and intuitive model parameters. It allows virus load analysis without solving a full virus load dynamic model. We validate our model on data from influenza A as well as SARS-CoV-2 infection data for Macaque monkeys and humans. Further, we compare the virus load function to an established target model of virus dynamics, which shows an excellent fit. Our virus-load function offers a new way to analyse patient virus load data, and it can be used as input to higher level models for the physiological effects of a virus infection, for models of tissue damage, and to estimate patient risks."
hasCategory dp "physiology"
hasLicense dp "cc_no"
hasLink dp "https://biorxiv.org/cgi/content/short/2021.01.21.427676"
hasNumberOfAuthors dp "3"^^integer
hasRealeaseDate dp "44217"^^date time
hasSite dp "bioRxiv"
hasTitle dp "Personalized Virus Load Curves of SARS-CoV-2 Infection"
hasTypeOfPublication dp "new results"

10.1101/2021.01.22.21250283ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.22.21250283

belongs to
Paper c
has facts
hasAbstract dp "Background: Since the emergence of COVID-19, cases of excess mortality from all causes have been very few in Japan. Object: To evaluate COVID-19 effects precisely, we specifically examine deaths caused by pneumonia and examine excess mortality attributable to pneumonia in Japan. Method: We applied the NIID model to pneumonia deaths from 2005 up through August, 2020 for the whole of Japan. Introduction of routine pneumococcal vaccination for elderly people and revision in ICD10 were incorporated into the estimation model. Results: No excess mortality was found for 2020. However, negative excess mortality was observed as 178 in May, 314 in June, and 75 in July. Discussion and Conclusion: Significantly negative excess mortality might reflect precautions taken by people including wearing masks, washing hands with alcohol, and maintaining social distance. They reduced the infection risk not only of for COVID-19 but also of other infectious diseases causing pneumonia."
hasCategory dp "public and global health"
hasLicense dp "cc_no"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.22.21250283"
hasNumberOfAuthors dp "4"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Negative Excess Mortality in Pneumonia Death caused by COVID-19 in Japan"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10.1101/2021.01.22.21250289ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10.1101/2021.01.22.21250289

belongs to
Paper c
has facts
hasAbstract dp "Background: Identifying factors that can predict severe disease in patients needing hospitalization for COVID-19 is crucial for early recognition of patients at greatest risk. Objective: (1) Identify factors predicting intensive care unit (ICU) transfer and (2) develop a simple calculator for clinicians managing patients hospitalized with COVID-19. Methods: A total of 2,685 patients with laboratory-confirmed COVID-19 admitted to a large metropolitan health system in Georgia, USA between March and July 2020 were included in the study. Seventy-five percent of patients were included in the training dataset (admitted March 1 to July 10). Through multivariable logistic regression, we developed a prediction model (probability score) for ICU transfer. Then, we validated the model by estimating its performance accuracy (area under the curve [AUC]) using data from the remaining 25% of patients (admitted July 11 to July 31). Results: We included 2,014 and 671 patients in the training and validation datasets, respectively. Diabetes mellitus, coronary artery disease, chronic kidney disease, serum C-reactive protein, and serum lactate dehydrogenase were identified as significant risk factors for ICU transfer, and a prediction model was developed. The AUC was 0.752 for the training dataset and 0.769 for the validation dataset. We developed a free, web-based calculator to facilitate use of the prediction model (https://icucovid19.shinyapps.io/ICUCOVID19/). Conclusion: Our validated, simple, and accessible prediction model and web-based calculator for ICU transfer may be useful in assisting healthcare providers in identifying hospitalized patients with COVID-19, who are at high risk for clinical deterioration. Triage of such patients for early aggressive treatment can impact clinical outcomes for this potentially deadly disease."
hasCategory dp "intensive care and critical care medicine"
hasLicense dp "cc_no"
hasLink dp "https://medrxiv.org/cgi/content/short/2021.01.22.21250289"
hasNumberOfAuthors dp "5"^^integer
hasRealeaseDate dp "44218"^^date time
hasSite dp "medRxiv"
hasTitle dp "Development and validation of a predictive model for critical illness in adult patients requiring hospitalization for COVID-19"
hasTypeOfPublication dp "PUBLISHAHEADOFPRINT"

10027278ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10027278

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44094"^^date time
hasMF dp "C26H19F3N4O"
hasMW dp "400"^^integer
hasName dp "AR-12"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

10034073ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10034073

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C52H74Cl2O18"
hasMW dp "0"^^integer
hasName dp "Fidaxomicin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

100945367ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#100945367

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C43H34O22"
hasMW dp "700"^^integer
hasName dp "Thearubigin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10114ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10114

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44118"^^date time
hasMF dp "C30H46O4"
hasMW dp "700"^^integer
hasName dp "Glycyrrhetinic acid"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

10121883ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10121883

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44110"^^date time
hasMF dp "C30H38N2O5"
hasMW dp "600"^^integer
hasName dp "Ramipril benzyl ester"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

10129151ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10129151

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44076"^^date time
hasMF dp "C28H38FN5O6S"
hasMW dp "700"^^integer
hasName dp "P2,P3 Ketoamide derivative"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

10133ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10133

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43993"^^date time
hasMF dp "C24H40O4"
hasMW dp "600"^^integer
hasName dp "Chenodeoxycholic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

10150497ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10150497

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C5H13ClN4O2S2"
hasMW dp "900"^^integer
hasName dp "SAX-187"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

10168ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10168

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44199"^^date time
hasLatestPublicationDate dp "44114"^^date time
hasMF dp "C15H8O6"
hasMW dp "220"^^integer
hasName dp "Rhein"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

101700644ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#101700644

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43893"^^date time
hasMF dp "C96H139N27O13"
hasMW dp "300"^^integer
hasName dp "CP-11"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

10173277ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10173277

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44049"^^date time
hasMF dp "C23H26N6O2"
hasMW dp "500"^^integer
hasName dp "Apilimod"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

10177ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10177

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C16H10N2O2"
hasMW dp "260"^^integer
hasName dp "Indirubin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

1018ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#1018

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C6H5NO2"
hasMW dp "110"^^integer
hasName dp "2-picolinic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

10182969ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10182969

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C25H25N5O4"
hasMW dp "500"^^integer
hasName dp "Apixaban"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

101835682ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#101835682

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C24H20O10"
hasMW dp "400"^^integer
hasName dp "Edgeworoside C"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

101886302ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#101886302

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43993"^^date time
hasMF dp "C26H46O3"
hasMW dp "600"^^integer
hasName dp "BAR501"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

101886309ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#101886309

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43993"^^date time
hasMF dp "C25H44O3"
hasMW dp "600"^^integer
hasName dp "BAR502"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

102004710ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#102004710

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44029"^^date time
hasMF dp "C21H26N2O4"
hasMW dp "400"^^integer
hasName dp "18-Hydroxy-3-epi-alpha-yohimbine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10206ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10206

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44023"^^date time
hasMF dp "C37H38N2O6"
hasMW dp "700"^^integer
hasName dp "Cepharanthine"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

10207ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10207

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44070"^^date time
hasMF dp "C15H10O5"
hasMW dp "240"^^integer
hasName dp "Aloe-emodin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10219ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10219

belongs to
Drug c
has facts
has common name dp "EMETINE; Emetin; Cephaeline methyl ether"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S,3R,11bS)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoqui..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C29H40N2O4"
hasMW dp "480"^^integer
hasName dp "Emetine"
hasNumberOfReferences dp "5"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

102208345ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#102208345

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44117"^^date time
hasMF dp "C17H16O6"
hasMW dp "300"^^integer
hasName dp "Eryvarin M"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10250777ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10250777

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44125"^^date time
hasMF dp "C25H26O5"
hasMW dp "500"^^integer
hasName dp "Lupinifolin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10281ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10281

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C10H12O2"
hasMW dp "200"^^integer
hasName dp "Thymoquinone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10288191ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10288191

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C7H15BrF2N4O3"
hasMW dp "200"^^integer
hasName dp "Binimetinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

10324367ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10324367

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44143"^^date time
hasMF dp "C27H45N5O5"
hasMW dp "700"^^integer
hasName dp "Boceprevir"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

10334137ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10334137

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44001"^^date time
hasMF dp "C14H15N5S"
hasMW dp "370"^^integer
hasName dp "Dp44mT"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

10343070ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10343070

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C25H26O7"
hasMW dp "500"^^integer
hasName dp "Papyriflavonol A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10364ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10364

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44016"^^date time
hasMF dp "C10H14O"
hasMW dp "220"^^integer
hasName dp "Carvacrol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10433813ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10433813

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44126"^^date time
hasMF dp "C29H28N4O"
hasMW dp "600"^^integer
hasName dp "10-hydroxyusambarensine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10436839ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10436839

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C27H45IN2"
hasMW dp "600"^^integer
hasName dp "NH125"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

10458788ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10458788

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C25H28O11"
hasMW dp "500"^^integer
hasName dp "Vitexfolin A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10474335ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10474335

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C24H38N2O"
hasMW dp "600"^^integer
hasName dp "PB28"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

104838ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#104838

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44096"^^date time
hasMF dp "C12H17N3O4S"
hasMW dp "350"^^integer
hasName dp "Imipenem"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

104850ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#104850

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43974"^^date time
hasMF dp "C22H21Cl3N4O"
hasMW dp "800"^^integer
hasName dp "Rimonabant"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

10494ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10494

belongs to
Drug c
has facts
has common name dp "OLEANOLIC ACID; 508-02-1; Oleanic acid"
hasFunction dp "Antiviral"
hasIUPACName dp "(4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C30H48O3"
hasMW dp "456"^^integer
hasName dp "Oleanolic acid"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

10531ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10531

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C33H37N5O5"
hasMW dp "700"^^integer
hasName dp "Dihydroergotamine"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

10621ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10621

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44131"^^date time
hasMF dp "C28H34O15"
hasMW dp "600"^^integer
hasName dp "Hesperidin"
hasNumberOfReferences dp "6"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10700345ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10700345

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44070"^^date time
hasMF dp "C40H62O14"
hasMW dp "900"^^integer
hasName dp "Withanoside V"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

107704ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#107704

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C13H10N2O2"
hasMW dp "230"^^integer
hasName dp "beta-CCM"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

107751ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#107751

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44153"^^date time
hasMF dp "C21H23NO4S"
hasMW dp "500000"^^integer
hasName dp "Racecadotril"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

107771ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#107771

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C29H32ClN5O2"
hasMW dp "0"^^integer
hasName dp "Pyronaridine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

107778ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#107778

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C25H38O3"
hasMW dp "600"^^integer
hasName dp "Dexanabinol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

107876ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#107876

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44096"^^date time
hasMF dp "C30H26O13"
hasMW dp "500"^^integer
hasName dp "Procyanidin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

10814212ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#10814212

belongs to
Drug c
has facts
has common name dp "Gnetin D; 84870-53-1; 256415-38-0"
hasFunction dp "Antiviral"
hasIUPACName dp "4-[(2R,3R)-3-(3,5-dihydroxyphenyl)-6-hydroxy-4-[(E)-2-(4-hyd..."
hasLatestDatabaseUpdate dp "44174"^^date time
hasLatestPublicationDate dp "44166"^^date time
hasMF dp "C28H22O7"
hasMW dp "470"^^integer
hasName dp "Gnetin-D"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

1102ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#1102

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43936"^^date time
hasMF dp "C7H19N3"
hasMW dp "250"^^integer
hasName dp "Spermidine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

11024923ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11024923

belongs to
Drug c
has facts
has common name dp "Leporin A; 2,6,6abeta,7,8,9,10,10abeta-Octahydro-2-methoxy-10beta-methyl-4-phenyl-6beta-[(E)-1-propenyl]-1H-[2]benzopyrano[4,3-c]pyridin-1-one"
hasFunction dp "Antiviral"
hasIUPACName dp "(6S,6aR,10R,10aS)-2-methoxy-10-methyl-4-phenyl-6-[(E)-prop-1..."
hasLatestDatabaseUpdate dp "44174"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C23H27NO3"
hasMW dp "365"^^integer
hasName dp "Leporin A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

1110ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#1110

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44044"^^date time
hasMF dp "C4H6O4"
hasMW dp "90"^^integer
hasName dp "Succinic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

11167602ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11167602

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43909"^^date time
hasMF dp "C1H15ClF4N4O3"
hasMW dp "800"^^integer
hasName dp "Regorafenib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

11242315ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11242315

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44090"^^date time
hasMF dp "C10H12FN3O4"
hasMW dp "220"^^integer
hasName dp "RX-3117"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

11285588ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11285588

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43950"^^date time
hasMF dp "C35H46FN5O9S"
hasMW dp "800"^^integer
hasName dp "Danoprevir"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

11285792ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11285792

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44042"^^date time
hasMF dp "C41H52N4O4S"
hasMW dp "900"^^integer
hasName dp "Cenicriviroc"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

11294368ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11294368

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C28H38O6"
hasMW dp "600"^^integer
hasName dp "Withanolide A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

1130ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#1130

belongs to
Drug c
has facts
has common name dp "thiamine; thiamin; vitamin B1"
hasFunction dp "Antiviral"
hasIUPACName dp "2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-t..."
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C12H17N4OS+"
hasMW dp "265"^^integer
hasName dp "Thiamine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

11313622ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11313622

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C19H14N2O2S"
hasMW dp "400"^^integer
hasName dp "Tideglusib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

11317348ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11317348

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C24H18F3N3O4"
hasMW dp "400"^^integer
hasName dp "Ki8751"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

11404337ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11404337

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C20H19N3O"
hasMW dp "400"^^integer
hasName dp "Obatoclax"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

11494412ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11494412

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C23H19N3O2"
hasMW dp "400"^^integer
hasName dp "Tivantinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

11511120ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11511120

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44069"^^date time
hasMF dp "C24H25ClFN5O2"
hasMW dp "900"^^integer
hasName dp "Dacomitinib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

11520894ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11520894

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C53H84NO14P"
hasMW dp "200"^^integer
hasName dp "Deforolimus"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

115237ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#115237

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C23H27FN4O3"
hasMW dp "500"^^integer
hasName dp "Paliperidone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

115358ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#115358

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44024"^^date time
hasMF dp "C24H28F3N3O3"
hasMW dp "500"^^integer
hasName dp "Tafenoquine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

115368ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#115368

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C23H30N4O2S"
hasMW dp "600"^^integer
hasName dp "Perospirone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

11538455ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11538455

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C21H26N6O2"
hasMW dp "500"^^integer
hasName dp "Quisinostat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

11556711ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11556711

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44084"^^date time
hasMF dp "C40H57N5O7"
hasMW dp "900"^^integer
hasName dp "Carfilzomib"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

11560842ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11560842

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C23H31N7O"
hasMW dp "500"^^integer
hasName dp "Dutacatib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

11570805ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11570805

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C26H37FN6O6S2"
hasMW dp "700"^^integer
hasName dp "LY2228820"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

11582982ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11582982

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C21H34N4O4S"
hasMW dp "600"^^integer
hasName dp "ONO 5334"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

11609955ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11609955

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C16H19N3O4S"
hasMW dp "400"^^integer
hasName dp "Resminostat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

11617ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11617

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H10S"
hasMW dp "210"^^integer
hasName dp "Allyl sulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

11629084ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11629084

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C36H30O16"
hasMW dp "600"^^integer
hasName dp "Salvianolic acid b"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

11667893ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11667893

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C22H23N5O"
hasMW dp "500"^^integer
hasName dp "Motesanib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

11671467ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11671467

belongs to
Drug c
has facts
has common name dp "Fostamatinib; 901119-35-5; Fostamatinib (R788)"
hasFunction dp "Other treatment"
hasIUPACName dp "[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amin..."
hasLatestDatabaseUpdate dp "44205"^^date time
hasLatestPublicationDate dp "44189"^^date time
hasMF dp "C23H26FN6O9P"
hasMW dp "580"^^integer
hasName dp "Fostamatinib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

11707110ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11707110

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C26H23FIN5O4"
hasMW dp "400"^^integer
hasName dp "Trametinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

118502708ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#118502708

belongs to
Drug c
has facts
has common name dp "AZD0156; 1821428-35-6; AZD-0156"
hasFunction dp "Antiviral"
hasIUPACName dp "8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-(oxa..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C26H31N5O3"
hasMW dp "461"^^integer
hasName dp "AZD0156"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

11856170ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11856170

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C22H17F4N3O4"
hasMW dp "400"^^integer
hasName dp "Setileuton"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

11857239ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11857239

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44143"^^date time
hasMF dp "C36H61N5O7S"
hasMW dp "0"^^integer
hasName dp "Narlaprevir"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

118598754ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#118598754

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C17H20N6O2"
hasMW dp "400"^^integer
hasName dp "Tomivosertib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

119171ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#119171

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44129"^^date time
hasMF dp "C34H38N3O7P"
hasMW dp "700"^^integer
hasName dp "Efonidipine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

11977753ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11977753

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43930"^^date time
hasMF dp "C30H23N5O"
hasMW dp "500"^^integer
hasName dp "Dactolisib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

11980904ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11980904

belongs to
Drug c
has facts
has common name dp "Visudyne (TN); SCHEMBL6218; Verteporfin (JAN/USP/INN)"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[(23S,24R)-14-ethenyl-22,23-bis(methoxycarbonyl)-5-(3-meth..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44174"^^date time
hasMF dp "C82H84N8O16"
hasMW dp "1437"^^integer
hasName dp "Verteporfin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

11980943ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11980943

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C50H50N4O26"
hasMW dp "900"^^integer
hasName dp "Camellia sinensis extract"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

11982272ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#11982272

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44117"^^date time
hasMF dp "C25H22O10"
hasMW dp "400"^^integer
hasName dp "Silydianin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

12004512ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#12004512

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44120"^^date time
hasMF dp "C28H34O7"
hasMW dp "600"^^integer
hasName dp "Gedunin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

12035ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#12035

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44153"^^date time
hasMF dp "C5H9NO3S"
hasMW dp "200000"^^integer
hasName dp "N-acetylcysteine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

120716ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#120716

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44029"^^date time
hasMF dp "C21H26N2O3"
hasMW dp "400"^^integer
hasName dp "Alloyohimbine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

120734ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#120734

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C20H17NO6"
hasMW dp "400"^^integer
hasName dp "Adlumidine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

121304016ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#121304016

belongs to
Drug c
has facts
has common name dp "1809249-37-3; 3QKI37EEHE; GS 5734"
hasFunction dp "Antiviral"
hasIUPACName dp "2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f..."
hasLatestDatabaseUpdate dp "44175"^^date time
hasLatestPublicationDate dp "44174"^^date time
hasMF dp "C27H35N6O8P"
hasMW dp "602"^^integer
hasName dp "Remdesivir"
hasNumberOfReferences dp "54"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Approved by FDA"

121427831ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#121427831

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C42H45ClN8O7S"
hasMW dp "400"^^integer
hasName dp "DBET6"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

121855ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#121855

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44079"^^date time
hasMF dp "C19H35N3O4S"
hasMW dp "600"^^integer
hasName dp "Calpain inhibitor II"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

122019ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#122019

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "C21H23FN2O4"
hasMW dp "400"^^integer
hasName dp "Z-FA-FMK"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

122068ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#122068

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C18H18ClN3O"
hasMW dp "800"^^integer
hasName dp "Desethylamodiaquine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

122262ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#122262

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44137"^^date time
hasMF dp "C29H32Cl2N6"
hasMW dp "500"^^integer
hasName dp "Piperaquine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

122281ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#122281

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C24H32O9"
hasMW dp "500"^^integer
hasName dp "16-Glucuronide-estriol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

122672ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#122672

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44203"^^date time
hasLatestPublicationDate dp "44147"^^date time
hasMF dp "C14H18ClN3"
hasMW dp "760"^^integer
hasName dp "Bisdesethylchloroquine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

122850ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#122850

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C15H12O6"
hasMW dp "250"^^integer
hasName dp "Aromadendrin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

12315492ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#12315492

belongs to
Drug c
has facts
has common name dp "beta-Sesquiphellandrene; (-)-beta-Sesquiphellandrene; (-)-(6R,7S)-sesquiphellandrene"
hasFunction dp "Antiviral"
hasIUPACName dp "(3R)-3-[(2S)-6-methylhept-5-en-2-yl]-6-methylidenecyclohexen..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44162"^^date time
hasMF dp "C15H24"
hasMW dp "204"^^integer
hasName dp "(-)-beta-Sesquiphellandrene"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

123630ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#123630

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C10H12N4O5S"
hasMW dp "290"^^integer
hasName dp "Tazobactam"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

123694ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#123694

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C0H30N10O25P6"
hasMW dp "300"^^integer
hasName dp "Diadenosine hexaphosphate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

123976ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#123976

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44053"^^date time
hasMF dp "C27H46O2"
hasMW dp "700"^^integer
hasName dp "27-hydroxycholesterol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

124221649ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#124221649

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43893"^^date time
hasMF dp "C28H30F3N3O3"
hasMW dp "600"^^integer
hasName dp "CP-1"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

12629ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#12629

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C22H40O7"
hasMW dp "500"^^integer
hasName dp "Agaric acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

126456119ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#126456119

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "CH226N46O29S3"
hasMW dp "800"^^integer
hasName dp "Lactoferrin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

126961334ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#126961334

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C13H15FN2O"
hasMW dp "270"^^integer
hasName dp "AZ8838"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

126961335ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#126961335

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C30H27BrN4O3"
hasMW dp "500"^^integer
hasName dp "AZ3451"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

128861ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#128861

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44049"^^date time
hasMF dp "C15H11O6+"
hasMW dp "240"^^integer
hasName dp "Cyanidin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

129138801ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#129138801

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C28H29N3O5"
hasMW dp "500"^^integer
hasName dp "Zotatifin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

12947ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#12947

belongs to
Drug c
has facts
has common name dp "HYDROXYCHLOROQUINE SULFATE; 747-36-4; Hydroxychloroquine sulphate"
hasFunction dp "Antiviral"
hasIUPACName dp "2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44189"^^date time
hasMF dp "C18H28ClN3O5S"
hasMW dp "434"^^integer
hasName dp "Hydroxychloroquine sulfate"
hasNumberOfReferences dp "78"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

129626603ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#129626603

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43972"^^date time
hasMF dp "C28H27ClN4OS"
hasMW dp "100"^^integer
hasName dp "ROC-325"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

130313ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#130313

belongs to
Drug c
has facts
has common name dp "SULBACTAM; 68373-14-8; sulbactam acid"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C8H11NO5S"
hasMW dp "233"^^integer
hasName dp "Sulbactam"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

130786ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#130786

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C22H25Cl2N3"
hasMW dp "400"^^integer
hasName dp "SDZ-62-434"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

131411ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#131411

belongs to
Drug c
has facts
has common name dp "Arbidol; umifenovir; 131707-25-0"
hasFunction dp "Antiviral"
hasIUPACName dp "ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2..."
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44179"^^date time
hasMF dp "C22H25BrN2O3S"
hasMW dp "477"^^integer
hasName dp "Arbidol"
hasNumberOfReferences dp "15"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Recommended by China's NHC Guidelines"

131536ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#131536

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C25H36N3O9PS"
hasMW dp "600"^^integer
hasName dp "Fosamprenavir"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

131801119ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#131801119

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43946"^^date time
hasMF dp "C2H52N7O18P3S"
hasMW dp "800"^^integer
hasName dp "Biotin-16-dUTP"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

132010322ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#132010322

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C28H30FN3O4"
hasMW dp "600"^^integer
hasName dp "ABBV-744"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

132991317ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#132991317

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44144"^^date time
hasMF dp "C21H26N2O2"
hasMW dp "400"^^integer
hasName dp "Sophaline D"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

133065662ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#133065662

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44067"^^date time
hasMF dp "C8H97Cl2N9O33"
hasMW dp "700"^^integer
hasName dp "Teicoplanin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

133337ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#133337

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H8S2"
hasMW dp "300"^^integer
hasName dp "2-vinyl-4H-1,3-dithiine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

134160274ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#134160274

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44135"^^date time
hasMF dp "MF: C150H188N57O97P15"
hasMW dp "100"^^integer
hasName dp "BC 007"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

134780ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#134780

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C13H11N3O4"
hasMW dp "240"^^integer
hasName dp "Pomalidomide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135398508ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398508

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44066"^^date time
hasMF dp "C12H15N5O3"
hasMW dp "280"^^integer
hasName dp "Entecavir"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

135398510ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398510

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C21H21FN6O"
hasMW dp "400"^^integer
hasName dp "Dovitinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

135398513ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398513

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43863"^^date time
hasMF dp "C8H11N5O3"
hasMW dp "200"^^integer
hasName dp "Acyclovir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135398658ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398658

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44098"^^date time
hasMF dp "C19H19N7O6"
hasMW dp "400"^^integer
hasName dp "Folic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

135398671ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398671

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44084"^^date time
hasMF dp "C25H43N13O10"
hasMW dp "700"^^integer
hasName dp "Viomycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135398740ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398740

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C9H13N5O4"
hasMW dp "230"^^integer
hasName dp "Ganciclovir"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

135398742ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398742

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C13H20N6O4"
hasMW dp "340"^^integer
hasName dp "Valaciclovir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135398743ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398743

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C46H62N4O11"
hasMW dp "0"^^integer
hasName dp "Rifabutin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135398744ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398744

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44095"^^date time
hasMF dp "C22H30N6O4S"
hasMW dp "600"^^integer
hasName dp "Sildenafil"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135398748ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135398748

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43865"^^date time
hasMF dp "C10H15N5O3"
hasMW dp "260"^^integer
hasName dp "Penciclovir"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

135403648ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135403648

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44063"^^date time
hasMF dp "C20H23N7O7"
hasMW dp "400"^^integer
hasName dp "Leucovorin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135403795ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135403795

belongs to
Drug c
has facts
has common name dp "Theaflavin 3,3'-digallate; 30462-35-2; CHEMBL434864"
hasFunction dp "Antiviral"
hasIUPACName dp "[(2R,3R)-2-[1-[(2R,3R)-5,7-dihydroxy-3-(3,4,5-trihydroxybenz..."
hasLatestDatabaseUpdate dp "44181"^^date time
hasLatestPublicationDate dp "44158"^^date time
hasMF dp "C43H32O20"
hasMW dp "868"^^integer
hasName dp "Theaflavin 3,3'-digallate"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

135403798ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135403798

belongs to
Drug c
has facts
has common name dp "Theaflavin; Theaflavine; 4670-05-7"
hasFunction dp "Antiviral"
hasIUPACName dp "3,4,6-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydr..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44174"^^date time
hasMF dp "C29H24O12"
hasMW dp "564"^^integer
hasName dp "Theaflavin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

135403821ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135403821

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C47H64N4O12"
hasMW dp "0"^^integer
hasName dp "Rifapentine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135410875ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135410875

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C20H21N5O6"
hasMW dp "400"^^integer
hasName dp "Pemetrexed"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135413536ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135413536

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C23H21F7N4O3"
hasMW dp "400"^^integer
hasName dp "Aprepitant"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

135438004ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135438004

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43893"^^date time
hasMF dp "C44H34N6+2"
hasMW dp "800"^^integer
hasName dp "CP-4"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

135449332ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135449332

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C25H22N4O4"
hasMW dp "500"^^integer
hasName dp "Eltrombopag"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

135464322ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135464322

belongs to
Drug c
has facts
has common name dp "futalosine; 210644-32-9; 3-{3-[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-2-yl]propanoyl}benzoic acid"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[3-[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxo..."
hasLatestDatabaseUpdate dp "44212"^^date time
hasLatestPublicationDate dp "44204"^^date time
hasMF dp "C19H18N4O7"
hasMW dp "414"^^integer
hasName dp "Futalosine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

135499583ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135499583

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43946"^^date time
hasMF dp "C11H16N5O11P3"
hasMW dp "190"^^integer
hasName dp "Carbovir triphosphate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

135533054ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135533054

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44063"^^date time
hasMF dp "C18H14N2O4"
hasMW dp "300"^^integer
hasName dp "Dynasore"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

135539077ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135539077

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C26H31N3O5"
hasMW dp "500"^^integer
hasName dp "Luminespib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

135545472ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135545472

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44044"^^date time
hasMF dp "C32H18N4O2"
hasMW dp "500"^^integer
hasName dp "Bisindigotin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

135564632ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135564632

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C14H12ClN3O2"
hasMW dp "710"^^integer
hasName dp "XL413"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

135564749ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135564749

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C20H22N2O5"
hasMW dp "400"^^integer
hasName dp "RVX-208"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

135565589ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135565589

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43889"^^date time
hasMF dp "C25H35N6O9PS"
hasMW dp "600"^^integer
hasName dp "IDX-184"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

135565674ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#135565674

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C34H41N7O5"
hasMW dp "700"^^integer
hasName dp "Dabigatran etexilate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

136828302ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#136828302

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44076"^^date time
hasMF dp "C18H18N2O2"
hasMW dp "300"^^integer
hasName dp "Nigellidine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

136859177ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#136859177

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43893"^^date time
hasMF dp "C21H25N5O3"
hasMW dp "500"^^integer
hasName dp "CP-2"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

136902555ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#136902555

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C25H21F2N3O5"
hasMW dp "400"^^integer
hasName dp "ZINC218242102"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

137566ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#137566

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43954"^^date time
hasMF dp "C7H7NO3"
hasMW dp "140"^^integer
hasName dp "4A3"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

13789ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#13789

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44085"^^date time
hasMF dp "C22H28O3"
hasMW dp "500"^^integer
hasName dp "Canrenone"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - clinical evidence"

138911323ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#138911323

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43893"^^date time
hasMF dp "C44H49N13O7"
hasMW dp "900"^^integer
hasName dp "CP-10"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

14106343ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#14106343

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44070"^^date time
hasMF dp "C36H36N2O7"
hasMW dp "700"^^integer
hasName dp "Somniferine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

1432799ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#1432799

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C22H19N5O2S"
hasMW dp "500"^^integer
hasName dp "Compound 10"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

14427423ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#14427423

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44057"^^date time
hasMF dp "C20H20O7"
hasMW dp "400"^^integer
hasName dp "Noricaritin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

145996610ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#145996610

belongs to
Drug c
has facts
has common name dp "EIDD 2801; EIDD-2801; EIDD2801"
hasFunction dp "Antiviral"
hasIUPACName dp "[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimi..."
hasLatestDatabaseUpdate dp "44174"^^date time
hasLatestPublicationDate dp "44168"^^date time
hasMF dp "C13H19N3O7"
hasMW dp "329"^^integer
hasName dp "EIDD-2801"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

146026181ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#146026181

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C31H39N5O7"
hasMW dp "700"^^integer
hasName dp "SARS-CoV-2-IN-1"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

14779700ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#14779700

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44057"^^date time
hasMF dp "C21H34O5"
hasMW dp "500"^^integer
hasName dp "[1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-yl] acetate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

148124ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#148124

belongs to
Drug c
has facts
has common name dp "docetaxel; Taxotere; 114977-28-5"
hasFunction dp "Antiviral"
hasIUPACName dp "[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydro..."
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44165"^^date time
hasMF dp "C43H53NO14"
hasMW dp "807"^^integer
hasName dp "Docetaxel"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

148192ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#148192

belongs to
Drug c
has facts
has common name dp "Atazanavir; 198904-31-3; Latazanavir"
hasFunction dp "Antiviral"
hasIUPACName dp "methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxyca..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C38H52N6O7"
hasMW dp "704"^^integer
hasName dp "Atazanavir"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

148195ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#148195

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "CH31Br2ClN4O2"
hasMW dp "800"^^integer
hasName dp "Lonafarnib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

14982ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#14982

belongs to
Drug c
has facts
has common name dp "Glycyrrhizic acid; glycyrrhizin; Glycyrrhizinic acid"
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS..."
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43982"^^date time
hasLatestPublicationDate dp "44174"^^date time
hasMF dp "C42H62O16"
hasMW dp "822"^^integer
hasMW dp "900"^^integer
hasName dp "Glycyrrhizic acid"
hasName dp "Glycyrrhizin"
hasNumberOfReferences dp "1"^^integer
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

15103ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#15103

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44044"^^date time
hasMF dp "C5H11NO2Se"
hasMW dp "120"^^integer
hasName dp "Selenomethionine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

151170ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#151170

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C20H25NO4"
hasMW dp "400"^^integer
hasName dp "Cilomilast"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

152946ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#152946

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43987"^^date time
hasMF dp "C21H24FN3O4"
hasMW dp "400"^^integer
hasName dp "Moxifloxacin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

153241ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#153241

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43930"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C23H24N4O6"
hasMW dp "500"^^integer
hasName dp "Merimepodib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"
hasStatus dp "Potential treatment - theoretical effect"

15385516ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#15385516

belongs to
Drug c
has facts
has common name dp "Arjunic acid; 31298-06-3; (1S,4aR,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid"
hasFunction dp "Antiviral"
hasIUPACName dp "(1S,4aR,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-1,10,11-trihydrox..."
hasLatestDatabaseUpdate dp "44210"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C30H48O5"
hasMW dp "488"^^integer
hasName dp "Arjunic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

154234ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#154234

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C15H28N4O4"
hasMW dp "410"^^integer
hasName dp "Peramivir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

154257ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#154257

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C30H34N2O3"
hasMW dp "600"^^integer
hasName dp "Bazedoxifene"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

154573793ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#154573793

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C22H31N5O5"
hasMW dp "500"^^integer
hasName dp "Z LVG CHN2"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

154584292ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#154584292

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44061"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C24H42N3O8S-"
hasMW dp "700"^^integer
hasName dp "3CLpro inhibitor 6e"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

154584298ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#154584298

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44061"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C1H34F2N3O8S-"
hasMW dp "600"^^integer
hasName dp "3CLpro inhibitor 6j"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

154699466ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#154699466

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44083"^^date time
hasMF dp "CH485N79O94S3"
hasMW dp "0"^^integer
hasName dp "LCB1"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

1548943ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#1548943

belongs to
Drug c
has facts
has common name dp "Capsaicin; 404-86-4; Zostrix"
hasFunction dp "Antiviral"
hasIUPACName dp "(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enam..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C18H27NO3"
hasMW dp "305"^^integer
hasName dp "Capsaicin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

15604015ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#15604015

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44005"^^date time
hasMF dp "C23H25ClN2O"
hasMW dp "900"^^integer
hasName dp "Opaganib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

156391ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#156391

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43952"^^date time
hasMF dp "C14H14O3"
hasMW dp "260"^^integer
hasName dp "Naproxen"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

15664ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#15664

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C12H12N2"
hasMW dp "240"^^integer
hasName dp "Abametapir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

15689808ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#15689808

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C21H22O10"
hasMW dp "400"^^integer
hasName dp "6-O-Caffeoylarbutin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

158781ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#158781

belongs to
Drug c
has facts
has common name dp "Olmesartan; 144689-24-7; Olmesartan Acid"
hasFunction dp "Antiviral"
hasIUPACName dp "5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44168"^^date time
hasMF dp "C24H26N6O3"
hasMW dp "446"^^integer
hasName dp "Olmesartan"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

160024ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#160024

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C12H10FN3O4"
hasMW dp "220"^^integer
hasName dp "Fidarestat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

16038120ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16038120

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C30H40ClN7O3S"
hasMW dp "200"^^integer
hasName dp "TAE684"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

16041424ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16041424

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C21H25N7"
hasMW dp "500"^^integer
hasName dp "ENMD-2076"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

160478ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#160478

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44076"^^date time
hasMF dp "C10H6O5"
hasMW dp "150"^^integer
hasName dp "Flaviolin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

16063245ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16063245

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C27H21F3N8O"
hasMW dp "500"^^integer
hasName dp "Radotinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

16076883ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16076883

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44078"^^date time
hasMF dp "C35H46ClN5O9S"
hasMW dp "300"^^integer
hasName dp "Asunaprevir"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

16130295ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16130295

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44134"^^date time
hasMF dp "C284H432N84O79S7"
hasMW dp "100"^^integer
hasName dp "Aprotinin"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

16134395ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16134395

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C72H101N17O26"
hasMW dp "700"^^integer
hasName dp "Daptomycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

16134627ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16134627

belongs to
Drug c
has facts
has common name dp "dalbavancin B0; VER001; A-A-1"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S,3S,4R,5R,6S)-6-[[(1S,2R,19R,22R,34S,37R,40R,52S)-5,32-di..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44166"^^date time
hasMF dp "C88H100Cl2N10O28"
hasMW dp "1816"^^integer
hasName dp "Dalbavancin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

16220172ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16220172

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C24H28N2O3"
hasMW dp "500"^^integer
hasName dp "Ivacaftor"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

16222096ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16222096

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C21H21F3IN3O2"
hasMW dp "300"^^integer
hasName dp "Cobimetinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

16315ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16315

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H10S3"
hasMW dp "300"^^integer
hasName dp "Allyl trisulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

163311ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#163311

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43946"^^date time
hasMF dp "C8H15N3O9P2"
hasMW dp "170"^^integer
hasName dp "Cidofovir diphosphate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

16362ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16362

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43974"^^date time
hasMF dp "C28H29F2N3O"
hasMW dp "500"^^integer
hasName dp "Pimozide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

163829ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#163829

belongs to
Drug c
has facts
has common name dp "Bhsar-SP; (Sar(9))SP sulfone; 9-Sar-substance P sulfone"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-5-(di..."
hasLatestDatabaseUpdate dp "44212"^^date time
hasLatestPublicationDate dp "44204"^^date time
hasMF dp "C64H100N18O15S"
hasMW dp "1393"^^integer
hasName dp "Sar9, Met (O2)11-Substance P"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

163884ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#163884

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C2H30N7O13P2+"
hasMW dp "500"^^integer
hasName dp "Carba-nicotinamide-adenine-dinucleotide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

16590ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16590

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H10S2"
hasMW dp "300"^^integer
hasName dp "Allyl disulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

166548ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#166548

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C58H73N7O17"
hasMW dp "200"^^integer
hasName dp "Anidulafungin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

16678941ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16678941

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44060"^^date time
hasMF dp "C24H18F2N2O5"
hasMW dp "400"^^integer
hasName dp "Lumacaftor"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

16719221ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16719221

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C21H18FN5O5S"
hasMW dp "500"^^integer
hasName dp "RO5126766"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

16720766ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16720766

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C21H25N5O4S"
hasMW dp "500"^^integer
hasName dp "Pevonedistat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

16722836ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16722836

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "C27H36N6O3S"
hasMW dp "700"^^integer
hasName dp "Fedratinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

16747388ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16747388

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44007"^^date time
hasMF dp "C26H20F3N7O"
hasMW dp "500"^^integer
hasName dp "NVP-BHG712"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

16760340ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16760340

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44079"^^date time
hasMF dp "C26H34N4O5"
hasMW dp "600"^^integer
hasName dp "Calpain inhibitor XII"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

16779ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#16779

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C13H6Cl5NO3"
hasMW dp "400"^^integer
hasName dp "Oxyclozanide"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

168849ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#168849

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C29H34O15"
hasMW dp "600"^^integer
hasName dp "Pectolinarin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

169870ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#169870

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C27H40O4"
hasMW dp "600"^^integer
hasName dp "Hydroxyprogesterone caproate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

176077ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#176077

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C6H13NO4"
hasMW dp "170"^^integer
hasName dp "Migalastat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

176155ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#176155

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43990"^^date time
hasMF dp "C21H16FN3OS"
hasMW dp "400"^^integer
hasName dp "SB203580"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

176870ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#176870

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C22H23N3O4"
hasMW dp "400"^^integer
hasName dp "Erlotinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

176873ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#176873

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43962"^^date time
hasMF dp "C27H40N8O7"
hasMW dp "700"^^integer
hasName dp "Cilengitide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

177384ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#177384

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44070"^^date time
hasMF dp "C21H32O7"
hasMW dp "500"^^integer
hasName dp "Tinocordiside"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

17748ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#17748

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C10H6ClNO2"
hasMW dp "610"^^integer
hasName dp "Quinoclamine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

17755052ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#17755052

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C23H27N7O3S2"
hasMW dp "600"^^integer
hasName dp "Pictilisib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

179651ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#179651

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C26H30O8"
hasMW dp "500"^^integer
hasName dp "Limonin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

18283ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#18283

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44141"^^date time
hasMF dp "C10H12N2O4"
hasMW dp "210"^^integer
hasName dp "Stavudine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

184311ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#184311

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C25H32O4"
hasMW dp "500"^^integer
hasName dp "Kazinol F"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

185465ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#185465

belongs to
Drug c
has facts
has common name dp "Theasapogenol B; Escinidin; Jegosapogenol A"
hasFunction dp "Antiviral"
hasIUPACName dp "(3R,4R,4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bS)-4a-(hydroxymeth..."
hasLatestDatabaseUpdate dp "44210"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C30H50O5"
hasMW dp "490"^^integer
hasName dp "Theasapogenol B"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

185617ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#185617

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C21H18O12"
hasMW dp "400"^^integer
hasName dp "Scutellarin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

185954ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#185954

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44117"^^date time
hasMF dp "C21H23NO6"
hasMW dp "400"^^integer
hasName dp "Raddeanine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

189308ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#189308

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C20H13NO7"
hasMW dp "300"^^integer
hasName dp "(+)-oxoturkiyenine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

192ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#192

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C15H23N5O14P2"
hasMW dp "320"^^integer
hasName dp "Adenosine diphosphate ribose"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

193962ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#193962

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44130"^^date time
hasMF dp "C20H15BrN6O"
hasMW dp "300"^^integer
hasName dp "Etravirine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

19649ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#19649

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44013"^^date time
hasMF dp "C21H39N7O12"
hasMW dp "600"^^integer
hasName dp "Streptomycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

197020ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#197020

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44133"^^date time
hasMF dp "C9H13N3O6"
hasMW dp "220"^^integer
hasName dp "N(4)-Hydroxycytidine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

197081ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#197081

belongs to
Drug c
has facts
has common name dp "Kuromanine; Chrysontemin; Glucocyanidin"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychr..."
hasLatestDatabaseUpdate dp "44203"^^date time
hasLatestPublicationDate dp "44173"^^date time
hasMF dp "C21H21ClO11"
hasMW dp "484"^^integer
hasName dp "Cyanidin-3-O-glucoside"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

20345ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#20345

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C15H17N5O5"
hasMW dp "330"^^integer
hasName dp "Kinetin riboside"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

2081089ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2081089

belongs to
Drug c
has facts
has common name dp "MLS001010890; CHEMBL1568820; HMS2724K22"
hasFunction dp "Antiviral"
hasIUPACName dp "N-(1H-benzimidazol-2-yl)-2-(2-fluorophenyl)acetamide"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C15H12FN3O"
hasMW dp "269"^^integer
hasName dp "CHEMBL1568820"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

2083ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2083

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C13H21NO3"
hasMW dp "310"^^integer
hasName dp "Albuterol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

208917ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#208917

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C23H22FN3O"
hasMW dp "400"^^integer
hasName dp "Elopiprazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

21138ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#21138

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C16H21NO2"
hasMW dp "340"^^integer
hasName dp "Dexpropranolol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

21159455ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#21159455

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H10S3"
hasMW dp "300"^^integer
hasName dp "Trisulfide, (1Z)-1-propenyl 2-propenyl"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

21233ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#21233

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C40H48N2O6+2"
hasMW dp "800"^^integer
hasName dp "Metocurine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

213039ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#213039

belongs to
Drug c
has facts
has common name dp "Darunavir; 206361-99-1; Prezista"
hasFunction dp "Antiviral"
hasIUPACName dp "[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] ..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C27H37N3O7S"
hasMW dp "547"^^integer
hasName dp "Darunavir"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

213046ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#213046

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44150"^^date time
hasMF dp "C28H36N4O2S"
hasMW dp "700"^^integer
hasName dp "Lurasidone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2132ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2132

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C13H18Br2N2O"
hasMW dp "100"^^integer
hasName dp "Ambroxol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

2132298ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2132298

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43942"^^date time
hasMF dp "C14H15N2O+"
hasMW dp "280"^^integer
hasName dp "Enisamium"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2145ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2145

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C13H16N2O2"
hasMW dp "280"^^integer
hasName dp "Aminoglutethimide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

21577376ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#21577376

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C20H24O6"
hasMW dp "400"^^integer
hasName dp "1-(3-Methoxy-4-hydroxyphenyl)-5-hydroxy-7-(3,4-dihydroxyphenyl)-3-heptanone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

2162ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2162

belongs to
Drug c
has facts
has common name dp "amlodipine; 88150-42-9; Norvasc"
hasFunction dp "Antiviral"
hasIUPACName dp "3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophen..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44187"^^date time
hasMF dp "C20H25ClN2O5"
hasMW dp "408"^^integer
hasName dp "Amlodipine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

216239ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#216239

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "1H16ClF3N4O3"
hasMW dp "800"^^integer
hasName dp "Sorafenib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

216322ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#216322

belongs to
Drug c
has facts
has common name dp "Conivaptan hydrochloride; 168626-94-6; Conivaptan HCl"
hasFunction dp "Antiviral"
hasIUPACName dp "N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C32H27ClN4O2"
hasMW dp "535"^^integer
hasName dp "Conivaptan HCl"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

216326ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#216326

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C13H13N3O3"
hasMW dp "260"^^integer
hasName dp "Lenalidomide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

21637732ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#21637732

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C26H34O4"
hasMW dp "500"^^integer
hasName dp "Kazinol J"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

2164ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2164

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44141"^^date time
hasMF dp "C11H18N2O3"
hasMW dp "270"^^integer
hasName dp "Amobarbital"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2165ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2165

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44062"^^date time
hasMF dp "C20H22ClN3O"
hasMW dp "900"^^integer
hasName dp "Amodiaquine"
hasNumberOfReferences dp "6"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

21704ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#21704

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44064"^^date time
hasMF dp "C10H13N5O4"
hasMW dp "240"^^integer
hasName dp "Vidarabine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

21722930ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#21722930

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44029"^^date time
hasMF dp "C20H18O8"
hasMW dp "400"^^integer
hasName dp "Gummadiol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

219025ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#219025

belongs to
Drug c
has facts
has common name dp "Dronedarone hydrochloride; 141625-93-6; Dronedarone HCl"
hasFunction dp "Antiviral"
hasIUPACName dp "N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofur..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C31H45ClN2O5S"
hasMW dp "593"^^integer
hasName dp "Dronedarone HCl"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

219104ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#219104

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43895"^^date time
hasMF dp "C7H12N2S2"
hasMW dp "300"^^integer
hasName dp "PX-12"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

22227931ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#22227931

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44001"^^date time
hasMF dp "C27H29ClN6O2"
hasMW dp "0"^^integer
hasName dp "Y-320"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

222528ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#222528

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C24H40O4"
hasMW dp "600"^^integer
hasName dp "Deoxycholic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2244ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2244

belongs to
Drug c
has facts
has common name dp "aspirin; ACETYLSALICYLIC ACID; 50-78-2"
hasFunction dp "Other treatment"
hasIUPACName dp "2-acetyloxybenzoic acid"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C9H8O4"
hasMW dp "180"^^integer
hasName dp "Acetylsalicylic acid"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

2247ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2247

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C28H31FN4O"
hasMW dp "600"^^integer
hasName dp "Astemizole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

22571ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#22571

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43909"^^date time
hasMF dp "C24H27NO2"
hasMW dp "500"^^integer
hasName dp "Octocrylene"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2267ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2267

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C22H24ClN3O"
hasMW dp "900"^^integer
hasName dp "Azelastine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2280ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2280

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C17H16N8O+2"
hasMW dp "400"^^integer
hasName dp "Bis(5-amidino-2-benzimidazolyl)methane ketone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

2287236ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2287236

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C22H14ClNO4S2"
hasMW dp "900"^^integer
hasName dp "4E2RCat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

2327ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2327

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C10H15N3O5"
hasMW dp "240"^^integer
hasName dp "Benserazide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2351ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2351

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43974"^^date time
hasMF dp "C24H34N2O"
hasMW dp "500"^^integer
hasName dp "Bepridil"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2353ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2353

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C20H18NO4+"
hasMW dp "400"^^integer
hasName dp "Berberine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

23649154ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#23649154

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44067"^^date time
hasMF dp "C25H14F7N5"
hasMW dp "400"^^integer
hasName dp "Tegobuvir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

23652732ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#23652732

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "43971"^^date time
hasLatestPublicationDate dp "43970"^^date time
hasMF dp "C24H38N2O4"
hasMW dp "600"^^integer
hasName dp "Genz-123346"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

23662274ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#23662274

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43960"^^date time
hasMF dp "C3H3NaO3"
hasMW dp "40"^^integer
hasName dp "Sodium pyruvate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2375ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2375

belongs to
Drug c
has facts
has common name dp "bicalutamide; 90357-06-5; Casodex"
hasFunction dp "Antiviral"
hasIUPACName dp "N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulf..."
hasLatestDatabaseUpdate dp "44173"^^date time
hasLatestPublicationDate dp "44165"^^date time
hasMF dp "C18H14F4N2O4S"
hasMW dp "430"^^integer
hasName dp "Bicalutamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

238053ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#238053

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43917"^^date time
hasMF dp "C22H29NO4S"
hasMW dp "500"^^integer
hasName dp "Benztropine mesylate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

23958169ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#23958169

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44199"^^date time
hasLatestPublicationDate dp "44114"^^date time
hasMF dp "C29H36O15"
hasMW dp "600"^^integer
hasName dp "Forsythoside I"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

24199313ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24199313

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43980"^^date time
hasMF dp "C20H34AuO9PS"
hasMW dp "500"^^integer
hasName dp "Auranofin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

24424ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24424

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44089"^^date time
hasMF dp "O4SZn"
hasMW dp "400"^^integer
hasName dp "Zinc sulfate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

24748573ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24748573

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C19H12ClN3O2"
hasMW dp "800"^^integer
hasName dp "Silmitasertib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2475ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2475

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C14H22ClNO2"
hasMW dp "780"^^integer
hasName dp "Bupranolol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

24766ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24766

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43950"^^date time
hasMF dp "C13H21NO15S"
hasMW dp "370"^^integer
hasName dp "Chondroitin sulphate C"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

24769759ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24769759

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44026"^^date time
hasMF dp "C9H11FN6O4"
hasMW dp "220"^^integer
hasName dp "Azvudine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - clinical evidence"

2477ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2477

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C21H31N5O2"
hasMW dp "500"^^integer
hasName dp "Buspirone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

24772860ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24772860

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C23H27F3N4O3"
hasMW dp "500"^^integer
hasName dp "SNX-2112"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

24798764ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24798764

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43863"^^date time
hasMF dp "C25H35NO4S"
hasMW dp "600"^^integer
hasName dp "Lomibuvir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

24823ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24823

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43987"^^date time
hasMF dp "O3"
hasMW dp "998"^^integer
hasName dp "Ozone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

24826799ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24826799

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44095"^^date time
hasMF dp "C29H27F3N6O"
hasMW dp "600"^^integer
hasName dp "Ponatinib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

24847767ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24847767

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44147"^^date time
hasMF dp "C33H54N2O23"
hasMW dp "800"^^integer
hasName dp "Hyaluronic acid"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

24861960ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24861960

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44117"^^date time
hasMF dp "C26H30O7"
hasMW dp "500"^^integer
hasName dp "Tomentodiplacone B"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

24873435ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24873435

belongs to
Drug c
has facts
has common name dp "SIMEPREVIR; Olysio; TMC-435"
hasFunction dp "Antiviral"
hasIUPACName dp "(1R,4R,6S,7Z,15R,17R)-N-cyclopropylsulfonyl-17-[7-methoxy-8-..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C38H47N5O7S2"
hasMW dp "749"^^integer
hasName dp "Simeprevir"
hasNumberOfReferences dp "10"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

24963252ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24963252

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C17H15F2IN4O4"
hasMW dp "230"^^integer
hasName dp "TAK-733"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

24964624ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#24964624

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C25H21N5O"
hasMW dp "500"^^integer
hasName dp "MK-2206"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

25033539ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25033539

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C22H27N5O4"
hasMW dp "500"^^integer
hasName dp "PF-04691502"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

25062766ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25062766

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C23H22N6O2"
hasMW dp "500"^^integer
hasName dp "Momelotinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

25126798ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25126798

belongs to
Drug c
has facts
has common name dp "Ruxolitinib; 941678-49-5; INCB018424"
hasFunction dp "Other treatment"
hasIUPACName dp "(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyr..."
hasLatestDatabaseUpdate dp "44213"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C17H18N6"
hasMW dp "306"^^integer
hasName dp "Ruxolitinib"
hasNumberOfReferences dp "8"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

25141092ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25141092

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44095"^^date time
hasMF dp "C31H34F2N6O2"
hasMW dp "600"^^integer
hasName dp "Entrectinib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

25151504ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25151504

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44129"^^date time
hasMF dp "C40H53N7O5S2"
hasMW dp "0"^^integer
hasName dp "Cobicistat"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

25154714ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25154714

belongs to
Drug c
has facts
has common name dp "Daclatasvir; 1009119-64-5; BMS-790052"
hasFunction dp "Antiviral"
hasIUPACName dp "methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methox..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44183"^^date time
hasMF dp "C40H50N8O6"
hasMW dp "738"^^integer
hasName dp "Daclatasvir"
hasNumberOfReferences dp "6"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

25167777ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25167777

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "25H17F2N5O3S"
hasMW dp "500"^^integer
hasName dp "Omipalisib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

25183872ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25183872

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C4H19BCl2N2O4"
hasMW dp "0"^^integer
hasName dp "Ixazomib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2519ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2519

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44181"^^date time
hasLatestPublicationDate dp "44121"^^date time
hasMF dp "C8H10N4O2"
hasMW dp "190"^^integer
hasName dp "Caffeine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

25236288ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25236288

belongs to
Drug c
has facts
has common name dp "STK492016; ZINC12381430; AKOS003400368"
hasFunction dp "Antiviral"
hasIUPACName dp "3,3-dimethyl-N-[4-(piperidine-1-carbonyl)phenyl]butanamide"
hasLatestDatabaseUpdate dp "44174"^^date time
hasLatestPublicationDate dp "44166"^^date time
hasMF dp "C18H26N2O2"
hasMW dp "302"^^integer
hasName dp "3,3-Dimethyl-N-[4-(piperidin-1-ylcarbonyl)phenyl]butanamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

25260757ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25260757

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44001"^^date time
hasMF dp "C27H33N7O4"
hasMW dp "600"^^integer
hasName dp "WYE-125132"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

25262792ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25262792

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44007"^^date time
hasMF dp "C25H30N6O3"
hasMW dp "500"^^integer
hasName dp "AZD2014"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

25262965ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#25262965

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44001"^^date time
hasMF dp "C25H31N5O4"
hasMW dp "500"^^integer
hasName dp "AZD8055"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

253602ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#253602

belongs to
Drug c
has facts
has common name dp "anisomycin; 22862-76-6; Flagecidin"
hasFunction dp "Antiviral"
hasIUPACName dp "[(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C14H19NO4"
hasMW dp "265"^^integer
hasName dp "Anisomycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

2541ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2541

belongs to
Drug c
has facts
has common name dp "candesartan; 139481-59-7; CV-11974"
hasFunction dp "Antiviral"
hasIUPACName dp "2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]ben..."
hasLatestDatabaseUpdate dp "44176"^^date time
hasLatestPublicationDate dp "44168"^^date time
hasMF dp "C24H20N6O3"
hasMW dp "440"^^integer
hasName dp "Candesartan"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2577ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2577

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44040"^^date time
hasMF dp "C11H16FN3O3"
hasMW dp "260"^^integer
hasName dp "Carmofur"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2585ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2585

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C24H26N2O4"
hasMW dp "500"^^integer
hasName dp "Carvedilol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

26501160ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#26501160

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C23H22N2O8"
hasMW dp "400"^^integer
hasName dp "ZINC15275997"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

2662ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2662

belongs to
Drug c
has facts
has common name dp "celecoxib; 169590-42-5; Celebrex"
hasFunction dp "Antiviral"
hasIUPACName dp "4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzen..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C17H14F3N3O2S"
hasMW dp "381"^^integer
hasName dp "Celecoxib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

2663ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2663

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C20H33N3O4"
hasMW dp "500"^^integer
hasName dp "Celiprolol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2678ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2678

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44072"^^date time
hasMF dp "C21H25ClN2O3"
hasMW dp "900"^^integer
hasName dp "Cetirizine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

2683ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2683

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C21H38N+"
hasMW dp "500"^^integer
hasName dp "Cetylpyridinium"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

26987ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#26987

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C21H26ClNO"
hasMW dp "900"^^integer
hasName dp "Clemastine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

27126377ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#27126377

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C15H14N2O8S"
hasMW dp "300"^^integer
hasName dp "ZINC16429284"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

2723601ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2723601

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "C5H5N5S"
hasMW dp "190"^^integer
hasName dp "Thioguanine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2724385ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2724385

belongs to
Drug c
has facts
has common name dp "digoxin; 20830-75-5; Lanoxin"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C41H64O14"
hasMW dp "780"^^integer
hasName dp "Digoxin"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2726ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2726

belongs to
Drug c
has facts
has common name dp "chlorpromazine; Thorazine; 50-53-3"
hasFunction dp "Antiviral"
hasIUPACName dp "3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C17H19ClN2S"
hasMW dp "318"^^integer
hasName dp "Chlorpromazine"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2733484ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2733484

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C19H21ClN2O2S"
hasMW dp "900"^^integer
hasName dp "Capsazepine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

2733525ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2733525

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43917"^^date time
hasMF dp "C32H37NO8"
hasMW dp "600"^^integer
hasName dp "Tamoxifen citrate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2749ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2749

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C12H17NO2"
hasMW dp "270"^^integer
hasName dp "Ciclopirox"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

275196ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#275196

belongs to
Drug c
has facts
has common name dp "noscapine; NARCOTINE; 128-62-1"
hasFunction dp "Antiviral"
hasIUPACName dp "(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C22H23NO7"
hasMW dp "413"^^integer
hasName dp "Noscapine"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

2754ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2754

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44101"^^date time
hasMF dp "C20H27N5O2"
hasMW dp "500"^^integer
hasName dp "Cilostazol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2764ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2764

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44013"^^date time
hasMF dp "C17H18FN3O3"
hasMW dp "340"^^integer
hasName dp "Ciprofloxacin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2783ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2783

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C12H18Cl2N2O"
hasMW dp "190"^^integer
hasName dp "Clenbuterol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2794ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2794

belongs to
Drug c
has facts
has common name dp "clofazimine; 2030-63-9; Lamprene"
hasFunction dp "Antiviral"
hasIUPACName dp "N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C27H22Cl2N4"
hasMW dp "473"^^integer
hasName dp "Clofazimine"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

2801ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2801

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43972"^^date time
hasMF dp "C19H23ClN2"
hasMW dp "900"^^integer
hasName dp "Clomipramine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

285033ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#285033

belongs to
Drug c
has facts
has common name dp "homoharringtonine; Omacetaxine mepesuccinate; Synribo"
hasFunction dp "Antiviral"
hasIUPACName dp "1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7...."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C29H39NO9"
hasMW dp "545"^^integer
hasName dp "Homoharringtonine"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

287180ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#287180

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44097"^^date time
hasMF dp "C17H14N2O3"
hasMW dp "300"^^integer
hasName dp "Rosoxacin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

2950ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#2950

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44070"^^date time
hasMF dp "C14H8O4"
hasMW dp "210"^^integer
hasName dp "Dantron"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

3000237ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3000237

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C16H20ClN3S"
hasMW dp "900"^^integer
hasName dp "R-82913"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

3001497ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3001497

belongs to
Drug c
has facts
has common name dp "Geraniin; 60976-49-0; Geraniiin"
hasFunction dp "Antiviral"
hasIUPACName dp "[(1R,7R,8S,26R,28S,29R,38R)-1,13,14,15,18,19,20,34,35,39,39-..."
hasLatestDatabaseUpdate dp "44175"^^date time
hasLatestPublicationDate dp "44168"^^date time
hasMF dp "C41H28O27"
hasMW dp "952"^^integer
hasName dp "Geraniin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

3005573ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3005573

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C26H28ClNO"
hasMW dp "0"^^integer
hasName dp "Toremifene"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3010818ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3010818

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44143"^^date time
hasMF dp "C36H53N7O6"
hasMW dp "800"^^integer
hasName dp "Telaprevir"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3011897ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3011897

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44133"^^date time
hasMF dp "C12H15FN4O4"
hasMW dp "270"^^integer
hasName dp "(2R,3R,4R,5R)-2-(4-Amino-5-fluoropyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyloxolane-3,4-diol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

30323ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#30323

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C27H29NO10"
hasMW dp "500"^^integer
hasName dp "Daunorubicin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

3033832ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3033832

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43987"^^date time
hasMF dp "C32H36ClNO8"
hasMW dp "100"^^integer
hasName dp "Clomiphene citrate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3034034ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3034034

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C20H24N2O2"
hasMW dp "400"^^integer
hasName dp "Quinine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3035728ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3035728

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C23H13N3O2"
hasMW dp "400"^^integer
hasName dp "Qingdainone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

3038499ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3038499

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C9Cl2F3N4O3S2"
hasMW dp "600"^^integer
hasName dp "L-796568"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

3062316ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3062316

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C22H26ClN7O2S"
hasMW dp "0"^^integer
hasName dp "Dasatinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

3081361ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3081361

belongs to
Drug c
has facts
has common name dp "Vandetanib; 443913-73-3; Zactima"
hasFunction dp "Antiviral"
hasIUPACName dp "N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C22H24BrFN4O2"
hasMW dp "475"^^integer
hasName dp "Vandetanib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3084407ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3084407

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44070"^^date time
hasMF dp "C27H30O15"
hasMW dp "500"^^integer
hasName dp "Vicenin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

3085092ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3085092

belongs to
Drug c
has facts
has common name dp "salinomycin; Procoxacin; Coxistac"
hasFunction dp "Antiviral"
hasIUPACName dp "(2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C42H70O11"
hasMW dp "751"^^integer
hasName dp "Salinomycin"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3086451ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3086451

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C24H28N6O5"
hasMW dp "500"^^integer
hasName dp "Spirofylline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

3086576ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3086576

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C14H19N3O2"
hasMW dp "320"^^integer
hasName dp "Zilpaterol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

31101ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#31101

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C32H40BrN5O5"
hasMW dp "600"^^integer
hasName dp "Bromocriptine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

3117ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3117

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44079"^^date time
hasMF dp "C10H20N2S4"
hasMW dp "500"^^integer
hasName dp "Disulfiram"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

31202ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#31202

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C25H46ClN"
hasMW dp "100"^^integer
hasName dp "Cetalkonium chloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3121ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3121

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C8H16O2"
hasMW dp "210"^^integer
hasName dp "Valproic Acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

31256ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#31256

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H12O2"
hasMW dp "160"^^integer
hasName dp "Diacetonalcohol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

31307ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#31307

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C21H27FO6"
hasMW dp "400"^^integer
hasName dp "Triamcinolone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3163969ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3163969

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C15H12N4O2S2"
hasMW dp "400"^^integer
hasName dp "ZINC4511851"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

31703ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#31703

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C27H29NO11"
hasMW dp "500"^^integer
hasName dp "Doxorubicin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

3190778ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3190778

belongs to
Drug c
has facts
has common name dp "CHEMBL3752642; Oprea1_257365; Oprea1_815253"
hasFunction dp "Antiviral"
hasIUPACName dp "N-cyclohexyl-2-(N-[2-(1H-indol-3-yl)acetyl]-4-propan-2-ylani..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C36H43N3O5"
hasMW dp "597"^^integer
hasName dp "CHEMBL3752642"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

3191ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3191

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44001"^^date time
hasMF dp "C32H39NO2"
hasMW dp "700"^^integer
hasName dp "Ebastine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3194ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3194

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44108"^^date time
hasMF dp "C13H9NOSe"
hasMW dp "200"^^integer
hasName dp "Ebselen"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

3219ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3219

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44040"^^date time
hasMF dp "C17H26N4O"
hasMW dp "400"^^integer
hasName dp "Emedastine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3220ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3220

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44123"^^date time
hasMF dp "C15H10O5"
hasMW dp "240"^^integer
hasName dp "Emodin"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

32756ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#32756

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43950"^^date time
hasMF dp "C14H21NO15S-2"
hasMW dp "400"^^integer
hasName dp "Dermatan sulphate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3286789ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3286789

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C15H14O6"
hasMW dp "270"^^integer
hasName dp "Leucopelargonidin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

332427ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#332427

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44110"^^date time
hasMF dp "C20H24O6"
hasMW dp "400"^^integer
hasName dp "Lariciresinol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

3334ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3334

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C15H13N3O2S"
hasMW dp "300"^^integer
hasName dp "Fenbendazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

3343ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3343

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44117"^^date time
hasMF dp "C17H21NO4"
hasMW dp "350"^^integer
hasName dp "Fenoterol"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

33572ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#33572

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C17H21NO3"
hasMW dp "350"^^integer
hasName dp "Ritodrine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

33887ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#33887

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44125"^^date time
hasMF dp "C26H29F2N7"
hasMW dp "600"^^integer
hasName dp "Almitrine"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

3396ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3396

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43917"^^date time
hasMF dp "C29H31F2N3O"
hasMW dp "600"^^integer
hasName dp "Fluspirilene"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3440ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3440

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44075"^^date time
hasMF dp "C12H11ClN2O5S"
hasMW dp "740"^^integer
hasName dp "Furosemide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

3447ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3447

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44005"^^date time
hasMF dp "C16H23N3O4"
hasMW dp "370"^^integer
hasName dp "Gabexate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3469ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3469

belongs to
Drug c
has facts
has common name dp "2,5-DIHYDROXYBENZOIC ACID; gentisic acid; 490-79-9"
hasFunction dp "Antiviral"
hasIUPACName dp "2,5-dihydroxybenzoic acid"
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C7H6O4"
hasMW dp "154"^^integer
hasName dp "2,5-dihydroxybenzoic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

3475ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3475

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44002"^^date time
hasMF dp "C15H21N3O3S"
hasMW dp "400"^^integer
hasName dp "Gliclazide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3488ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3488

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C23H28ClN3O5S"
hasMW dp "0"^^integer
hasName dp "Glyburide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

3501ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3501

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44152"^^date time
hasMF dp "C24H18N4O"
hasMW dp "400"^^integer
hasName dp "Go6976"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

3559ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3559

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44097"^^date time
hasMF dp "C21H23ClFNO2"
hasMW dp "900"^^integer
hasName dp "Haloperidol"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

35802ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#35802

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C16H12FN3O3"
hasMW dp "280"^^integer
hasName dp "Flubendazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

3598ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3598

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C13H6Cl6O2"
hasMW dp "900"^^integer
hasName dp "Hexachlorophene"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3611ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3611

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C10H12O2"
hasMW dp "200"^^integer
hasName dp "Hinokitiol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3634ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3634

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43972"^^date time
hasMF dp "C20H24N2O2S"
hasMW dp "500"^^integer
hasName dp "Hycanthone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

36462ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#36462

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C29H32O13"
hasMW dp "600"^^integer
hasName dp "Etoposide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

3663ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3663

belongs to
Drug c
has facts
has common name dp "hypericin; 548-04-9; Hypericum red"
hasFunction dp "Antiviral"
hasIUPACName dp "9,11,13,16,18,20-hexahydroxy-5,24-dimethyloctacyclo[13.11.1...."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44173"^^date time
hasMF dp "C30H16O8"
hasMW dp "504"^^integer
hasName dp "Hypericin"
hasNumberOfReferences dp "5"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

36811ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#36811

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44199"^^date time
hasLatestPublicationDate dp "44117"^^date time
hasMF dp "C18H23NO3"
hasMW dp "400"^^integer
hasName dp "Dobutamine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

370ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#370

belongs to
Drug c
has facts
has common name dp "Gallic acid; 3,4,5-Trihydroxybenzoic acid; 149-91-7"
hasFunction dp "Antiviral"
hasIUPACName dp "3,4,5-trihydroxybenzoic acid"
hasLatestDatabaseUpdate dp "44210"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C7H6O5"
hasMW dp "170"^^integer
hasName dp "Gallic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

3715ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3715

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C19H16ClNO4"
hasMW dp "800"^^integer
hasName dp "Indomethacin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

37393ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#37393

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C26H30Cl2F3NO"
hasMW dp "400"^^integer
hasName dp "Halofantrine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

37542ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#37542

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44133"^^date time
hasMF dp "C8H12N4O5"
hasMW dp "200"^^integer
hasName dp "Ribavirin"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Recommended by China's NHC Guidelines"

3793ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3793

belongs to
Drug c
has facts
has common name dp "itraconazole; 84625-61-6; Sporanox"
hasFunction dp "Antiviral"
hasIUPACName dp "2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-tr..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C35H38Cl2N8O4"
hasMW dp "705"^^integer
hasName dp "Itraconazole"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

38258ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#38258

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44096"^^date time
hasMF dp "C11H16N8O8"
hasMW dp "290"^^integer
hasName dp "Imidazolidinyl urea"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

387447ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#387447

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "43930"^^date time
hasMF dp "C19H25BN4O4"
hasMW dp "200"^^integer
hasName dp "Bortezomib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3883ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3883

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43955"^^date time
hasMF dp "C16H14F3N3O2S"
hasMW dp "400"^^integer
hasName dp "Prevacid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

3899ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3899

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44095"^^date time
hasMF dp "C12H9F3N2O2"
hasMW dp "210"^^integer
hasName dp "Leflunomide"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

39186ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#39186

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44033"^^date time
hasMF dp "C22H26N2O4S"
hasMW dp "500"^^integer
hasName dp "Diltiazem"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

392622ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#392622

belongs to
Drug c
has facts
has common name dp "ritonavir; 155213-67-5; Norvir"
hasFunction dp "Antiviral"
hasIUPACName dp "1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-me..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44174"^^date time
hasMF dp "C37H48N6O5S2"
hasMW dp "720"^^integer
hasName dp "Ritonavir"
hasNumberOfReferences dp "33"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Recommended by China's NHC Guidelines"

3948ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3948

belongs to
Drug c
has facts
has common name dp "lomefloxacin; 98079-51-7; Lomefloxacine"
hasFunction dp "Antiviral"
hasIUPACName dp "1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoli..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C17H19F2N3O3"
hasMW dp "351"^^integer
hasName dp "Lomefloxacin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

3961ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#3961

belongs to
Drug c
has facts
has common name dp "losartan; 114798-26-4; DUP 89"
hasFunction dp "Antiviral"
hasIUPACName dp "[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]m..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44187"^^date time
hasMF dp "C22H23ClN6O"
hasMW dp "422"^^integer
hasName dp "Losartan"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

400769ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#400769

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C32H43NO4"
hasMW dp "700"^^integer
hasName dp "Bardoxolone Methyl"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

4008ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4008

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44129"^^date time
hasMF dp "C35H38N4O6"
hasMW dp "700"^^integer
hasName dp "Manidipine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

4030ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4030

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C16H13N3O3"
hasMW dp "290"^^integer
hasName dp "Mebendazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

40326ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#40326

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43909"^^date time
hasMF dp "C21H20Cl2O3"
hasMW dp "300"^^integer
hasName dp "Permethrin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

40486ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#40486

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43909"^^date time
hasMF dp "C29H37N3O6"
hasMW dp "600"^^integer
hasName dp "Calcimycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

4054ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4054

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44002"^^date time
hasMF dp "C12H21N"
hasMW dp "300"^^integer
hasName dp "Memantine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

4055ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4055

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43980"^^date time
hasMF dp "C11H8O2"
hasMW dp "180"^^integer
hasName dp "Menadione"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

40854ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#40854

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C15H13N3O3S"
hasMW dp "300"^^integer
hasName dp "Oxfendazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

4091ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4091

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44002"^^date time
hasMF dp "C4H11N5"
hasMW dp "160"^^integer
hasName dp "Metformin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

410087ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#410087

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43977"^^date time
hasMF dp "C6H9I2NO"
hasMW dp "950"^^integer
hasName dp "Povidone Iodine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

4124851ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4124851

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C10H10N2O2S"
hasMW dp "270"^^integer
hasName dp "TDZD-8"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

4168ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4168

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "C14H22ClN3O2"
hasMW dp "790"^^integer
hasName dp "Metoclopramide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

41684ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#41684

belongs to
Drug c
has facts
has common name dp "NITAZOXANIDE; 55981-09-4; Alinia"
hasFunction dp "Antiviral"
hasIUPACName dp "[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate"
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44189"^^date time
hasMF dp "C12H9N3O5S"
hasMW dp "307"^^integer
hasName dp "Nitazoxanide"
hasNumberOfReferences dp "6"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

41774ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#41774

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44147"^^date time
hasMF dp "C25H43NO18"
hasMW dp "600"^^integer
hasName dp "Acarbose"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

4212ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4212

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44139"^^date time
hasMF dp "C22H28N4O6"
hasMW dp "500"^^integer
hasName dp "Mitoxantrone"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

42601552ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#42601552

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44123"^^date time
hasMF dp "C40H49BrN6O9S"
hasMW dp "800"^^integer
hasName dp "Faldaprevir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

42608235ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#42608235

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C28H39ClO9"
hasMW dp "100"^^integer
hasName dp "(-)-solenolide A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

4286ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4286

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C19H27N5O"
hasMW dp "500"^^integer
hasName dp "n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

4368136ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4368136

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43950"^^date time
hasMF dp "C14H23NO15S"
hasMW dp "400"^^integer
hasName dp "Chondroitin sulphate A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

4369270ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4369270

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43909"^^date time
hasMF dp "C23H34O4"
hasMW dp "500"^^integer
hasName dp "Digitoxigenin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

438692ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#438692

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C30H22O6"
hasMW dp "500"^^integer
hasName dp "Ararobinol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

439501ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#439501

belongs to
Drug c
has facts
has common name dp "ouabain; G-Strophanthin; Oubain"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydro..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C29H44O12"
hasMW dp "584"^^integer
hasName dp "Ouabain"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

439533ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#439533

belongs to
Drug c
has facts
has common name dp "TAXIFOLIN; 480-18-2; (+)-Taxifolin"
hasFunction dp "Antiviral"
hasIUPACName dp "(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro..."
hasLatestDatabaseUpdate dp "44167"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C15H12O7"
hasMW dp "304"^^integer
hasName dp "Taxifolin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

44093ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44093

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C9H15NO3S"
hasMW dp "290"^^integer
hasName dp "Captopril"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

440936ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#440936

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C12H16O7"
hasMW dp "250"^^integer
hasName dp "Arbutin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

441145ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#441145

belongs to
Drug c
has facts
has common name dp "monensin; Monensic acid; monensin A"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-[(2R,5S)-5-ethyl-5-[(2R,3S,..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C36H62O11"
hasMW dp "670"^^integer
hasName dp "Monensin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

441207ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#441207

belongs to
Drug c
has facts
has common name dp "digitoxin; Digitoxoside; 71-63-6"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C41H64O13"
hasMW dp "764"^^integer
hasName dp "Digitoxin"
hasNumberOfReferences dp "6"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

441243ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#441243

belongs to
Drug c
has facts
has common name dp "SAQUINAVIR; 127779-20-8; Invirase"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C38H50N6O5"
hasMW dp "670"^^integer
hasName dp "Saquinavir"
hasNumberOfReferences dp "11"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

441300ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#441300

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C14H18N6O"
hasMW dp "330"^^integer
hasName dp "Abacavir"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

441401ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#441401

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C16H20FN3O4"
hasMW dp "350"^^integer
hasName dp "Linezolid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

44153669ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44153669

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C37H39ClN4O5S"
hasMW dp "200"^^integer
hasName dp "KW-8232"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

44182295ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44182295

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C9H20F3IN2O5S"
hasMW dp "300"^^integer
hasName dp "Refametinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

44187362ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44187362

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C15H15FIN3O3"
hasMW dp "200"^^integer
hasName dp "Pimasertib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

44205240ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44205240

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44214"^^date time
hasLatestPublicationDate dp "44148"^^date time
hasMF dp "C16H17N7O2S"
hasMW dp "400"^^integer
hasName dp "Baricitinib"
hasNumberOfReferences dp "6"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Emergency use authorization"

44217246ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44217246

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C30H29N5O6S2"
hasMW dp "700"^^integer
hasName dp "4SC-202"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

442428ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#442428

belongs to
Drug c
has facts
has common name dp "naringin; 10236-47-2; Naringoside"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C27H32O14"
hasMW dp "580"^^integer
hasName dp "Naringin"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

442439ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#442439

belongs to
Drug c
has facts
has common name dp "Neohesperidin; 13241-33-3; UNII-OA5C88H3L0"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44165"^^date time
hasMF dp "C28H34O15"
hasMW dp "610"^^integer
hasName dp "Neohesperidin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

44247568ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44247568

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "C20H23N3O2"
hasMW dp "400"^^integer
hasName dp "E-52862"
hasName dp "S1RA"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"
hasStatus dp "Potential treatment - theoretical effect"

44257178ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44257178

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C25H30O6"
hasMW dp "500"^^integer
hasName dp "Broussoflavan A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

442884ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#442884

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44123"^^date time
hasMF dp "C20H19N3O3"
hasMW dp "400"^^integer
hasName dp "Anisotine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

443654ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#443654

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C22H23O11"
hasMW dp "400"^^integer
hasName dp "Peonidin 3-O-glucoside"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

443869ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#443869

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C27H29N3O6"
hasMW dp "500"^^integer
hasName dp "Barnidipine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

444485ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#444485

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C1H35N7O13P2S"
hasMW dp "600"^^integer
hasName dp "Dephospho coenzyme A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

44462760ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44462760

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C3H20F3N5O2S2"
hasMW dp "600"^^integer
hasName dp "Dabrafenib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

44465558ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44465558

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C25H34N6O2"
hasMW dp "600"^^integer
hasName dp "ZINC95559591"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

44479007ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44479007

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C27H51N8O3P"
hasMW dp "700"^^integer
hasName dp "Burixafor"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

444795ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#444795

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C20H28O2"
hasMW dp "400"^^integer
hasName dp "Tretinoin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

445154ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#445154

belongs to
Drug c
has facts
has common name dp "resveratrol; 501-36-0; trans-resveratrol"
hasFunction dp "Antiviral"
hasIUPACName dp "5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44157"^^date time
hasMF dp "C14H12O3"
hasMW dp "228"^^integer
hasName dp "Resveratrol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

445643ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#445643

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C44H69NO12"
hasMW dp "0"^^integer
hasName dp "FK-506"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

446006ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#446006

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C15H24N5O16P3"
hasMW dp "300"^^integer
hasName dp "NA7"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

44603531ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44603531

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44078"^^date time
hasMF dp "C38H50N6O9S"
hasMW dp "900"^^integer
hasName dp "Grazoprevir"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

44606238ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44606238

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C26H32O13"
hasMW dp "500"^^integer
hasName dp "Khainaoside B"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

44606239ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#44606239

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C25H28O11"
hasMW dp "500"^^integer
hasName dp "Khainaoside C"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

446155ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#446155

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44026"^^date time
hasMF dp "C24H26FNO4"
hasMW dp "500"^^integer
hasName dp "Fluvastatin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

446157ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#446157

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C22H28FN3O6S"
hasMW dp "500"^^integer
hasName dp "Rosuvastatin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

446378ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#446378

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C34H50O12"
hasMW dp "800"^^integer
hasName dp "Thapsigargin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

446541ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#446541

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43956"^^date time
hasMF dp "C17H20O6"
hasMW dp "300"^^integer
hasName dp "Mycophenolic acid"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

447043ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#447043

belongs to
Drug c
has facts
has common name dp "azithromycin; Zithromax; 83905-01-5"
hasFunction dp "Other treatment"
hasIUPACName dp "(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(di..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44169"^^date time
hasMF dp "C38H72N2O12"
hasMW dp "749"^^integer
hasName dp "Azithromycin"
hasNumberOfReferences dp "25"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

4477ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4477

belongs to
Drug c
has facts
has common name dp "niclosamide; 50-65-7; 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide"
hasFunction dp "Antiviral"
hasIUPACName dp "5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide"
hasLatestDatabaseUpdate dp "44176"^^date time
hasLatestPublicationDate dp "44169"^^date time
hasMF dp "C13H8Cl2N2O4"
hasMW dp "327"^^integer
hasName dp "Niclosamide"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

447715ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#447715

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43993"^^date time
hasMF dp "C26H44O4"
hasMW dp "600"^^integer
hasName dp "Obeticholic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

448108ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#448108

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C19H27N7O20P4"
hasMW dp "300"^^integer
hasName dp "Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate]"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

449241ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#449241

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C20H20BrN3O2S"
hasMW dp "400"^^integer
hasName dp "H-89"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

45100495ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#45100495

belongs to
Drug c
has facts
has common name dp "1031413-61-2; 1'-(1h-indazol-7-ylcarbonyl)-6-methylspiro[chromene-2,4'-piperidin]-4(3h)-one; CHEMBL1090121"
hasFunction dp "Antiviral"
hasIUPACName dp "1'-(1H-indazole-7-carbonyl)-6-methylspiro[3H-chromene-2,4'-p..."
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44162"^^date time
hasMF dp "C22H21N3O3"
hasMW dp "375"^^integer
hasName dp "B38"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

45110509ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#45110509

belongs to
Drug c
has facts
has common name dp "Paritaprevir; Veruprevir; ABT-450"
hasFunction dp "Antiviral"
hasIUPACName dp "(1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyr..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C40H43N7O7S"
hasMW dp "765"^^integer
hasName dp "Paritaprevir"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

45137165ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#45137165

belongs to
Drug c
has facts
has common name dp "PBDNJ0803; (2R,3R,4R,5S)-1-[6-(2,5-Dimethylphenoxy)hexyl]-2-(hydroxymethyl)piperidine-3,4,5-triol; CHEMBL1652119"
hasFunction dp "Antiviral"
hasIUPACName dp "(2R,3R,4R,5S)-1-[6-(2,5-dimethylphenoxy)hexyl]-2-(hydroxymet..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C20H33NO5"
hasMW dp "367"^^integer
hasName dp "PBDNJ0803"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

451415ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#451415

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44123"^^date time
hasMF dp "C42H53NO15"
hasMW dp "900"^^integer
hasName dp "Aclarubicin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

451417ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#451417

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C30H49N9O9"
hasMW dp "800"^^integer
hasName dp "Thymopentin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

451658ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#451658

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43893"^^date time
hasMF dp "C24H52BrNO2S"
hasMW dp "600"^^integer
hasName dp "CP-7"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

452548ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#452548

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C32H32O13S"
hasMW dp "700"^^integer
hasName dp "Teniposide"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

45375808ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#45375808

belongs to
Drug c
has facts
has common name dp "SOFOSBUVIR; PSI-7977; SOVALDI"
hasFunction dp "Antiviral"
hasIUPACName dp "propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44183"^^date time
hasMF dp "C22H29FN3O9P"
hasMW dp "529"^^integer
hasName dp "Sofosbuvir"
hasNumberOfReferences dp "11"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

45375953ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#45375953

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C15H15N7O"
hasMW dp "330"^^integer
hasName dp "Sapanisertib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

454217ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#454217

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C22H30O6"
hasMW dp "500"^^integer
hasName dp "Prostratin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

45485025ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#45485025

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44126"^^date time
hasMF dp "C28H38N8O4"
hasMW dp "700"^^integer
hasName dp "Hordatine A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

454937ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#454937

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C6H11AuO5S"
hasMW dp "180"^^integer
hasName dp "Aurothioglucose"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

457193ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#457193

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43906"^^date time
hasMF dp "C62H86N12O16"
hasMW dp "400"^^integer
hasName dp "Dactinomycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

4594ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4594

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44173"^^date time
hasLatestPublicationDate dp "44040"^^date time
hasMF dp "C17H19N3O3S"
hasMW dp "400"^^integer
hasName dp "Omeprazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

46215462ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#46215462

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C30H34N8"
hasMW dp "600"^^integer
hasName dp "Bemcentinib"
hasName dp "R-428"
hasNumberOfReferences dp "1"^^integer
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

46220502ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#46220502

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44095"^^date time
hasMF dp "C27H32F2N8"
hasMW dp "600"^^integer
hasName dp "Abemaciclib"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

4628ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4628

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C13H11NO5"
hasMW dp "230"^^integer
hasName dp "Oxolinic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

464205ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#464205

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44141"^^date time
hasMF dp "C9H14N5O4P"
hasMW dp "210"^^integer
hasName dp "Tenofovir"
hasNumberOfReferences dp "6"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

468595ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#468595

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44145"^^date time
hasMF dp "C37H42F2N8O4"
hasMW dp "800"^^integer
hasName dp "Posaconazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

46907787ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#46907787

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C23H25ClN4O2S"
hasMW dp "0"^^integer
hasName dp "JQ1"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

46908905ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#46908905

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C23H21N3O4"
hasMW dp "400"^^integer
hasName dp "DS-6930"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

46912230ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#46912230

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C17H22N8O"
hasMW dp "400"^^integer
hasName dp "VS-5584"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

46934000ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#46934000

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44087"^^date time
hasMF dp "C24H20N4O4"
hasMW dp "400"^^integer
hasName dp "Z93"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

46943415ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#46943415

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44138"^^date time
hasMF dp "C11H9Br4N3O2"
hasMW dp "820"^^integer
hasName dp "TMCB"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

471161ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#471161

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C15H19Cl2N3O4"
hasMW dp "200"^^integer
hasName dp "Maribavir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

471426ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#471426

belongs to
Drug c
has facts
has common name dp "Euscaphic acid; 53155-25-2; Jacarandic acid"
hasFunction dp "Antiviral"
hasIUPACName dp "(1R,2R,4aS,6aR,6aS,6bR,8aR,10S,11R,12aR,14bS)-1,10,11-trihyd..."
hasLatestDatabaseUpdate dp "44210"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C30H48O5"
hasMW dp "488"^^integer
hasName dp "Euscaphic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

4735ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4735

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C19H24N4O2"
hasMW dp "400"^^integer
hasName dp "Pentamidine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

4775ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4775

belongs to
Drug c
has facts
has common name dp "4-PHENYLBUTYRIC ACID; 4-Phenylbutanoic acid; 1821-12-1"
hasFunction dp "Antiviral"
hasIUPACName dp "4-phenylbutanoic acid"
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C10H12O2"
hasMW dp "164"^^integer
hasName dp "4-Phenylbutyric acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

479503ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#479503

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44133"^^date time
hasMF dp "C16H16O5"
hasMW dp "290"^^integer
hasName dp "Shikonin"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

483477ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#483477

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44051"^^date time
hasMF dp "C27H52N3O7P"
hasMW dp "700"^^integer
hasName dp "Brincidofovir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

4893ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4893

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43939"^^date time
hasMF dp "C19H21N5O4"
hasMW dp "400"^^integer
hasName dp "Prazosin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

492405ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#492405

belongs to
Drug c
has facts
has common name dp "Favipiravir; 259793-96-9; 6-FLUORO-3-HYDROXYPYRAZINE-2-CARBOXAMIDE"
hasFunction dp "Antiviral"
hasIUPACName dp "5-fluoro-2-oxo-1H-pyrazine-3-carboxamide"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C5H4FN3O2"
hasMW dp "157"^^integer
hasName dp "Favipiravir"
hasNumberOfReferences dp "24"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Approved for COVID-19 treatment (China, India, Russia)"

493570ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#493570

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44064"^^date time
hasMF dp "C17H20N4O6"
hasMW dp "400"^^integer
hasName dp "Riboflavin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

4971ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#4971

belongs to
Drug c
has facts
has common name dp "protoporphyrin IX; protoporphyrin; 553-12-8"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetrameth..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44174"^^date time
hasMF dp "C34H34N4O4"
hasMW dp "562"^^integer
hasName dp "Protoporphyrin IX"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

49800004ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#49800004

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C56H98N16O13"
hasMW dp "500"^^integer
hasName dp "Polymyxin B"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

49803313ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#49803313

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "C29H44N8O3"
hasMW dp "700"^^integer
hasName dp "Gilteritinib"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

49806720ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#49806720

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C30H34N4O2"
hasMW dp "600"^^integer
hasName dp "Alectinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

49836020ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#49836020

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44063"^^date time
hasMF dp "C42H56F2N8O6"
hasMW dp "900"^^integer
hasName dp "Birinapant"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

49843508ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#49843508

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C33H48N6O5"
hasMW dp "800"^^integer
hasName dp "GB110"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

49849508ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#49849508

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43987"^^date time
hasMF dp "C17H17Cl2NO"
hasMW dp "200"^^integer
hasName dp "Asenapine hydrochloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

500902ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#500902

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44133"^^date time
hasMF dp "C10H15N3O5"
hasMW dp "240"^^integer
hasName dp "2'-C-Methylcytidine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

50248ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#50248

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44040"^^date time
hasMF dp "C14H9Cl3N2OS"
hasMW dp "700"^^integer
hasName dp "Triclabendazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5035ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5035

belongs to
Drug c
has facts
has common name dp "raloxifene; 84449-90-1; Keoxifene"
hasFunction dp "Antiviral"
hasIUPACName dp "[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-p..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C28H27NO4S"
hasMW dp "473"^^integer
hasName dp "Raloxifene"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

503737ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#503737

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43953"^^date time
hasMF dp "C21H22O9"
hasMW dp "400"^^integer
hasName dp "Liquiritin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

503982ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#503982

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44100"^^date time
hasMF dp "C16H33NO5"
hasMW dp "440"^^integer
hasName dp "N-9-Methoxynonyldeoxynojirimycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

5083ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5083

belongs to
Drug c
has facts
has common name dp "ro 31-8220; bisindolylmaleimide IX; 125314-64-9"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl..."
hasLatestDatabaseUpdate dp "44214"^^date time
hasLatestPublicationDate dp "44210"^^date time
hasMF dp "C25H23N5O2S"
hasMW dp "457"^^integer
hasName dp "Bisindolylmaleimide IX"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

50918847ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#50918847

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44150"^^date time
hasMF dp "C28H36N4O2S"
hasMW dp "700"^^integer
hasName dp "S,S-Exo-lurasidone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

51358113ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#51358113

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44007"^^date time
hasMF dp "C24H15F3N4O"
hasMW dp "400"^^integer
hasName dp "Torin2"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

515964ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#515964

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44044"^^date time
hasMF dp "C20H14N2O3"
hasMW dp "300"^^integer
hasName dp "1-(2-Naphthylmethyl)-2,3-dioxo-indoline-5-carboxamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

51634ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#51634

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43969"^^date time
hasMF dp "C10H21NO4"
hasMW dp "280"^^integer
hasName dp "Miglustat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

525328ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#525328

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H8S2"
hasMW dp "300"^^integer
hasName dp "3-vinyl-1,2-dithiacyclohex-4-ene"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

525330ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#525330

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H12S3"
hasMW dp "400"^^integer
hasName dp "Trisulfide, 2-propenyl propyl"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

525331ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#525331

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C3H4S2"
hasMW dp "200"^^integer
hasName dp "1,2-dithiole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5271805ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5271805

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44138"^^date time
hasMF dp "C32H22O10"
hasMW dp "500"^^integer
hasName dp "Ginkgetin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5273567ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5273567

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44065"^^date time
hasMF dp "C23H26O11"
hasMW dp "400"^^integer
hasName dp "Calceolarioside B"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5276890ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5276890

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44126"^^date time
hasMF dp "C22H18O11"
hasMW dp "400"^^integer
hasName dp "Gallocatechin gallate"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5277135ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5277135

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C23H23ClFNO5"
hasMW dp "900"^^integer
hasName dp "Elvitegravir"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5280343ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280343

belongs to
Drug c
has facts
has common name dp "quercetin; 117-39-5; Meletin"
hasFunction dp "Antiviral"
hasIUPACName dp "2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one"
hasLatestDatabaseUpdate dp "44175"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C15H10O7"
hasMW dp "302"^^integer
hasName dp "Quercetin"
hasNumberOfReferences dp "9"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5280445ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280445

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44142"^^date time
hasMF dp "C15H10O6"
hasMW dp "240"^^integer
hasName dp "Luteolin"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5280453ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280453

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44153"^^date time
hasMF dp "C27H44O3"
hasMW dp "600"^^integer
hasName dp "Calcitriol"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5280459ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280459

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C21H20O11"
hasMW dp "400"^^integer
hasName dp "Quercitrin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5280544ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280544

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C15H10O7"
hasMW dp "230"^^integer
hasName dp "Herbacetin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

5280633ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280633

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44199"^^date time
hasLatestPublicationDate dp "44114"^^date time
hasMF dp "C16H18O9"
hasMW dp "310"^^integer
hasName dp "Neochlorogenic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

5280637ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280637

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C21H20O11"
hasMW dp "400"^^integer
hasName dp "Galuteolin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5280795ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280795

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44147"^^date time
hasMF dp "C27H44O"
hasMW dp "600"^^integer
hasName dp "Vitamin D3"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5280805ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280805

belongs to
Drug c
has facts
has common name dp "RUTIN; 153-18-4; rutoside"
hasFunction dp "Antiviral"
hasIUPACName dp "2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,..."
hasLatestDatabaseUpdate dp "44203"^^date time
hasLatestPublicationDate dp "44173"^^date time
hasMF dp "C27H30O16"
hasMW dp "610"^^integer
hasName dp "Rutin"
hasNumberOfReferences dp "5"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

5280863ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280863

belongs to
Drug c
has facts
has common name dp "kaempferol; 520-18-3; Kempferol"
hasFunction dp "Antiviral"
hasIUPACName dp "3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one"
hasLatestDatabaseUpdate dp "44215"^^date time
hasLatestPublicationDate dp "44211"^^date time
hasMF dp "C15H10O6"
hasMW dp "286"^^integer
hasName dp "Kaempferol"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

5280965ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5280965

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44145"^^date time
hasMF dp "C47H73NO17"
hasMW dp "100"^^integer
hasName dp "Amphotericin B"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5281040ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281040

belongs to
Drug c
has facts
has common name dp "montelukast; 158966-92-8; Singulair"
hasFunction dp "Antiviral"
hasIUPACName dp "2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]pheny..."
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44176"^^date time
hasMF dp "C35H36ClNO3S"
hasMW dp "586"^^integer
hasName dp "Montelukast"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5281081ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281081

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C14H15N3O5"
hasMW dp "290"^^integer
hasName dp "Entacapone"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5281104ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281104

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C27H44O3"
hasMW dp "600"^^integer
hasName dp "Paricalcitol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5281232ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281232

belongs to
Drug c
has facts
has common name dp "Crocetin; 27876-94-4; Transcrocetin"
hasFunction dp "Antiviral"
hasIUPACName dp "(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44177"^^date time
hasMF dp "C20H24O4"
hasMW dp "328"^^integer
hasName dp "Crocetin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281599ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281599

belongs to
Drug c
has facts
has common name dp "Agathisflavone; 6,8''-Biapigenin; 28441-98-7"
hasFunction dp "Antiviral"
hasIUPACName dp "8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-6-yl]-5,7-..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C30H18O10"
hasMW dp "538"^^integer
hasName dp "Agathisflavone"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281600ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281600

belongs to
Drug c
has facts
has common name dp "Amentoflavone; 1617-53-4; Didemethyl-ginkgetin"
hasFunction dp "Antiviral"
hasIUPACName dp "8-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenyl]-5,7-..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C30H18O10"
hasMW dp "538"^^integer
hasName dp "Amentoflavone"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281605ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281605

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44148"^^date time
hasMF dp "C15H10O5"
hasMW dp "240"^^integer
hasName dp "Baicalein"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

5281607ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281607

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44123"^^date time
hasMF dp "MF: C15H10O4"
hasMW dp "240"^^integer
hasName dp "Chrysin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281609ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281609

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C30H18O10"
hasMW dp "500"^^integer
hasName dp "Cupressuflavone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281616ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281616

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44061"^^date time
hasMF dp "C15H10O5"
hasMW dp "240"^^integer
hasName dp "Galangin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281654ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281654

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44175"^^date time
hasLatestPublicationDate dp "44142"^^date time
hasMF dp "C16H12O7"
hasMW dp "260"^^integer
hasName dp "Isorhamnetin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281672ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281672

belongs to
Drug c
has facts
has common name dp "myricetin; 529-44-2; Cannabiscetin"
hasFunction dp "Antiviral"
hasIUPACName dp "3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44193"^^date time
hasMF dp "C15H10O8"
hasMW dp "318"^^integer
hasName dp "Myricetin"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281673ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281673

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C21H20O12"
hasMW dp "400"^^integer
hasName dp "Myricitrin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281691ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281691

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44117"^^date time
hasMF dp "C16H12O7"
hasMW dp "260"^^integer
hasName dp "Rhamnetin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281694ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281694

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C30H18O10"
hasMW dp "500"^^integer
hasName dp "Robustaflavone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281701ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281701

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C15H10O7"
hasMW dp "230"^^integer
hasName dp "Tricetin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281703ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281703

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44126"^^date time
hasMF dp "C16H12O5"
hasMW dp "260"^^integer
hasName dp "Wogonin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281718ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281718

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44126"^^date time
hasMF dp "C20H22O8"
hasMW dp "400"^^integer
hasName dp "Polydatin"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281773ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281773

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44199"^^date time
hasLatestPublicationDate dp "44114"^^date time
hasMF dp "C29H36O15"
hasMW dp "600"^^integer
hasName dp "Forsythiaside"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

5281855ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281855

belongs to
Drug c
has facts
has common name dp "ellagic acid; 476-66-4; Benzoaric acid"
hasFunction dp "Antiviral"
hasIUPACName dp "6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,1..."
hasLatestDatabaseUpdate dp "44210"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C14H6O8"
hasMW dp "302"^^integer
hasName dp "Ellagic acid"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5281881ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5281881

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C23H25F3N2OS"
hasMW dp "500"^^integer
hasName dp "Flupentixol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5282398ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5282398

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43917"^^date time
hasMF dp "C30H37N3O8S2"
hasMW dp "800"^^integer
hasName dp "Thiethylperazine maleate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5282411ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5282411

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44101"^^date time
hasMF dp "C20H32O5"
hasMW dp "500"^^integer
hasName dp "Epoprostenol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5282452ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5282452

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44097"^^date time
hasMF dp "C25H24FNO4"
hasMW dp "500"^^integer
hasName dp "Pitavastatin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5282745ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5282745

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C16H30O2"
hasMW dp "410"^^integer
hasName dp "9-hexadecenoic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

5283731ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5283731

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44072"^^date time
hasMF dp "C27H44O2"
hasMW dp "600"^^integer
hasName dp "Calcifediol"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5283734ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5283734

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C27H44O3"
hasMW dp "600"^^integer
hasName dp "Tacalcitol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5283748ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5283748

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C27H44O3"
hasMW dp "600"^^integer
hasName dp "Secalciferol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5284360ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5284360

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44141"^^date time
hasMF dp "C21H26N4O8S"
hasMW dp "500"^^integer
hasName dp "Camostat mesylate"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5284373ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5284373

belongs to
Drug c
has facts
has common name dp "cyclosporin A; cyclosporine; Ciclosporin"
hasFunction dp "Other treatment"
hasIUPACName dp "(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44176"^^date time
hasMF dp "C62H111N11O12"
hasMW dp "1202"^^integer
hasName dp "Cyclosporine"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5284596ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5284596

belongs to
Drug c
has facts
has common name dp "naloxone; l-Naloxone; 465-65-6"
hasFunction dp "Antiviral"
hasIUPACName dp "(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13..."
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C19H21NO4"
hasMW dp "327"^^integer
hasName dp "Naloxone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5284613ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5284613

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C30H42O8"
hasMW dp "600"^^integer
hasName dp "Proscillaridin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5284616ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5284616

belongs to
Drug c
has facts
has common name dp "(-)-Rapamycin; 53123-88-9; AY 22989"
hasFunction dp "Antiviral"
hasIUPACName dp "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44176"^^date time
hasMF dp "C51H79NO13"
hasMW dp "914"^^integer
hasName dp "Rapamycin"
hasNumberOfReferences dp "5"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5288783ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5288783

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C27H40O3"
hasMW dp "600"^^integer
hasName dp "Calcipotriene"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5291ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5291

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44095"^^date time
hasMF dp "C29H31N7O"
hasMW dp "600"^^integer
hasName dp "Imatinib"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

52938427ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#52938427

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C23H24N4O3"
hasMW dp "500"^^integer
hasName dp "Ozanimod"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

52947239ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#52947239

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C5H7N6NaO5S"
hasMW dp "200"^^integer
hasName dp "Triazavirin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - clinical evidence"

5311054ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5311054

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C52H98N16O13"
hasMW dp "400"^^integer
hasName dp "Polymyxin E"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5311180ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5311180

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C21H25N5O8S2"
hasMW dp "600"^^integer
hasName dp "Nafamostat mesylate"
hasNumberOfReferences dp "10"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5311181ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5311181

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44101"^^date time
hasMF dp "C22H32O4"
hasMW dp "500"^^integer
hasName dp "Iloprost"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5311497ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5311497

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C45H54N4O8"
hasMW dp "900"^^integer
hasName dp "Vinorelbine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5311498ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5311498

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44061"^^date time
hasMF dp "CH88CoN14O14P"
hasMW dp "400"^^integer
hasName dp "Vitamin B12"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - clinical evidence"

5312125ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5312125

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44129"^^date time
hasMF dp "C25H32F3N3O4"
hasMW dp "500"^^integer
hasName dp "Silodosin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5315ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5315

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C13H13N3O5S2"
hasMW dp "400"^^integer
hasName dp "Succinylsulfathiazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

5315459ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5315459

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44138"^^date time
hasMF dp "C31H20O10"
hasMW dp "500"^^integer
hasName dp "Bilobetin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5315472ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5315472

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C19H16O4"
hasMW dp "300"^^integer
hasName dp "Bisdemethoxycurcumin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5316606ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5316606

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C21H24O8"
hasMW dp "400"^^integer
hasName dp "Deoxyrhapontin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

5318517ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5318517

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44068"^^date time
hasMF dp "C20H30O5"
hasMW dp "400"^^integer
hasName dp "Andrographolide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

5318997ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5318997

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C33H40O15"
hasMW dp "700"^^integer
hasName dp "Icariin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5320053ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5320053

belongs to
Drug c
has facts
has common name dp "Neobavaisoflavone; 41060-15-5; 3'-Prenyldaidzein"
hasFunction dp "Antiviral"
hasIUPACName dp "7-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromen-..."
hasLatestDatabaseUpdate dp "44174"^^date time
hasLatestPublicationDate dp "44163"^^date time
hasMF dp "C20H18O4"
hasMW dp "322"^^integer
hasName dp "Neobavaisoflavone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5320863ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5320863

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C20H18O11"
hasMW dp "300"^^integer
hasName dp "Quercetin-3-D-xyloside"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5324346ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5324346

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44147"^^date time
hasMF dp "C15H21F3N2O2"
hasMW dp "330"^^integer
hasName dp "Fluvoxamine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5328940ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5328940

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C26H29Cl2N5O3"
hasMW dp "400"^^integer
hasName dp "Bosutinib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5329ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5329

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C10H11N3O3S"
hasMW dp "280"^^integer
hasName dp "Sulfamethoxazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5329102ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5329102

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44139"^^date time
hasMF dp "C22H27FN4O2"
hasMW dp "500"^^integer
hasName dp "Sunitinib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5330286ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5330286

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C24H29N7O2"
hasMW dp "500"^^integer
hasName dp "Palbociclib"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5333ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5333

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C6H8N2O2S"
hasMW dp "210"^^integer
hasName dp "Sulfanilamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

53340666ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#53340666

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C24H27N5O3"
hasMW dp "500"^^integer
hasName dp "Rocilinostat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

5335621ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5335621

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C17H13N3O7"
hasMW dp "300"^^integer
hasName dp "PYR-41"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

53361968ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#53361968

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44123"^^date time
hasMF dp "C38H53N5O7S2"
hasMW dp "0"^^integer
hasName dp "TMC-310911"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

53477715ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#53477715

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43961"^^date time
hasMF dp "C14H25NO21S3"
hasMW dp "500"^^integer
hasName dp "Heparan sulphate"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5352855ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5352855

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H10S2"
hasMW dp "300"^^integer
hasName dp "Allyl (E)-1-propenyl disulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5352907ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5352907

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H10S2"
hasMW dp "300"^^integer
hasName dp "Allyl (Z)-1-propenyl disulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5352909ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5352909

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H10S3"
hasMW dp "300"^^integer
hasName dp "Trisulfide, (1E)-1-propenyl 2-propenyl"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5353365ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5353365

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C16H15ClN4O2"
hasMW dp "770"^^integer
hasName dp "8-(3-Chlorostyryl)caffeine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

5361ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5361

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44034"^^date time
hasMF dp "C51H40N6O23S6"
hasMW dp "300"^^integer
hasName dp "Suramin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5362119ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5362119

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C21H31N3O5"
hasMW dp "500"^^integer
hasName dp "Lisinopril"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5362391ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5362391

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44097"^^date time
hasMF dp "C18H17F3N2O3"
hasMW dp "300"^^integer
hasName dp "Ridogrel"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

5362440ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5362440

belongs to
Drug c
has facts
has common name dp "indinavir; 150378-17-9; Compound J"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C36H47N5O4"
hasMW dp "613"^^integer
hasName dp "Indinavir"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5366552ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5366552

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C4H8S2"
hasMW dp "200"^^integer
hasName dp "1-propenyl methyl disulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5388906ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5388906

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44129"^^date time
hasMF dp "C32H31BrN2O2"
hasMW dp "500"^^integer
hasName dp "Bedaquiline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5388925ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5388925

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C60H91N5O13"
hasMW dp "400"^^integer
hasName dp "Sanglifehrin A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

5388962ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5388962

belongs to
Drug c
has facts
has common name dp "enalapril; 75847-73-3; Vasotec"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amin..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44187"^^date time
hasMF dp "C20H28N2O5"
hasMW dp "376"^^integer
hasName dp "Enalapril"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5403ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5403

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C12H19NO3"
hasMW dp "280"^^integer
hasName dp "Terbutaline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5426ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5426

belongs to
Drug c
has facts
has common name dp "thalidomide; 50-35-1; Thalomid"
hasFunction dp "Other treatment"
hasIUPACName dp "2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione"
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C13H10N2O4"
hasMW dp "258"^^integer
hasName dp "Thalidomide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

54445ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54445

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44151"^^date time
hasMF dp "C8H15NO4"
hasMW dp "210"^^integer
hasName dp "Castanospermine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

54454ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54454

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C25H38O5"
hasMW dp "600"^^integer
hasName dp "Simvastatin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5452ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5452

belongs to
Drug c
has facts
has common name dp "thioridazine; Mellaril; 50-52-2"
hasFunction dp "Antiviral"
hasIUPACName dp "10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenoth..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C21H26N2S2"
hasMW dp "370"^^integer
hasName dp "Thioridazine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

54575456ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54575456

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C23H24N8O4S"
hasMW dp "600"^^integer
hasName dp "Fimepinostat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

5458428ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5458428

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C30H37NO6"
hasMW dp "600"^^integer
hasName dp "Cytochalasin D"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5462224ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5462224

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43992"^^date time
hasMF dp "No MF"
hasMW dp "305"^^integer
hasName dp "Magnesium"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5467ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5467

belongs to
Drug c
has facts
has common name dp "tiapride; 51012-32-9; Thiapride"
hasFunction dp "Antiviral"
hasIUPACName dp "N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamid..."
hasLatestDatabaseUpdate dp "44182"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C15H24N2O4S"
hasMW dp "328"^^integer
hasName dp "Tiapride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

54670067ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54670067

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44152"^^date time
hasMF dp "C6H8O6"
hasMW dp "120"^^integer
hasName dp "Ascorbic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - clinical evidence"

54671008ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54671008

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44141"^^date time
hasMF dp "C20H21FN6O5"
hasMW dp "400"^^integer
hasName dp "Raltegravir"
hasNumberOfReferences dp "5"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

54671203ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54671203

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44135"^^date time
hasMF dp "C22H24N2O8"
hasMW dp "400"^^integer
hasName dp "Doxycycline"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

54675776ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54675776

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C22H24N2O8"
hasMW dp "400"^^integer
hasName dp "Tetracycline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

54675777ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54675777

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44145"^^date time
hasMF dp "C22H23ClN2O8"
hasMW dp "900"^^integer
hasName dp "Chlortetracycline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

54675779ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54675779

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C22H24N2O9"
hasMW dp "400"^^integer
hasName dp "Oxytetracycline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

54682461ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54682461

belongs to
Drug c
has facts
has common name dp "Tipranavir; 174484-41-4; Aptivus"
hasFunction dp "Antiviral"
hasIUPACName dp "N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propy..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C31H33F3N2O5S"
hasMW dp "602"^^integer
hasName dp "Tipranavir"
hasNumberOfReferences dp "6"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

54686904ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54686904

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C29H39N5O8"
hasMW dp "600"^^integer
hasName dp "Tigecycline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

54687ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54687

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C23H36O7"
hasMW dp "500"^^integer
hasName dp "Pravastatin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5469424ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5469424

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C20H18O5"
hasMW dp "400"^^integer
hasName dp "Demethoxycurcumin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

54708748ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54708748

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44076"^^date time
hasMF dp "C32H44N2O9"
hasMW dp "700"^^integer
hasName dp "Streptolydigin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

54713659ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54713659

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C19H17F2N3O5"
hasMW dp "400"^^integer
hasName dp "Cabotegravir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

54726191ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54726191

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44130"^^date time
hasMF dp "C20H19F2N3O5"
hasMW dp "400"^^integer
hasName dp "Dolutegravir"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

54732242ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#54732242

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C32H34N4O6"
hasMW dp "600"^^integer
hasName dp "Naldemedine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5475ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5475

belongs to
Drug c
has facts
has common name dp "tilorone; 27591-97-5; Bis-DEAE-fluorenone"
hasFunction dp "Antiviral"
hasIUPACName dp "2,7-bis[2-(diethylamino)ethoxy]fluoren-9-one"
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C25H34N2O3"
hasMW dp "410"^^integer
hasName dp "Tilorone"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5475158ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5475158

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C20H24N2OS"
hasMW dp "500"^^integer
hasName dp "Cinanserin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

5479530ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5479530

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43868"^^date time
hasMF dp "C18H18N8O7S3"
hasMW dp "600"^^integer
hasName dp "Ceftriaxone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5479537ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5479537

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44095"^^date time
hasMF dp "C19H24N6O5S2"
hasMW dp "600"^^integer
hasName dp "Cefepime"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5479539ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5479539

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44095"^^date time
hasMF dp "C22H22N6O5S2"
hasMW dp "600"^^integer
hasName dp "Cefpirome"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5481224ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5481224

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C20H18O11"
hasMW dp "300"^^integer
hasName dp "Guaijaverin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5481663ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5481663

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "43969"^^date time
hasMF dp "C28H32O16"
hasMW dp "500"^^integer
hasName dp "Narcissoside"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

5483ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5483

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44153"^^date time
hasMF dp "C5H9NO3S"
hasMW dp "200000"^^integer
hasName dp "Tiopronin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5494422ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5494422

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C22H26FN3O2"
hasMW dp "500"^^integer
hasName dp "N-({(2S)-1-[(3R)-3-Amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-YL}methyl)benzamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

5503ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5503

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C14H21N3O3S"
hasMW dp "400"^^integer
hasName dp "Tolazamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5566ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5566

belongs to
Drug c
has facts
has common name dp "trifluoperazine; Trifluperazine; Trifluoroperazine"
hasFunction dp "Antiviral"
hasIUPACName dp "10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phe..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C21H24F3N3S"
hasMW dp "407"^^integer
hasName dp "Trifluoperazine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5574ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5574

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C18H22N2S"
hasMW dp "400"^^integer
hasName dp "Trimeprazine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5584ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5584

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44023"^^date time
hasMF dp "C20H26N2"
hasMW dp "400"^^integer
hasName dp "Trimipramine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5625ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5625

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43955"^^date time
hasMF dp "C22H28N6O3S"
hasMW dp "600"^^integer
hasName dp "Delavirdine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

56841801ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#56841801

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C23H24ClFeN3"
hasMW dp "800"^^integer
hasName dp "Ferroquine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

56843850ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#56843850

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43987"^^date time
hasMF dp "C18H23BrN2S"
hasMW dp "400"^^integer
hasName dp "Vortioxetine hydrobromide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

56845155ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#56845155

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C37H41ClN2O6"
hasMW dp "200"^^integer
hasName dp "Berbamine hydrochloride"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

5702160ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5702160

belongs to
Drug c
has facts
has common name dp "famotidine; 76824-35-6; Pepcid AC"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfa..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44169"^^date time
hasMF dp "C8H15N7O2S3"
hasMW dp "337"^^integer
hasName dp "Famotidine"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5702162ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5702162

belongs to
Drug c
has facts
has common name dp "Fendiline hydrochloride; 13636-18-5; Fendiline HCl"
hasFunction dp "Antiviral"
hasIUPACName dp "3,3-diphenyl-N-(1-phenylethyl)propan-1-amine;hydrochloride"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C23H26ClN"
hasMW dp "351"^^integer
hasName dp "Fendiline HCl"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

5702220ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5702220

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44077"^^date time
hasMF dp "C14H21Br2ClN2"
hasMW dp "590"^^integer
hasName dp "Bromhexine hydrochloride"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

57030ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#57030

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44025"^^date time
hasMF dp "C23H15F2NO2"
hasMW dp "400"^^integer
hasName dp "Brequinar"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

57389999ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#57389999

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C20H16ClN3O2"
hasMW dp "800"^^integer
hasName dp "CPI-0610"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

57412325ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#57412325

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44006"^^date time
hasMF dp "C51H88O60S13"
hasMW dp "100"^^integer
hasName dp "Pixatimod"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

5743ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5743

belongs to
Drug c
has facts
has common name dp "dexamethasone; 50-02-2; Decadron"
hasFunction dp "Other treatment"
hasIUPACName dp "(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44182"^^date time
hasMF dp "C22H29FO5"
hasMW dp "392"^^integer
hasName dp "Dexamethasone"
hasNumberOfReferences dp "10"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Emergency use authorization"

5754ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5754

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44076"^^date time
hasMF dp "C21H30O5"
hasMW dp "500"^^integer
hasName dp "Hydrocortisone"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

5755ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5755

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44118"^^date time
hasMF dp "C21H28O5"
hasMW dp "400"^^integer
hasName dp "Prednisolone"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

57697ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#57697

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C10H8N6O"
hasMW dp "210"^^integer
hasName dp "Pemirolast"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

57976227ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#57976227

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43954"^^date time
hasMF dp "C28H27Cl2N9O5"
hasMW dp "500"^^integer
hasName dp "4D5"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

58029842ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#58029842

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C24H30ClN7O3S"
hasMW dp "100"^^integer
hasName dp "Presatovir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5816ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5816

belongs to
Drug c
has facts
has common name dp "epinephrine; l-Adrenaline; L-epinephrine"
hasFunction dp "Antiviral"
hasIUPACName dp "4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol"
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C9H13NO3"
hasMW dp "183"^^integer
hasName dp "Epinephrine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

5819ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5819

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44141"^^date time
hasMF dp "C15H11I4NO4"
hasMW dp "870"^^integer
hasName dp "Levothyroxine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

58298316ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#58298316

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C21H27N5O3"
hasMW dp "500"^^integer
hasName dp "CC-223"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

58406357ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#58406357

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C20H19N5O3"
hasMW dp "400"^^integer
hasName dp "Enzaplatovir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

59472121ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#59472121

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44007"^^date time
hasMF dp "C24H25N5O3S"
hasMW dp "600"^^integer
hasName dp "Berzosertib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

5959ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#5959

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C11H12Cl2N2O5"
hasMW dp "130"^^integer
hasName dp "Chloramphenicol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6014ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6014

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43917"^^date time
hasMF dp "C17H21ClN2S"
hasMW dp "900"^^integer
hasName dp "Promethazine hydrochloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6032ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6032

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C18H36N4O11"
hasMW dp "500"^^integer
hasName dp "Kanamycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6041ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6041

belongs to
Drug c
has facts
has common name dp "phenylephrine; L-Phenylephrine; 59-42-7"
hasFunction dp "Antiviral"
hasIUPACName dp "3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol"
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C9H13NO2"
hasMW dp "167"^^integer
hasName dp "Phenylephrine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6047ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6047

belongs to
Drug c
has facts
has common name dp "levodopa; L-dopa; 59-92-7"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid"
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C9H11NO4"
hasMW dp "197"^^integer
hasName dp "Levodopa"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

60657ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#60657

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C18H29NO3"
hasMW dp "400"^^integer
hasName dp "Levobetaxolol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

60734ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#60734

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44100"^^date time
hasMF dp "C12H21NO5"
hasMW dp "300"^^integer
hasName dp "Celgosivir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

60795ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#60795

belongs to
Drug c
has facts
has common name dp "Aripiprazole; 129722-12-9; Abilify"
hasFunction dp "Antiviral"
hasIUPACName dp "7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihyd..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C23H27Cl2N3O2"
hasMW dp "448"^^integer
hasName dp "Aripiprazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

60823ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#60823

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C33H35FN2O5"
hasMW dp "600"^^integer
hasName dp "Atorvastatin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

60825ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#60825

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44133"^^date time
hasMF dp "C8H11N3O3S"
hasMW dp "260"^^integer
hasName dp "Lamivudine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

60855ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#60855

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C12H20N4O7"
hasMW dp "310"^^integer
hasName dp "Zanamivir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

60877ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#60877

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44133"^^date time
hasMF dp "C8H10FN3O3S"
hasMW dp "250"^^integer
hasName dp "Emtricitabine"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6099ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6099

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44199"^^date time
hasLatestPublicationDate dp "44120"^^date time
hasMF dp "C16H18ClN3S"
hasMW dp "900"^^integer
hasName dp "Methylene blue"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

61253ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#61253

belongs to
Drug c
has facts
has common name dp "Octyl gallate; 1034-01-1; Octyl 3,4,5-trihydroxybenzoate"
hasFunction dp "Antiviral"
hasIUPACName dp "octyl 3,4,5-trihydroxybenzoate"
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C15H22O5"
hasMW dp "282"^^integer
hasName dp "Octyl gallate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

6133ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6133

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C9H15N2O15P3"
hasMW dp "140"^^integer
hasName dp "Uridine triphosphate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

6166ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6166

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C21H30O3"
hasMW dp "500"^^integer
hasName dp "Desoxycortone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

61926ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#61926

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C4H8S3"
hasMW dp "300"^^integer
hasName dp "Allyl methyl trisulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

6197ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6197

belongs to
Drug c
has facts
has common name dp "No Usual Name"
has common name dp "cycloheximide; 66-81-9; ACTIDIONE"
hasFunction dp "Antiviral"
hasIUPACName dp "4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydrox..."
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43909"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C15H23NO4"
hasMW dp "281"^^integer
hasMW dp "350"^^integer
hasName dp "Actidione"
hasName dp "Cycloheximide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"
hasStatus dp "Potential treatment - theoretical effect"

6239ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6239

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43953"^^date time
hasMF dp "C23H32Cl3N3O"
hasMW dp "900"^^integer
hasName dp "Quinacrine dihydrochloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

62434ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#62434

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C4H8S2"
hasMW dp "200"^^integer
hasName dp "Methyl allyl disulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

6293ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6293

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44070"^^date time
hasMF dp "C14H8O4"
hasMW dp "210"^^integer
hasName dp "Alizarine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

6303ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6303

belongs to
Drug c
has facts
has common name dp "Cordycepin; 3'-Deoxyadenosine; 73-03-0"
hasFunction dp "Antiviral"
hasIUPACName dp "(2R,3R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-o..."
hasLatestDatabaseUpdate dp "44175"^^date time
hasLatestPublicationDate dp "44172"^^date time
hasMF dp "C10H13N5O3"
hasMW dp "251"^^integer
hasName dp "Cordycepin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

6321416ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6321416

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43955"^^date time
hasMF dp "C20H22N4O10S"
hasMW dp "500"^^integer
hasName dp "Cefuroxime axetil"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6321424ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6321424

belongs to
Drug c
has facts
has common name dp "IVERMECTIN; Ivermectin B1a; 70288-86-7"
hasFunction dp "Antiviral"
hasIUPACName dp "(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C48H74O14"
hasMW dp "875"^^integer
hasName dp "Ivermectin"
hasNumberOfReferences dp "12"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

6321425ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6321425

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44145"^^date time
hasMF dp "C47H72O14"
hasMW dp "100"^^integer
hasName dp "Ivermectin B1b"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6324659ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6324659

belongs to
Drug c
has facts
has common name dp "Remikiren; 126222-34-2; Ro 42-5892"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-2-benzyl-3-tert-butylsulfonyl-N-[(2S)-1-[[(2S,3R,4S)-1-..."
hasLatestDatabaseUpdate dp "44205"^^date time
hasLatestPublicationDate dp "44189"^^date time
hasMF dp "C33H50N4O6S"
hasMW dp "630"^^integer
hasName dp "Remikiren"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

636405ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#636405

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C25H24N8O7S2"
hasMW dp "600"^^integer
hasName dp "Cefpiramide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

637511ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#637511

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44016"^^date time
hasMF dp "C9H8O"
hasMW dp "160"^^integer
hasName dp "Cinnamaldehyde"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

637517ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#637517

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C18H34O2"
hasMW dp "500"^^integer
hasName dp "Elaidic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

637563ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#637563

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44016"^^date time
hasMF dp "C10H12O"
hasMW dp "200"^^integer
hasName dp "Anethole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

637760ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#637760

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43883"^^date time
hasMF dp "C15H12O"
hasMW dp "250"^^integer
hasName dp "Chalcone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

638024ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#638024

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C17H19NO3"
hasMW dp "340"^^integer
hasName dp "Piperine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

638678ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#638678

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C16H22N6O4"
hasMW dp "380"^^integer
hasName dp "Protirelin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

6398761ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6398761

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C26H42O4"
hasMW dp "600"^^integer
hasName dp "Maxacalcitol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

64139ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#64139

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43863"^^date time
hasMF dp "C14H9ClF3NO2"
hasMW dp "670"^^integer
hasName dp "Efavirenz"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

64142ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#64142

belongs to
Drug c
has facts
has common name dp "Nelfinavir mesylate; 159989-65-8; Viracept"
hasFunction dp "Antiviral"
hasIUPACName dp "(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C33H49N3O7S2"
hasMW dp "663"^^integer
hasName dp "Nelfinavir mesylate"
hasNumberOfReferences dp "10"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6436173ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6436173

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44098"^^date time
hasMF dp "C43H51N3O11"
hasMW dp "900"^^integer
hasName dp "Rifaximin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6436223ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6436223

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C35H58O9"
hasMW dp "800"^^integer
hasName dp "Bafilomycin A1"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

6437380ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6437380

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C30H32Cl3NO"
hasMW dp "900"^^integer
hasName dp "Lumefantrine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6438353ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6438353

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44181"^^date time
hasLatestPublicationDate dp "44139"^^date time
hasMF dp "C27H27NO4"
hasMW dp "500"^^integer
hasName dp "BNTX"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

6438825ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6438825

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C20H20O5"
hasMW dp "400"^^integer
hasName dp "Broussochalcone A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

644019ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#644019

belongs to
Drug c
has facts
has common name dp "cannabidiol; 13956-29-1; (-)-Cannabidiol"
hasFunction dp "Antiviral"
hasIUPACName dp "2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pe..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44170"^^date time
hasMF dp "C21H30O2"
hasMW dp "314"^^integer
hasName dp "Cannabidiol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6440352ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6440352

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44013"^^date time
hasMF dp "C31H39FN4O7"
hasMW dp "700"^^integer
hasName dp "Rupintrivir"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

644076ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#644076

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C6H65N13O12S2"
hasMW dp "200"^^integer
hasName dp "Lypressin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6442177ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6442177

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C53H83NO14"
hasMW dp "200"^^integer
hasName dp "Everolimus"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

644241ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#644241

belongs to
Drug c
has facts
has common name dp "Nilotinib; 641571-10-0; Tasigna"
hasFunction dp "Antiviral"
hasIUPACName dp "4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phe..."
hasLatestDatabaseUpdate dp "44166"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C28H22F3N7O"
hasMW dp "529"^^integer
hasName dp "Nilotinib"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6444318ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6444318

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44126"^^date time
hasMF dp "C42H47O25"
hasMW dp "800"^^integer
hasName dp "Albireodelphin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

6451164ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6451164

belongs to
Drug c
has facts
has common name dp "Rilpivirine; 500287-72-9; TMC278"
hasFunction dp "Antiviral"
hasIUPACName dp "4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-..."
hasLatestDatabaseUpdate dp "44175"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C22H18N6"
hasMW dp "366"^^integer
hasName dp "Rilpivirine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6476696ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6476696

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C20H43N5"
hasMW dp "600"^^integer
hasName dp "SL-11128"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

6483648ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6483648

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44152"^^date time
hasMF dp "C26H30O4"
hasMW dp "500"^^integer
hasName dp "Panduratin A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

64927ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#64927

belongs to
Drug c
has facts
has common name dp "Chloroquine diphosphate; Chloroquine phosphate; 50-63-5"
hasFunction dp "Antiviral"
hasIUPACName dp "4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diami..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44187"^^date time
hasMF dp "C18H32ClN3O8P2"
hasMW dp "515"^^integer
hasName dp "Chloroquine phosphate"
hasNumberOfReferences dp "31"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Recommended by China's NHC Guidelines"

64945ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#64945

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44139"^^date time
hasMF dp "C30H48O3"
hasMW dp "700"^^integer
hasName dp "Ursolic acid"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

64971ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#64971

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43993"^^date time
hasMF dp "C30H48O3"
hasMW dp "700"^^integer
hasName dp "Betulinic Acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

64982ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#64982

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44050"^^date time
hasMF dp "C21H18O11"
hasMW dp "400"^^integer
hasName dp "Baicalin"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

65028ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65028

belongs to
Drug c
has facts
has common name dp "oseltamivir; 196618-13-0; Tamvir"
hasFunction dp "Antiviral"
hasIUPACName dp "ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohe..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44176"^^date time
hasMF dp "C16H28N2O4"
hasMW dp "312"^^integer
hasName dp "Oseltamivir"
hasNumberOfReferences dp "8"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

6505803ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6505803

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43956"^^date time
hasMF dp "C31H43N3O8"
hasMW dp "700"^^integer
hasName dp "Tanespimycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

65064ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65064

belongs to
Drug c
has facts
has common name dp "(-)-Epigallocatechin gallate; EGCG; Epigallocatechin gallate"
hasFunction dp "Antiviral"
hasIUPACName dp "[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydr..."
hasLatestDatabaseUpdate dp "44174"^^date time
hasLatestPublicationDate dp "44166"^^date time
hasMF dp "C22H18O11"
hasMW dp "458"^^integer
hasName dp "Epigallocatechin Gallate"
hasNumberOfReferences dp "7"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

65329ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65329

belongs to
Drug c
has facts
has common name dp "Mefloquine hydrochloride; Mefloquine HCL; 51773-92-3"
hasFunction dp "Antiviral"
hasIUPACName dp "(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-..."
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C17H17ClF6N2O"
hasMW dp "414"^^integer
hasName dp "Mefloquine hydrochloride"
hasNumberOfReferences dp "9"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6536ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6536

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43917"^^date time
hasMF dp "C27H32ClNO2"
hasMW dp "0"^^integer
hasName dp "Triparanol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

65380ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65380

belongs to
Drug c
has facts
has common name dp "Psychotrine; UNII-8S2PXP3P7C; CHEBI:8622"
hasFunction dp "Antiviral"
hasIUPACName dp "1-[[(2R,3R,11bS)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahy..."
hasLatestDatabaseUpdate dp "44210"^^date time
hasLatestPublicationDate dp "44202"^^date time
hasMF dp "C28H36N2O4"
hasMW dp "464"^^integer
hasName dp "Psychotrine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

65399ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65399

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C13H16N6O4"
hasMW dp "300"^^integer
hasName dp "Triciribine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

65452ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65452

belongs to
Drug c
has facts
has common name dp "narasin; Narasin A; Monteban"
hasFunction dp "Antiviral"
hasIUPACName dp "(2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,1..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C43H72O11"
hasMW dp "765"^^integer
hasName dp "Narasin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

65628ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65628

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44040"^^date time
hasMF dp "C16H21Cl2N3O2"
hasMW dp "300"^^integer
hasName dp "Bendamustine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

65636ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65636

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C22H26FN5O3"
hasMW dp "500"^^integer
hasName dp "Fluprofylline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

656580ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#656580

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44096"^^date time
hasMF dp "C15H16Cl2N2O8"
hasMW dp "200"^^integer
hasName dp "Chloramphenicol succinate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

65663ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65663

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C17H30N2O5"
hasMW dp "400"^^integer
hasName dp "Aloxistatin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

656630ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#656630

belongs to
Drug c
has facts
has common name dp "lanatoside C; 17575-22-3; UNII-5RR3JFZ771"
hasFunction dp "Antiviral"
hasIUPACName dp "[(2R,3R,4S,6S)-6-[(2R,3S,4S,6S)-6-[(2R,3S,4S,6R)-6-[[(3S,5R,..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C49H76O20"
hasMW dp "985"^^integer
hasName dp "Lanatoside C"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

656656ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#656656

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44098"^^date time
hasMF dp "C42H68N2O16"
hasMW dp "0"^^integer
hasName dp "Diammonium glycyrrhizinate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

656668ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#656668

belongs to
Drug c
has facts
has common name dp "Benidipine; 105979-17-7; Benidipene"
hasFunction dp "Antiviral"
hasIUPACName dp "5-O-[(3R)-1-benzylpiperidin-3-yl] 3-O-methyl (4R)-2,6-dimeth..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44187"^^date time
hasMF dp "C28H31N3O6"
hasMW dp "505"^^integer
hasName dp "Benidipine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

657144ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#657144

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44082"^^date time
hasMF dp "C12H15NO3S"
hasMW dp "320"^^integer
hasName dp "3-{[(1R)-1-Benzyl-2-sulfanylethyl]amino}-3-oxopropanoic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

657181ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#657181

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C59H84N16O12"
hasMW dp "400"^^integer
hasName dp "Leuprorelin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

657237ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#657237

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44098"^^date time
hasMF dp "C10H12FN5O4"
hasMW dp "230"^^integer
hasName dp "Fludarabine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

65814ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65814

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C13H19Cl2NO2"
hasMW dp "200"^^integer
hasName dp "Cloranolol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

65863ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65863

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43974"^^date time
hasMF dp "C20H15Cl3N2OS"
hasMW dp "800"^^integer
hasName dp "Sertaconazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

65866ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65866

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44190"^^date time
hasLatestPublicationDate dp "44129"^^date time
hasMF dp "C36H41N3O6"
hasMW dp "700"^^integer
hasName dp "Lercanidipine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

65947ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#65947

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C21H20FN3O6S"
hasMW dp "500"^^integer
hasName dp "Prulifloxacin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

6604200ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6604200

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C8H6N4O5"
hasMW dp "160"^^integer
hasName dp "Nitrofurantoin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6604915ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6604915

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C27H45NO3"
hasMW dp "700"^^integer
hasName dp "OMDM-2"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

66069ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#66069

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44013"^^date time
hasMF dp "C18H20ClF3N2S"
hasMW dp "900"^^integer
hasName dp "Triflupromazine hydrochloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

661498ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#661498

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C15H12N4O3S"
hasMW dp "300"^^integer
hasName dp "ZINC4326719"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

667490ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#667490

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43906"^^date time
hasMF dp "C5H4N4S"
hasMW dp "180"^^integer
hasName dp "Mercaptopurine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

66828839ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#66828839

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44029"^^date time
hasMF dp "38H46F4N6O9S"
hasMW dp "900"^^integer
hasName dp "Glecaprevir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

67315776ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#67315776

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44069"^^date time
hasMF dp "C31H29ClFN5O3"
hasMW dp "0"^^integer
hasName dp "(E)-N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

67356ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#67356

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43917"^^date time
hasMF dp "CH28Cl2F3N3OS"
hasMW dp "400"^^integer
hasName dp "Fluphenazine dihydrochloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6741ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6741

belongs to
Drug c
has facts
has common name dp "methylprednisolone; 83-43-2; Medrol"
hasFunction dp "Other treatment"
hasIUPACName dp "(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxy..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44181"^^date time
hasMF dp "C22H30O5"
hasMW dp "374"^^integer
hasName dp "Methylprednisolone"
hasNumberOfReferences dp "29"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

68165256ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#68165256

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C29H39ClN7O2P"
hasMW dp "100"^^integer
hasName dp "Brigatinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6839ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6839

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C11H11NO2"
hasMW dp "210"^^integer
hasName dp "Phensuximide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6852141ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6852141

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C21H19N3O4"
hasMW dp "400"^^integer
hasName dp "6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

68539ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#68539

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43917"^^date time
hasMF dp "C19H24Cl2N2"
hasMW dp "300"^^integer
hasName dp "Clomipramine hydrochloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

68591ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#68591

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C18H14F3N3O4S"
hasMW dp "400"^^integer
hasName dp "Toltrazuril"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

68595ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#68595

belongs to
Drug c
has facts
has common name dp "Maduramicin; Maduramicin ammonium; Cygro"
hasFunction dp "Antiviral"
hasIUPACName dp "azane;2-[(2R,3S,4S,5R,6S)-6-[(1R)-1-[(2S,5R,7S,8R,9S)-2-[(2R..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C47H83NO17"
hasMW dp "934"^^integer
hasName dp "Maduramicin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

68827ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#68827

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44137"^^date time
hasMF dp "C15H22O5"
hasMW dp "330"^^integer
hasName dp "Artemisinin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"

68871ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#68871

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C17H17Cl2NO"
hasMW dp "200"^^integer
hasName dp "Diclofensine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

68933ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#68933

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C11H12N4O2S"
hasMW dp "310"^^integer
hasName dp "Sulfaperin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

6917864ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6917864

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44056"^^date time
hasMF dp "C19H28O8"
hasMW dp "400"^^integer
hasName dp "Artesunate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6918155ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918155

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C32H44O7"
hasMW dp "700"^^integer
hasName dp "Ciclesonide"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6918289ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918289

belongs to
Drug c
has facts
has common name dp "Temsirolimus; CCI-779; Torisel"
hasFunction dp "Antiviral"
hasIUPACName dp "[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C56H87NO16"
hasMW dp "1030"^^integer
hasName dp "Temsirolimus"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6918296ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918296

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44048"^^date time
hasMF dp "C27H30F6N2O2"
hasMW dp "500"^^integer
hasName dp "Dutasteride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6918328ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918328

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C34H49N5O6"
hasMW dp "800"^^integer
hasName dp "Apicidin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

6918456ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918456

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44101"^^date time
hasMF dp "C20H20FNO3S"
hasMW dp "400"^^integer
hasName dp "Prasugrel"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6918554ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918554

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C24H28N2O3"
hasMW dp "500"^^integer
hasName dp "Indacaterol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

6918606ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918606

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44076"^^date time
hasMF dp "C5H35F2N8O5S"
hasMW dp "800"^^integer
hasName dp "Isavuconazonium"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6918638ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918638

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C15H14N2O4S"
hasMW dp "300"^^integer
hasName dp "Belinostat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

6918736ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918736

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44009"^^date time
hasMF dp "C21H25NO8S"
hasMW dp "500"^^integer
hasName dp "Rigosertib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

6918837ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#6918837

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C21H23N3O2"
hasMW dp "400"^^integer
hasName dp "Panobinostat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

7028ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#7028

belongs to
Drug c
has facts
has common name dp "PSEUDOEPHEDRINE; (+)-Pseudoephedrine; d-Pseudoephedrine"
hasFunction dp "Antiviral"
hasIUPACName dp "(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol"
hasLatestDatabaseUpdate dp "44184"^^date time
hasLatestPublicationDate dp "44175"^^date time
hasMF dp "C10H15NO"
hasMW dp "165"^^integer
hasName dp "Pseudoephedrine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

70945511ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#70945511

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C23H29F4N3O5S"
hasMW dp "600"^^integer
hasName dp "VBY-825"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

71301ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71301

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44090"^^date time
hasMF dp "C22H25F2NO4"
hasMW dp "400"^^integer
hasName dp "Nebivolol"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

71342ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71342

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C18H24ClN3O2"
hasMW dp "900"^^integer
hasName dp "Pancopride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

71420ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71420

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43963"^^date time
hasMF dp "C29H34Cl2N2O2"
hasMW dp "500"^^integer
hasName dp "Loperamide hydrochloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

71433ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71433

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C6H20Cl2N4"
hasMW dp "150"^^integer
hasName dp "Trientine hydrochloride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

71481097ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71481097

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C17H11F6N7O"
hasMW dp "300"^^integer
hasName dp "Selinexor"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

71481119ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71481119

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44079"^^date time
hasMF dp "C21H30N3NaO8S"
hasMW dp "500"^^integer
hasName dp "GC376"
hasNumberOfReferences dp "5"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

71481187ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71481187

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44141"^^date time
hasMF dp "C17H18N2O4"
hasMW dp "340"^^integer
hasName dp "ABP-700"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

71492799ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71492799

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C18H12F6N6O"
hasMW dp "300"^^integer
hasName dp "Verdinexor"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

71496458ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71496458

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C28H33N7O2"
hasMW dp "600"^^integer
hasName dp "Osimertinib"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

71522234ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71522234

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44152"^^date time
hasMF dp "C14H20N2"
hasMW dp "320"^^integer
hasName dp "GSK-LSD1"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

71576678ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71576678

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C28H36F2N8O3S"
hasMW dp "700"^^integer
hasName dp "LY2835219"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

71692ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71692

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C22H20N6O6"
hasMW dp "400"^^integer
hasName dp "Diniprofylline"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

71713800ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71713800

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C23H45N3O5"
hasMW dp "600"^^integer
hasName dp "IHVR-19029"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

71739ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71739

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C18H22N2O2"
hasMW dp "400"^^integer
hasName dp "Carazolol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

71751812ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#71751812

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44110"^^date time
hasMF dp "C39H45NO6"
hasMW dp "800"^^integer
hasName dp "Propafenone dimer"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

72081ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72081

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C2H74N16O15S2"
hasMW dp "400"^^integer
hasName dp "Terlipressin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

72193633ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72193633

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44126"^^date time
hasMF dp "C29H40N8O5"
hasMW dp "700"^^integer
hasName dp "Hordatine B"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

72271ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72271

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp ": C28H26N4O4"
hasMW dp "500"^^integer
hasName dp "UCN-01"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

72276ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72276

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C15H14O6"
hasMW dp "270"^^integer
hasName dp "(-)-Epicatechin"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

72307ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72307

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44061"^^date time
hasMF dp "C20H18O6"
hasMW dp "400"^^integer
hasName dp "Sesamin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

72376ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72376

belongs to
Drug c
has facts
has common name dp "Narciclasine; 29477-83-6; Lycoricidinol"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S,3R,4S,4aR)-2,3,4,7-tetrahydroxy-3,4,4a,5-tetrahydro-2H-[..."
hasLatestDatabaseUpdate dp "44186"^^date time
hasLatestPublicationDate dp "44167"^^date time
hasMF dp "C14H13NO7"
hasMW dp "307"^^integer
hasName dp "Narciclasine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

72378ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72378

belongs to
Drug c
has facts
has common name dp "lycorine; Amarylline; Galanthidine"
hasFunction dp "Antiviral"
hasIUPACName dp "(1S,17S,18S,19S)-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,..."
hasLatestDatabaseUpdate dp "44207"^^date time
hasLatestPublicationDate dp "44181"^^date time
hasMF dp "C16H17NO4"
hasMW dp "287"^^integer
hasName dp "Lycorine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

72394ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72394

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C29H55N5O18"
hasMW dp "800"^^integer
hasName dp "Lividomycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

72430ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#72430

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasMF dp "C22H26N2O4"
hasMW dp "500"^^integer
hasName dp "MDL-28170"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

7304ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#7304

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43992"^^date time
hasMF dp "C5H7N"
hasMW dp "120"^^integer
hasName dp "MR3"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

73078ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#73078

belongs to
Drug c
has facts
has common name dp "No Usual Name"
has common name dp "tetrandrine; 518-34-3; D-Tetrandrine"
hasFunction dp "Antiviral"
hasIUPACName dp "(1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-1..."
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44036"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C38H42N2O6"
hasMW dp "622"^^integer
hasMW dp "700"^^integer
hasName dp "Hanfangchin A"
hasName dp "Tetrandrine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Experimental"
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

73296ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#73296

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C41H66O12"
hasMW dp "100"^^integer
hasName dp "alpha-Hederin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

73364ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#73364

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C20H30N2O4"
hasMW dp "500"^^integer
hasName dp "Calpeptin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

73568ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#73568

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C27H22O18"
hasMW dp "500"^^integer
hasName dp "Corilagin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

73659186ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#73659186

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44047"^^date time
hasMF dp "C25H27FN2O"
hasMW dp "500"^^integer
hasName dp "N-[(3-Fluorophenyl)methyl]-1-[(1r)-1-Naphthalen-1-Ylethyl]piperidine-4-Carboxamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

7405ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#7405

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44044"^^date time
hasMF dp "C5H7NO3"
hasMW dp "110"^^integer
hasName dp "L-pyroglutamic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

7439ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#7439

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C10H14O"
hasMW dp "220"^^integer
hasName dp "Carvone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

74989ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#74989

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44145"^^date time
hasMF dp "C22H19ClO3"
hasMW dp "800"^^integer
hasName dp "Atovaquone"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

75552ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#75552

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43921"^^date time
hasMF dp "C6H10S4"
hasMW dp "400"^^integer
hasName dp "Diallyl tetrasulfide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

76372196ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#76372196

belongs to
Drug c
has facts
has common name dp "Callophycin A"
hasFunction dp "Antiviral"
hasIUPACName dp "2-[(4-hydroxyphenyl)methyl]-1,3,4,9-tetrahydropyrido[3,4-b]i..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44156"^^date time
hasMF dp "C19H18N2O3"
hasMW dp "322"^^integer
hasName dp "Callophycin A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

7673ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#7673

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43980"^^date time
hasMF dp "C7H5NS"
hasMW dp "190"^^integer
hasName dp "Phenyl isothiocyanate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

77050711ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#77050711

belongs to
Drug c
has facts
has common name dp "Oteseconazole; 1340593-59-0; VT-1161"
hasFunction dp "Antiviral"
hasIUPACName dp "(2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1..."
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C23H16F7N5O2"
hasMW dp "527"^^integer
hasName dp "Oteseconazole"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

772ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#772

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "43951"^^date time
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "43950"^^date time
hasLatestPublicationDate dp "44145"^^date time
hasMF dp "C26H42N2O37S5"
hasMW dp "900"^^integer
hasName dp "Enoxaparin"
hasName dp "Heparin"
hasName dp "Nadroparin"
hasName dp "Parnaparin"
hasName dp "Reviparin"
hasName dp "Tinzaparin"
hasNumberOfReferences dp "1"^^integer
hasNumberOfReferences dp "12"^^integer
hasNumberOfReferences dp "5"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - clinical evidence"
hasStatus dp "Potential treatment - pre-clinical evidence"

77254ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#77254

belongs to
Drug c
has facts
has common name dp "5-Bromo-4'-chlorosalicylanilide; 3679-64-9; Salifungin"
hasFunction dp "Antiviral"
hasIUPACName dp "5-bromo-N-(4-chlorophenyl)-2-hydroxybenzamide"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C13H9BrClNO2"
hasMW dp "326"^^integer
hasName dp "Salifungin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

78357788ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#78357788

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44138"^^date time
hasMF dp "C28H18N2O6"
hasMW dp "500"^^integer
hasName dp "4E1RCat"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

820777ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#820777

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44044"^^date time
hasMF dp "C8H9NS"
hasMW dp "230"^^integer
hasName dp "Thioacetanilide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

8223ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#8223

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C33H35N5O5"
hasMW dp "700"^^integer
hasName dp "Ergotamine"
hasNumberOfReferences dp "3"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

8328ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#8328

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44070"^^date time
hasMF dp "C14H8O4"
hasMW dp "210"^^integer
hasName dp "Anthrarufin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

8378ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#8378

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44025"^^date time
hasMF dp "C23H46N6O13"
hasMW dp "600"^^integer
hasName dp "Neomycin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

865855ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#865855

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44055"^^date time
hasMF dp "C12H12FN5OS"
hasMW dp "320"^^integer
hasName dp "2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

86763204ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#86763204

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C22H17ClFN9O"
hasMW dp "900"^^integer
hasName dp "GS-9901"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

89594ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#89594

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44121"^^date time
hasMF dp "C10H14N2"
hasMW dp "230"^^integer
hasName dp "Nicotine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

896ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#896

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44141"^^date time
hasMF dp "C13H16N2O2"
hasMW dp "280"^^integer
hasName dp "Melatonin"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

89670174ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#89670174

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C25H17F3N4O3"
hasMW dp "400"^^integer
hasName dp "Lifirafenib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

89741632ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#89741632

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C24H28N6O"
hasMW dp "500"^^integer
hasName dp "SMN-C3"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

90311989ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#90311989

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44054"^^date time
hasMF dp "C21H18F3N3O5"
hasMW dp "400"^^integer
hasName dp "Bictegravir"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

91532ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#91532

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44046"^^date time
hasMF dp "C11H18N5O12P3"
hasMW dp "210"^^integer
hasName dp "AMP-PCP"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

91610ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#91610

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44091"^^date time
hasMF dp "C27H33N3O6S"
hasMW dp "600"^^integer
hasName dp "Gliquidone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

92095ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#92095

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44077"^^date time
hasMF dp "C27H44O3"
hasMW dp "600"^^integer
hasName dp "Sarsasapogenin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

92097ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#92097

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44140"^^date time
hasMF dp "C30H50O"
hasMW dp "700"^^integer
hasName dp "Taraxerol"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

92305ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#92305

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "C27H38N2O4"
hasMW dp "600"^^integer
hasName dp "S-verapamil"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

92727ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#92727

belongs to
Drug c
has facts
has common name dp "Lopinavir; 192725-17-0; ABT-378"
hasFunction dp "Antiviral"
hasIUPACName dp "(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-..."
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44161"^^date time
hasMF dp "C37H48N4O5"
hasMW dp "628"^^integer
hasName dp "Lopinavir"
hasNumberOfReferences dp "34"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Recommended by China's NHC Guidelines"

932ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#932

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C15H12O5"
hasMW dp "250"^^integer
hasName dp "Naringenin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - pre-clinical evidence"

948801ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#948801

belongs to
Drug c
has facts
has common name dp "MLS000114443; 4-chloro-N-(1-methyl-1H-benzimidazol-5-yl)benzamide; SMR000091830"
hasFunction dp "Antiviral"
hasIUPACName dp "4-chloro-N-(1-methylbenzimidazol-5-yl)benzamide"
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44158"^^date time
hasMF dp "C15H12ClN3O"
hasMW dp "285"^^integer
hasName dp "4-Chloro-N-(1-methyl-1H-benzimidazol-5-yl)benzamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

95168ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#95168

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44117"^^date time
hasMF dp "C25H24O5"
hasMW dp "500"^^integer
hasName dp "Osajin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

95478ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#95478

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44203"^^date time
hasLatestPublicationDate dp "44147"^^date time
hasMF dp "C16H22ClN3"
hasMW dp "820"^^integer
hasName dp "Desethylchloroquine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9552079ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9552079

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "43981"^^date time
hasMF dp "C22H30Cl2N10"
hasMW dp "400"^^integer
hasName dp "Chlorhexidine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

95779ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#95779

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44132"^^date time
hasMF dp "C10H14O2"
hasMW dp "220"^^integer
hasName dp "Thymohydroquinone"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

9578507ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9578507

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43896"^^date time
hasMF dp "C43H63NO11"
hasMW dp "0"^^integer
hasName dp "Selamectin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

9589606ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9589606

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C25H20BrN5O3"
hasMW dp "400"^^integer
hasName dp "AC-55541"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9661141ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9661141

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44049"^^date time
hasMF dp "C26H24IN7O"
hasMW dp "400"^^integer
hasName dp "Vacuolin-1"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

969516ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#969516

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44076"^^date time
hasMF dp "C21H20O6"
hasMW dp "400"^^integer
hasName dp "Curcumin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

97489240ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#97489240

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44043"^^date time
hasMF dp "C25H18O10"
hasMW dp "400"^^integer
hasName dp "ZINC96222891"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9794222ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9794222

belongs to
Drug c
has facts
has common name dp "Luminol sodium salt; 20666-12-0; 1,4-Phthalazinedione, 5-amino-2,3-dihydro-, monosodium salt"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44155"^^date time
hasMF dp "C8H7N3NaO2"
hasMW dp "200"^^integer
hasName dp "Luminol sodium salt"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9808998ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9808998

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C29H28N4O11"
hasMW dp "600"^^integer
hasName dp "Edotecarin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9817231ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9817231

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C18H22N2O"
hasMW dp "400"^^integer
hasName dp "PD-144418"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9820475ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9820475

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C16H24Cl3N3"
hasMW dp "700"^^integer
hasName dp "AQ-13"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9821849ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9821849

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44025"^^date time
hasMF dp "C26H33NO2"
hasMW dp "500"^^integer
hasName dp "Abiraterone acetate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

9826520ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9826520

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C25H24ClN3O3S"
hasMW dp "0"^^integer
hasName dp "GW-803430"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9826528ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9826528

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C16H14F3IN2O4"
hasMW dp "190"^^integer
hasName dp "PD0325901"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9827968ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9827968

belongs to
Drug c
has facts
has common name dp "GSK256066; 801312-28-7; GSK-256066"
hasFunction dp "Antiviral"
hasIUPACName dp "6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)..."
hasLatestDatabaseUpdate dp "44173"^^date time
hasLatestPublicationDate dp "44165"^^date time
hasMF dp "C27H26N4O5S"
hasMW dp "518"^^integer
hasName dp "GSK-256066"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9829523ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9829523

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43951"^^date time
hasMF dp "C35H30N4O4"
hasMW dp "600"^^integer
hasName dp "Midostaurin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

9831415ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9831415

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44101"^^date time
hasMF dp "C22H34O2"
hasMW dp "500"^^integer
hasName dp "Icosapent ethyl"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

9846339ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9846339

belongs to
Drug c
has facts
has common name dp "gallium maltolate; 108560-70-9; UNII-17LEI49C2G"
hasFunction dp "Antiviral"
hasIUPACName dp "gallium;2-methyl-4-oxopyran-3-olate"
hasLatestDatabaseUpdate dp "44207"^^date time
hasLatestPublicationDate dp "44187"^^date time
hasMF dp "C18H15GaO9"
hasMW dp "445"^^integer
hasName dp "Gallium maltolate"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9853053ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9853053

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43978"^^date time
hasMF dp "C39H37F6N3O2"
hasMW dp "700"^^integer
hasName dp "Lomitapide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

9853654ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9853654

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44124"^^date time
hasMF dp "C37H49N7O9S"
hasMW dp "900"^^integer
hasName dp "Pentagastrin"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

9853710ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9853710

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44022"^^date time
hasMF dp "C40H50N6O8S"
hasMW dp "900"^^integer
hasName dp "Ciluprevir"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

9854012ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9854012

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44165"^^date time
hasLatestPublicationDate dp "44098"^^date time
hasMF dp "C2F3N5O12P3S2"
hasMW dp "400"^^integer
hasName dp "Cangrelor"
hasNumberOfReferences dp "4"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

9854219ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9854219

belongs to
Drug c
has facts
has common name dp "36505-48-3; X-206; CHEBI:80126"
hasFunction dp "Antiviral"
hasIUPACName dp "(2R)-2-[(2S,3S,6R)-6-[(2R,3S)-3-[(2R,5S,6R)-6-[[(2R,3S,5R,6R..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C47H82O14"
hasMW dp "871"^^integer
hasName dp "X-206"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9855027ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9855027

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44081"^^date time
hasMF dp "C56H78N16O12"
hasMW dp "300"^^integer
hasName dp "Alarelin"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9870652ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9870652

belongs to
Drug c
has facts
has common name dp "FIMASARTAN; 247257-48-3; Fimasartan [INN]"
hasFunction dp "Antiviral"
hasIUPACName dp "2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]..."
hasLatestDatabaseUpdate dp "44176"^^date time
hasLatestPublicationDate dp "44168"^^date time
hasMF dp "C27H31N7OS"
hasMW dp "501"^^integer
hasName dp "Fimasartan"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

9876378ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9876378

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43944"^^date time
hasMF dp "C52H79N5O12"
hasMW dp "200"^^integer
hasName dp "Zotarolimus"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

9884685ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9884685

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C19H16N4O3"
hasMW dp "400"^^integer
hasName dp "PI-103"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9890209ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9890209

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44077"^^date time
hasMF dp "C30H46O3"
hasMW dp "700"^^integer
hasName dp "Ursonic acid"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

9912771ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9912771

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C27H30N4O4"
hasMW dp "600"^^integer
hasName dp "Darexaban"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9914081ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9914081

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44126"^^date time
hasMF dp "C34H24N4O"
hasMW dp "600"^^integer
hasName dp "Cryptospirolepine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Natural product"
hasStatus dp "Potential treatment - theoretical effect"

9915743ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9915743

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44069"^^date time
hasMF dp "C30H29ClN6O3"
hasMW dp "0"^^integer
hasName dp "Neratinib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - theoretical effect"

9918381ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9918381

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44193"^^date time
hasLatestPublicationDate dp "44035"^^date time
hasMF dp "C40H38F5N3O3S"
hasMW dp "800"^^integer
hasName dp "Rilapladib"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

99315ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#99315

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43956"^^date time
hasMF dp "C7H8FNO2S"
hasMW dp "210"^^integer
hasName dp "4-(2-aminomethyl)benzenesulfonyl fluoride"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

9936746ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9936746

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Other treatment"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43968"^^date time
hasMF dp "C25H22ClN5O2S"
hasMW dp "0"^^integer
hasName dp "OTX015"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9939865ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9939865

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C27H33N5O2"
hasMW dp "600"^^integer
hasName dp "N-[(1R)-2-[4-(1-Methylpiperidin-4-yl)piperazin-1-yl]-2-oxo-1-phenylethyl]-1H-indole-6-carboxamide"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Approved for COVID-19 treatment (China, India, Russia)"

9954082ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9954082

belongs to
Drug c
has facts
has common name dp "U 18666A; 3039-71-2; U18666A"
hasFunction dp "Antiviral"
hasIUPACName dp "(3S,8R,9S,10R,13S,14S)-3-[2-(diethylamino)ethoxy]-10,13-dime..."
hasLatestDatabaseUpdate dp "44168"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C25H42ClNO2"
hasMW dp "424"^^integer
hasName dp "U18666A"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9956222ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9956222

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44007"^^date time
hasMF dp "C25H21N7O3"
hasMW dp "500"^^integer
hasName dp "YM201636"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9960285ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9960285

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "43998"^^date time
hasMF dp "C23H35N9O8S"
hasMW dp "600"^^integer
hasName dp "ATN-161"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - pre-clinical evidence"

9963057ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9963057

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44092"^^date time
hasMF dp "C24H32N2O5"
hasMW dp "500"^^integer
hasName dp "Bedoradrine"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

9966051ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9966051

belongs to
Drug c
has facts
has common name dp "VORTIOXETINE; 508233-74-7; 1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine"
hasFunction dp "Antiviral"
hasIUPACName dp "1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44160"^^date time
hasMF dp "C18H22N2S"
hasMW dp "298"^^integer
hasName dp "Vortioxetine"
hasNumberOfReferences dp "2"^^integer
hasResearchPhase dp "Used to treat other disease"
hasStatus dp "Potential treatment - pre-clinical evidence"

9988405ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#9988405

belongs to
Drug c
has facts
has common name dp "No Usual Name"
hasFunction dp "Antiviral"
hasIUPACName dp "NoPUBmedName"
hasLatestDatabaseUpdate dp "44159"^^date time
hasLatestPublicationDate dp "44051"^^date time
hasMF dp "C40H52O25"
hasMW dp "800"^^integer
hasName dp "Torososide B"
hasNumberOfReferences dp "1"^^integer
hasResearchPhase dp "Experimental"
hasStatus dp "Potential treatment - theoretical effect"

a0 a6 b9 w i k4ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6B9WIK4

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794116"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALSVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQRLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 c0 q e n3ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6C0QEN3

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794086"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQFESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHXNLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHCVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 f8 z1 d7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6F8Z1D7

belongs to
Protein c
has facts
hasFunction dp "RNA binding"
hasFunction dp "host cell Golgi apparatus"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45635"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDHELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 f8 z994ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6F8Z994

belongs to
Protein c
has facts
hasFunction dp "modulation by virus of host G0/G1 transition checkpoint"
hasFunction dp "virion"
hasISOpoint dp "7.2487597"^^float
hasLenght dp "122"^^integer
hasMass dp "13804"^^integer
hasSequence dp "MKIILFLALITLATCELYHYQECVRGTTVLLKEPCSFGTYEGNSPFHPLADNKFALTCFSTQFAFACPDGVKHVYQLRARSVSPKLFIRQEEVQELYSPIFLIVAAIVFITLCFTLKRKTE"

a0 a6 g7 c r90ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G7CR90

belongs to
Protein c
has facts
hasFunction dp "RNA binding"
hasFunction dp "host cell Golgi apparatus"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.560127"^^float
hasLenght dp "420"^^integer
hasMass dp "45610"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKVPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 g7 k r d9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G7KRD9

belongs to
Protein c
has facts
hasFunction dp "structural constituent of virion"
hasFunction dp "viral envelope"
hasISOpoint dp "9.048115"^^float
hasLenght dp "223"^^integer
hasMass dp "25161"^^integer
hasSequence dp "MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYANRNRFLYIIKLIFLWLLWPVTLACFVLAAIYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTRSMWSFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCDIKDLPKEITVATSRTLSYYKLGASQRVAGDSGFAAYSRYRIGNYKLNTDHSSSSDNIALLVQ"

a0 a6 g7 k2 f6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G7K2F6

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794108"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADLIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFFYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 g7 k2 s5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G7K2S5

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794104"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSIQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFFYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 g7 k2 v2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G7K2V2

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794118"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACYNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFFYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 g9 k d h5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G9KDH5

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.9569044"^^float
hasLenght dp "7097"^^integer
hasMass dp "794058"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRDFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELNHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 g9 z x a5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G9ZXA5

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.995049"^^float
hasLenght dp "7097"^^integer
hasMass dp "794033"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAXWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTNFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 g9 z x30ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G9ZX30

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794068"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLAXALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 g9 z x45ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G9ZX45

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794126"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKFKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFFYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 g9 z y b8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6G9ZYB8

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794044"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFFYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDVVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPLEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKLAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMIISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 c2 p8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C2P8

belongs to
Protein c
has facts
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transferase activity"
hasFunction dp "viral genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4401"^^integer
hasMass dp "489198"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h0 c4 h2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C4H2

belongs to
Protein c
has facts
hasFunction dp "cytoplasm"
hasFunction dp "host cell Golgi membrane"
hasFunction dp "host cell plasma membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "ion channel activity"
hasFunction dp "plasma membrane"
hasFunction dp "pore formation by virus in membrane of host cell"
hasFunction dp "virion"
hasISOpoint dp "4.9524317"^^float
hasLenght dp "276"^^integer
hasMass dp "30380"^^integer
hasSequence dp "MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFQSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAAGLEAPFLYLYAXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXYCIPYNSVTSSIVITSGDGTTSPISXXXCQNGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLSTDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL"

a0 a6 h0 c4 k2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C4K2

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.995049"^^float
hasLenght dp "7058"^^integer
hasMass dp "789697"^^integer
hasSequence dp "SEARQHLKDGTCGLVEVEKGVLPQLEQPYVXXXXXXXXXXXXXXXXXXXXXXLEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 c4 m2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C4M2

belongs to
Protein c
has facts
hasFunction dp "structural constituent of virion"
hasFunction dp "viral envelope"
hasISOpoint dp "9.545498"^^float
hasLenght dp "223"^^integer
hasMass dp "25159"^^integer
hasSequence dp "MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYANRNRFLYIIKLIFLWLLWPVTLACFVLAAVYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTRSMWSFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCXXXXXXXXXXXXTSRTLSYYKLGASQRVAGDSGFAAYSRYRIGNYKLNTDHSSSSDNIALLVQ"

a0 a6 h0 c4 z4ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C4Z4

belongs to
Protein c
has facts
hasFunction dp "ion channel activity"
hasFunction dp "pore formation by virus in membrane of host cell"
hasFunction dp "virion"
hasISOpoint dp "5.321162"^^float
hasLenght dp "276"^^integer
hasMass dp "31137"^^integer
hasSequence dp "MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFQSASKIITLKKRWQLALSKGVHFVCNLLLLFATVYSHLLLVAAGLEAPFLYLYALVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWHTNCYDYCIPYNSVTSSIVITSGDGTTSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLSTDTGVEHVTFFIYNKIVDEPEEHVQIHTIDVSSGVVNPVMEPIYDEPTTTTSVPL"

a0 a6 h0 c5 f7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C5F7

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.9696193"^^float
hasLenght dp "7097"^^integer
hasMass dp "794086"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVEPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 c5 k7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C5K7

belongs to
Protein c
has facts
hasFunction dp "cytoplasm"
hasFunction dp "host cell Golgi membrane"
hasFunction dp "host cell plasma membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "ion channel activity"
hasFunction dp "plasma membrane"
hasFunction dp "pore formation by virus in membrane of host cell"
hasFunction dp "virion"
hasISOpoint dp "5.321162"^^float
hasLenght dp "276"^^integer
hasMass dp "31183"^^integer
hasSequence dp "MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFQSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAAGLEAPFLYLYALVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWHTNYYDYCIPYNSVTSSIVITSGDGTTSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLSTDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL"

a0 a6 h0 c5 l9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C5L9

belongs to
Protein c
has facts
hasFunction dp "host cell membrane"
hasFunction dp "integral component of membrane"
hasISOpoint dp "4.0115333"^^float
hasLenght dp "44"^^integer
hasMass dp "5029"^^integer
hasSequence dp "MIELSLIDFYLCFLAFLLFLVXXXXXXXXXXLELQDHNETCHA"

a0 a6 h0 c599ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C599

belongs to
Protein c
has facts
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transferase activity"
hasFunction dp "viral genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490035"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVFALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h0 c6 j2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C6J2

belongs to
Protein c
has facts
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "viral envelope"
hasISOpoint dp "5.906045"^^float
hasLenght dp "1274"^^integer
hasMass dp "141219"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTXSALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h0 c6 k8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C6K8

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "6.007764"^^float
hasLenght dp "7082"^^integer
hasMass dp "792138"^^integer
hasSequence dp "LSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEXXXXXXXXXXXXXXXXQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPXXXXXXXXXXXXXXXMKCDHCGETSWQTGDFVKATCEFCGTENXXXXXXXXXXXXXXXXXVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKXXXXXXXXLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTXNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 c680ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C680

belongs to
Protein c
has facts
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "viral envelope"
hasISOpoint dp "5.982334"^^float
hasLenght dp "1274"^^integer
hasMass dp "141177"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLNSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h0 c761ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0C761

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7087"^^integer
hasMass dp "792959"^^integer
hasSequence dp "KTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIXYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEXXXXXKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCXXXXMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFXRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPFTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 j g71ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0JG71

belongs to
Protein c
has facts
hasFunction dp "RNA binding"
hasFunction dp "host cell Golgi apparatus"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.560127"^^float
hasLenght dp "420"^^integer
hasMass dp "45685"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNLTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 h0 j m c1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0JMC1

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794042"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMVYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 j m d6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0JMD6

belongs to
Protein c
has facts
hasFunction dp "structural constituent of virion"
hasFunction dp "viral envelope"
hasISOpoint dp "9.048115"^^float
hasLenght dp "223"^^integer
hasMass dp "25145"^^integer
hasSequence dp "MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYANRNRFLYIIKLIFLWLLWPVTLACFVLAAVYRINWITGGIAIAMACLVGLMWXSYFIASFRLFARTRSMWSFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCDIKDLPKEITVATSRTLSYYKLGASQRVAGDSGFAAYSRYRIGNYKLNTDHSSSSDNIALLVQ"

a0 a6 h0 j n e9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0JNE9

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "6.0331936"^^float
hasLenght dp "7097"^^integer
hasMass dp "794285"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEIGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNXXXXXXXXXXXXXXXXXXXXXXXXXXSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSXXXXXXXXXXXXXXXXXXXXSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFFYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSIGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 j n q1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0JNQ1

belongs to
Protein c
has facts
hasFunction dp "endocytosis involved in viral entry into host cell"
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "host cell plasma membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "pathogenesis"
hasFunction dp "receptor-mediated virion attachment to host cell"
hasFunction dp "viral envelope"
hasFunction dp "virion membrane"
hasISOpoint dp "5.8424706"^^float
hasLenght dp "1274"^^integer
hasMass dp "141150"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXCVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h0 j n75ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0JN75

belongs to
Protein c
has facts
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transferase activity"
hasFunction dp "viral genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490023"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFFAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h0 j p42ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0JP42

belongs to
Protein c
has facts
hasFunction dp "host cell Golgi membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "mitigation of host immune response by virus"
hasFunction dp "structural constituent of virion"
hasFunction dp "viral envelope"
hasFunction dp "virion membrane"
hasISOpoint dp "9.048115"^^float
hasLenght dp "223"^^integer
hasMass dp "25145"^^integer
hasSequence dp "MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYANRNRFLYIIKLIFXWLLWPVTLACFVLAAVYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTRSMWSFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCDIKDLPKEITVATSRTLSYYKLGASQRVAGDSGFAAYSRYRIGNYKLNTDHSSSSDNIALLVQ"

a0 a6 h0 m b y8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0MBY8

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794074"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVIYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFFYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 m9 z2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0M9Z2

belongs to
Protein c
has facts
hasFunction dp "cytoplasm"
hasFunction dp "host cell Golgi membrane"
hasFunction dp "host cell plasma membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "ion channel activity"
hasFunction dp "plasma membrane"
hasFunction dp "pore formation by virus in membrane of host cell"
hasFunction dp "virion"
hasISOpoint dp "5.410166"^^float
hasLenght dp "276"^^integer
hasMass dp "31160"^^integer
hasSequence dp "MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFHSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAVGLEAPFLYLYALVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWHTNCYDYCIPYNSVTSSIVITSGDGTTSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLSTDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL"

a0 a6 h0 q t k2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0QTK2

belongs to
Protein c
has facts
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "viral envelope"
hasISOpoint dp "6.045908"^^float
hasLenght dp "1274"^^integer
hasMass dp "141273"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h0 q t90ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0QT90

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.9441895"^^float
hasLenght dp "7097"^^integer
hasMass dp "793451"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVXVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVXXXXXXNGLMXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPTKVTFGDDTVIEVQGYKSVNITFELDEXXXXXXXXXXXAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDXXXXXXXXXXXXXXXXXXXDXXXXQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVXXXXXXXXXXXXXDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSVVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPLPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSXGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h0 q u b7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0QUB7

belongs to
Protein c
has facts
hasFunction dp "ion channel activity"
hasFunction dp "pore formation by virus in membrane of host cell"
hasFunction dp "virion"
hasISOpoint dp "5.321162"^^float
hasLenght dp "276"^^integer
hasMass dp "31135"^^integer
hasSequence dp "MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFQSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAAGLEAPFLYLYALVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWHTNCYDYCIPYNSVTSSIVITSGDGITSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLSTDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL"

a0 a6 h0 z2 d7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H0Z2D7

belongs to
Protein c
has facts
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment membrane"
hasFunction dp "host cell Golgi membrane"
hasFunction dp "host cell endoplasmic reticulum"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host G0/G1 transition checkpoint"
hasFunction dp "virion"
hasISOpoint dp "6.478213"^^float
hasLenght dp "122"^^integer
hasMass dp "13767"^^integer
hasSequence dp "MKIILFLALITLATCELYHYQECVRGTTVLLKEPCSSGTYEGNSPFHPLADNKLXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKLFIRQEEVQELYSPIFLIVAAIVFITLCFTLKRKTE"

a0 a6 h1 p h i9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PHI9

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasISOpoint dp "5.7661815"^^float
hasLenght dp "4406"^^integer
hasMass dp "490049"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQYDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h1 p h s8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PHS8

belongs to
Protein c
has facts
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment membrane"
hasFunction dp "host cell Golgi membrane"
hasFunction dp "host cell endoplasmic reticulum"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host G0/G1 transition checkpoint"
hasFunction dp "virion"
hasISOpoint dp "7.2487597"^^float
hasLenght dp "122"^^integer
hasMass dp "13762"^^integer
hasSequence dp "MKIILFLALITLATCELYHYQECVRGTTVLLKEPCSSGTYEGNSPFHPLADNKFALTCFXXXFAFACPDGVKHVYQLRARSVSPKLFIRQEEVQELYSPIFLIVAAIVFITLCFTLKRKTE"

a0 a6 h1 p i g6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PIG6

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.995049"^^float
hasLenght dp "7087"^^integer
hasMass dp "792982"^^integer
hasSequence dp "KTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 p i k0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PIK0

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral genome replication"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490033"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETMKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h1 p i k7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PIK7

belongs to
Protein c
has facts
hasFunction dp "host cell Golgi membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "structural constituent of virion"
hasFunction dp "viral envelope"
hasFunction dp "virion membrane"
hasISOpoint dp "8.945713"^^float
hasLenght dp "220"^^integer
hasMass dp "24609"^^integer
hasSequence dp "MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYAXXXXXXXXIKLIFLWLLWPVTLACFVLAAVYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTRSMWSFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCDIKDLPKEITVATSRTLSYYKLGASQRVAGDSGFAAYSRYRIGXXXLNTXXXXXXXXIAL"

a0 a6 h1 p i q8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PIQ8

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral genome replication"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490001"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h1 p j l6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PJL6

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794114"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNVTNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 p j v4ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PJV4

belongs to
Protein c
has facts
hasFunction dp "host cell Golgi membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "structural constituent of virion"
hasFunction dp "viral envelope"
hasFunction dp "virion membrane"
hasISOpoint dp "9.633271"^^float
hasLenght dp "211"^^integer
hasMass dp "23435"^^integer
hasSequence dp "LKKLLEQWNLVIGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAVYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTRSMWSFNPETNILLNVPLHGTILTRPLLESELVIGAVILRGHLRIAGHHLGRCDIKDLPKEITVATSRTLSYYKLGASQRVAGDSGFAAYSRYRIGNYKLNTDHSSSSDNIALLVQ"

a0 a6 h1 p j z2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PJZ2

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794098"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRIIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 p k i7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PKI7

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794071"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVXXVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWXEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNXXFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCVSLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 p k90ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PK90

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794086"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 p l k8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PLK8

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7094"^^integer
hasMass dp "793688"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHVVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 p l x6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PLX6

belongs to
Protein c
has facts
hasFunction dp "endocytosis involved in viral entry into host cell"
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "host cell plasma membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "pathogenesis"
hasFunction dp "receptor-mediated virion attachment to host cell"
hasFunction dp "viral envelope"
hasFunction dp "virion membrane"
hasISOpoint dp "5.9569044"^^float
hasLenght dp "1274"^^integer
hasMass dp "141147"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFXXXXXXXXXXXXXXXXXXXXSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAXXYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVXXPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQXXXXXXXSALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKXXXXXXXICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINAXXXXIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h1 p l25ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PL25

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "793940"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGXXSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKXXXXXXXQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 p m n4ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PMN4

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "6.058623"^^float
hasLenght dp "6997"^^integer
hasMass dp "782911"^^integer
hasSequence dp "GETLGVLVPXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXDLGDELGTDXXXXXXXNWNTKHSSGVTRELMRELNGGAYTRXVXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTKXXVYCCREHEHEIAWYTERSEKSYELXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGXXXXXTCEFCGTENLTKXXATTCGYLPQNAVVKIYCPACHNSEVGPXHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKXXKXXXXTGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHXDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 p n56ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PN56

belongs to
Protein c
has facts
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment membrane"
hasFunction dp "host cell Golgi membrane"
hasFunction dp "host cell endoplasmic reticulum"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host G0/G1 transition checkpoint"
hasFunction dp "virion"
hasISOpoint dp "7.2487597"^^float
hasLenght dp "122"^^integer
hasMass dp "13768"^^integer
hasSequence dp "MKIILFLALITLATCELYHYQECVRGTTVLLKEPCSSGTYEGNSPFHPLADNKFALTCFSTQFAFACPDGVKHVYQLRARXVSPKLFIRQEEVQELYSPIFLIVAAIVFITLCFTLKRKTE"

a0 a6 h1 p n84ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PN84

belongs to
Protein c
has facts
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transferase activity"
hasFunction dp "viral genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490019"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSEARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQLEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h1 p q x1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1PQX1

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45650"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGXQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 h1 t f g9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1TFG9

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "6.147627"^^float
hasLenght dp "7097"^^integer
hasMass dp "794031"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHXXXXSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADXXXKTLQPVSELLTPLGIDLDEWSMATYYLFDXSGEFKLASHMYCSFYPPDEXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHIXXXXXXXXXXXXXWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTXXXXSACVLAAECXXXXXXXGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVXXXXXQYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAXXXXXDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 t f j7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1TFJ7

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.9314747"^^float
hasLenght dp "7097"^^integer
hasMass dp "793924"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTXXXXXXTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 t f p8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1TFP8

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794093"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPXXXXXXXXXXXXXXXXXXXXXCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 t f95ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1TF95

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.9696193"^^float
hasLenght dp "7097"^^integer
hasMass dp "794027"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSXXXXXXXXXTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNLAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 t g t0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1TGT0

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "11.535029"^^float
hasLenght dp "62"^^integer
hasMass dp "6568"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGK"

a0 a6 h1 t h f0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1THF0

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral genome replication"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490089"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSVALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSFKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h1 t h n6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1THN6

belongs to
Protein c
has facts
hasFunction dp "modulation by virus of host G0/G1 transition checkpoint"
hasFunction dp "virion"
hasISOpoint dp "7.351162"^^float
hasLenght dp "86"^^integer
hasMass dp "9489"^^integer
hasSequence dp "MKIILFLALITLATCELYHYQECVRGTTVLLKEPCSSGTYEGNSPFHPLADNKFALTCFSTQFAFACPDGVKHVYQLRARSVSPK"

a0 a6 h1 t h t0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1THT0

belongs to
Protein c
has facts
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transferase activity"
hasFunction dp "viral genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490061"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSFKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h1 t j r7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1TJR7

belongs to
Protein c
has facts
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "viral envelope"
hasISOpoint dp "5.906045"^^float
hasLenght dp "1239"^^integer
hasMass dp "137620"^^integer
hasSequence dp "VYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLFSTASALGKLQDVVNQNAQALNTLVKQLXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h1 x l n4ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XLN4

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "6.007764"^^float
hasLenght dp "7058"^^integer
hasMass dp "789778"^^integer
hasSequence dp "SEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELXAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 x m00ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XM00

belongs to
Protein c
has facts
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "viral envelope"
hasISOpoint dp "5.982334"^^float
hasLenght dp "1274"^^integer
hasMass dp "141151"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKISDYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMXXXMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h1 x m98ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XM98

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794114"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREVACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 x n d5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XND5

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490001"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLIAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h1 x n k2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XNK2

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.995049"^^float
hasLenght dp "7006"^^integer
hasMass dp "783953"^^integer
hasSequence dp "LEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNLCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPXXXXXXNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNXXXXXXXXXXXXSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGVFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 x n u0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XNU0

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794042"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNLCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLSYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 x n68ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XN68

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.9441895"^^float
hasLenght dp "7097"^^integer
hasMass dp "793925"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTTLRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 x p f6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XPF6

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794076"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDXFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAXFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNXAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSECDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 x p s2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XPS2

belongs to
Protein c
has facts
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "viral envelope"
hasISOpoint dp "5.982334"^^float
hasLenght dp "1274"^^integer
hasMass dp "141154"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEFGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h1 x p u5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XPU5

belongs to
Protein c
has facts
hasFunction dp "cytoplasm"
hasFunction dp "host cell Golgi membrane"
hasFunction dp "host cell plasma membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "ion channel activity"
hasFunction dp "plasma membrane"
hasFunction dp "pore formation by virus in membrane of host cell"
hasFunction dp "virion"
hasISOpoint dp "5.410166"^^float
hasLenght dp "276"^^integer
hasMass dp "31122"^^integer
hasSequence dp "MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLSFGWLIVGVALLAVFHSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAAGLEAPFLYLYALVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWHTNCYDYCIPYNSVTSSIVITSGDGTTSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLSTDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL"

a0 a6 h1 x p76ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1XP76

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794034"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNLCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFIIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 z3 h4ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1Z3H4

belongs to
Protein c
has facts
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "viral envelope"
hasISOpoint dp "5.982334"^^float
hasLenght dp "1274"^^integer
hasMass dp "141134"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHLTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h1 z310ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1Z310

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.9696193"^^float
hasLenght dp "7097"^^integer
hasMass dp "794090"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNNGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLMIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h1 z4 x5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H1Z4X5

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794136"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTVQAAGTDTTITVNVLAWLYAAVINGDRWFFNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h2 e f f6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2EFF6

belongs to
Protein c
has facts
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transferase activity"
hasFunction dp "viral genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490001"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSTYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVIYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h2 e g i5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2EGI5

belongs to
Protein c
has facts
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transferase activity"
hasFunction dp "viral genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.7534666"^^float
hasLenght dp "4406"^^integer
hasMass dp "490001"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSEARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQLEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLIVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h2 e g u7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2EGU7

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.9696193"^^float
hasLenght dp "7097"^^integer
hasMass dp "793971"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKHLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKXXXXXXXXXXXXXXXLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYXXKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h2 e i u5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2EIU5

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasISOpoint dp "5.7407517"^^float
hasLenght dp "4406"^^integer
hasMass dp "489978"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSXXXXIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h2 e i78ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2EI78

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45635"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRHKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 h2 e j69ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2EJ69

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral genome replication"
hasISOpoint dp "5.7407517"^^float
hasLenght dp "4406"^^integer
hasMass dp "490079"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRDFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVMENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h2 l a h8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2LAH8

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "793955"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNXXXXXXTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSXXYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESLSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAVLLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h2 l a32ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2LA32

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasISOpoint dp "5.7407517"^^float
hasLenght dp "4406"^^integer
hasMass dp "489702"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNXXXXXXXLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTXXXXYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNGFAV"

a0 a6 h2 l c t9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2LCT9

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794059"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINASQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h2 l c v8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2LCV8

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794102"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESLSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFSVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h2 l6 i0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2L6I0

belongs to
Protein c
has facts
hasFunction dp "endocytosis involved in viral entry into host cell"
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "host cell plasma membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "pathogenesis"
hasFunction dp "receptor-mediated virion attachment to host cell"
hasFunction dp "viral envelope"
hasFunction dp "virion membrane"
hasISOpoint dp "6.045908"^^float
hasLenght dp "1274"^^integer
hasMass dp "141133"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINXXXXXXXXXXXXXXXXXXXXXXXXXXXXTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h2 l673ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2L673

belongs to
Protein c
has facts
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "viral envelope"
hasISOpoint dp "5.982334"^^float
hasLenght dp "1274"^^integer
hasMass dp "141168"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGFYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h2 l683ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2L683

belongs to
Protein c
has facts
hasFunction dp "endocytosis involved in viral entry into host cell"
hasFunction dp "fusion of virus membrane with host endosome membrane"
hasFunction dp "fusion of virus membrane with host plasma membrane"
hasFunction dp "host cell plasma membrane"
hasFunction dp "integral component of membrane"
hasFunction dp "pathogenesis"
hasFunction dp "receptor-mediated virion attachment to host cell"
hasFunction dp "viral envelope"
hasFunction dp "virion membrane"
hasISOpoint dp "6.045908"^^float
hasLenght dp "1274"^^integer
hasMass dp "141189"^^integer
hasSequence dp "MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT"

a0 a6 h2 l7 p8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2L7P8

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45642"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPASDLDDFSKQLQQSMSSADSTQA"

a0 a6 h2 l8 b6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2L8B6

belongs to
Protein c
has facts
hasFunction dp "ATP binding"
hasFunction dp "DNA helicase activity"
hasFunction dp "RNA helicase activity"
hasFunction dp "RNA-directed 5'-3' RNA polymerase activity"
hasFunction dp "cysteine-type endopeptidase activity"
hasFunction dp "endonuclease activity"
hasFunction dp "endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "exonuclease activity"
hasFunction dp "host cell endoplasmic reticulum-Golgi intermediate compartment"
hasFunction dp "host cell membrane"
hasFunction dp "host cell perinuclear region of cytoplasm"
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "integral component of membrane"
hasFunction dp "methylation"
hasFunction dp "methyltransferase activity"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "single-stranded RNA binding"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "thiol-dependent ubiquitin-specific protease activity"
hasFunction dp "transcription, DNA-templated"
hasFunction dp "viral RNA genome replication"
hasFunction dp "viral protein processing"
hasFunction dp "zinc ion binding"
hasISOpoint dp "5.906045"^^float
hasLenght dp "7097"^^integer
hasMass dp "793930"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX"

a0 a6 h2 l8 h9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2L8H9

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.982334"^^float
hasLenght dp "7097"^^integer
hasMass dp "794140"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESLSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAVLLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 h2 l8 p2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6H2L8P2

belongs to
Protein c
has facts
hasFunction dp "induction by virus of catabolism of host mRNA"
hasFunction dp "induction by virus of host autophagy"
hasFunction dp "modulation by virus of host protein ubiquitination"
hasFunction dp "suppression by virus of host ISG15 activity"
hasFunction dp "suppression by virus of host NF-kappaB transcription factor activity"
hasFunction dp "suppression by virus of host type I interferon-mediated signaling pathway"
hasFunction dp "viral RNA genome replication"
hasISOpoint dp "5.995049"^^float
hasLenght dp "7097"^^integer
hasMass dp "794174"^^integer
hasSequence dp "MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDIFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIRLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDRATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN"

a0 a6 m3 v w l1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M3VWL1

belongs to
Protein c
has facts
hasFunction dp "viral envelope"
hasISOpoint dp "4.4311233"^^float
hasLenght dp "76"^^integer
hasMass dp "8355"^^integer
hasSequence dp "MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNIXXXXXXXXXXXXXXXXXXXXXXXXXXXLF"

a0 a6 m3 w m j8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M3WMJ8

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45642"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFALSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m3 w p v3ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M3WPV3

belongs to
Protein c
has facts
hasFunction dp "viral envelope"
hasISOpoint dp "8.302041"^^float
hasLenght dp "70"^^integer
hasMass dp "7728"^^integer
hasSequence dp "MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNIVNVSLVKPSFYVYSRVKNLNSSR"

a0 a6 m3 y r24ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M3YR24

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.428467"^^float
hasLenght dp "420"^^integer
hasMass dp "45694"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIXXXXXXXNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 b b q0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4BBQ0

belongs to
Protein c
has facts
hasFunction dp "viral envelope"
hasISOpoint dp "4.4311233"^^float
hasLenght dp "76"^^integer
hasMass dp "8316"^^integer
hasSequence dp "MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX"

a0 a6 m4 e n n1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4ENN1

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.604013"^^float
hasLenght dp "420"^^integer
hasMass dp "45520"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTXXXXXXXXXXXXXXXXXXXQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 e r w7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4ERW7

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.677158"^^float
hasLenght dp "420"^^integer
hasMass dp "45458"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 m y i3ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4MYI3

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.501612"^^float
hasLenght dp "420"^^integer
hasMass dp "45737"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSKRTSPARMXGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n d c2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4NDC2

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45704"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEAXKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTXAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n d y0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4NDY0

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45590"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAXGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n f71ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4NF71

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.560127"^^float
hasLenght dp "420"^^integer
hasMass dp "45759"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKYLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLXKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSKRTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n h q1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4NHQ1

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.428467"^^float
hasLenght dp "420"^^integer
hasMass dp "45638"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGXFGDQELIRQGTDYKHWPQIAQFAPSASXXXXXXXXXXEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n j80ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4NJ80

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.604013"^^float
hasLenght dp "420"^^integer
hasMass dp "45632"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSPRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFXDQELIRQGTDYKXXPXXXXFAPSAXXFFGMSRIGMEVTPSGTWLTYTGAIKXXXXDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n0 v5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4N0V5

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.604013"^^float
hasLenght dp "420"^^integer
hasMass dp "45611"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEXSKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAXDLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n1 v1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4N1V1

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.838077"^^float
hasLenght dp "420"^^integer
hasMass dp "45627"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLXQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n2 n5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4N2N5

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.457725"^^float
hasLenght dp "420"^^integer
hasMass dp "45533"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXMSRIGMEVTPSGTWLTYTGXXXXXXXDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n2 w7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4N2W7

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.560127"^^float
hasLenght dp "420"^^integer
hasMass dp "45621"^^integer
hasSequence dp "MSDNGPQNQRNALRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDXQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTXA"

a0 a6 m4 n341ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4N341

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.5308695"^^float
hasLenght dp "420"^^integer
hasMass dp "45524"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFXYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n6 s0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4N6S0

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.618643"^^float
hasLenght dp "420"^^integer
hasMass dp "45826"^^integer
hasSequence dp "MSDNGPQNQRNALRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNLTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYXXXXXXXXXXPEQTQGNXXXXXLIRQGTDYKHWPQIAQFAXSASAFFGMSRIXMEXXXXXXXXXXXXXXXXXXKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m4 n9 b1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M4N9B1

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.545498"^^float
hasLenght dp "420"^^integer
hasMass dp "45464"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSKRTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPQIAQFAPSASAFFGMSRIGMEVXXSGXXXTYTXXXXXXXXXPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m5 k a w5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M5KAW5

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.443096"^^float
hasLenght dp "420"^^integer
hasMass dp "45654"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSLNSSRNSTPGSSKRTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m5 s x n6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M5SXN6

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.677158"^^float
hasLenght dp "420"^^integer
hasMass dp "45566"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAAXXXXXXXXXQQSMSSADSTQA"

a0 a6 m6 b8 z3ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M6B8Z3

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.428467"^^float
hasLenght dp "420"^^integer
hasMass dp "45583"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSLNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m8 d p u6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M8DPU6

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.618643"^^float
hasLenght dp "420"^^integer
hasMass dp "45566"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPGRMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADXXXXSKQLQQSMSSADSTQA"

a0 a6 m8 d y w3ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M8DYW3

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.735674"^^float
hasLenght dp "420"^^integer
hasMass dp "45503"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQQSMSSADSTQA"

a0 a6 m8 d z80ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M8DZ80

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.194405"^^float
hasLenght dp "420"^^integer
hasMass dp "46287"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m8 e x u6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M8EXU6

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45668"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAVNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m8 f b13ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M8FB13

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45654"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQVLPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m8 f5 v8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M8F5V8

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.750302"^^float
hasLenght dp "419"^^integer
hasMass dp "45517"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADXXXXXXXXXXXXXXXXLLPAAXXXXXXKXXXXXXXXXXXXQ"

a0 a6 m8 w f v2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M8WFV2

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.735674"^^float
hasLenght dp "420"^^integer
hasMass dp "45537"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXADSTQA"

a0 a6 m8 w m m2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M8WMM2

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45635"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPHRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m9 q c d0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M9QCD0

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45654"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEVGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 m9 t u q1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6M9TUQ1

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.472354"^^float
hasLenght dp "420"^^integer
hasMass dp "45612"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKNKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v q l9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VQL9

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.472354"^^float
hasLenght dp "418"^^integer
hasMass dp "45495"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASXKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v r n9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VRN9

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.179775"^^float
hasLenght dp "420"^^integer
hasMass dp "46325"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v r35ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VR35

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45773"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQXTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTXXXKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v r93ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VR93

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45551"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSKRTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDXXXXXXXXXXXPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v t90ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VT90

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.677158"^^float
hasLenght dp "420"^^integer
hasMass dp "45607"^^integer
hasSequence dp "MSDNGPQNQRNALRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKXFYAXGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAXEASXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v u j4ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VUJ4

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.92585"^^float
hasLenght dp "420"^^integer
hasMass dp "45635"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTAXKAYNVTQAFGRRGPEQTQXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v u49ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VU49

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.618643"^^float
hasLenght dp "420"^^integer
hasMass dp "45706"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSKRTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAXXSKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGXXXXXXXXXXXXXXXXXXFFGMSRIGMEVTPSGTWLTYTGAIKLDDXDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v w i0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VWI0

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.618643"^^float
hasLenght dp "420"^^integer
hasMass dp "45582"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v w p2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VWP2

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.823447"^^float
hasLenght dp "420"^^integer
hasMass dp "45617"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTXKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGXXXXXXLIXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v y m0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VYM0

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.574756"^^float
hasLenght dp "420"^^integer
hasMass dp "45562"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFXALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTXKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEAXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 v y77ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0VY77

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.560127"^^float
hasLenght dp "420"^^integer
hasMass dp "45668"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSKRTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n0 w0 n5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N0W0N5

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45666"^^integer
hasSequence dp "MSDNGPQNQRNALRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEAXKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n1 n c j1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N1NCJ1

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.560127"^^float
hasLenght dp "420"^^integer
hasMass dp "45648"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKHGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n1 n r r0ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N1NRR0

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45690"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDXYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADXTQA"

a0 a6 n1 n1 b1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N1N1B1

belongs to
Protein c
has facts
hasFunction dp "viral envelope"
hasISOpoint dp "8.302041"^^float
hasLenght dp "69"^^integer
hasMass dp "7561"^^integer
hasSequence dp "ETGTLIVNSVLLFLXFVVFLLVTLAILTALRLCAYCCNIVNVSLVKPSFYVYSRVKNLNSSRVPDLLV"

a0 a6 n1 q955ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N1Q955

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.486982"^^float
hasLenght dp "420"^^integer
hasMass dp "45642"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPSADLDDFSKQLQQSMSSADSTQA"

a0 a6 n1 w i29ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N1WI29

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.355322"^^float
hasLenght dp "420"^^integer
hasMass dp "45515"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n1 w j27ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N1WJ27

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.428467"^^float
hasLenght dp "420"^^integer
hasMass dp "45533"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHCPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALSQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

a0 a6 n1 w n h3ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#A0A6N1WNH3

belongs to
Protein c
has facts
hasFunction dp "viral nucleocapsid"
hasISOpoint dp "9.472354"^^float
hasLenght dp "420"^^integer
hasMass dp "45656"^^integer
hasSequence dp "MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGXXDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGXXXXGQTVTKXSAAEXXXKPRQKRTXXXXXXXXQAFGRRGPEXTQGNFGDQELXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA"

dis1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#dis1

belongs to
Disease c
has facts
hasName dp "COVID-19"@en

i d1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H1XPU5"

i d10ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID10

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d100ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID100

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d1000ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1000

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZXA5"

i d1001ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1001

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PHI9"

i d1002ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1002

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XP76"

i d1003ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1003

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8P2"

i d1004ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1004

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFG9"

i d1005ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1005

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNU0"

i d1006ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1006

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XN68"

i d1007ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1007

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EIU5"

i d1008ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1008

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LAH8"

i d1009ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1009

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZYB8"

i d101ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID101

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d1010ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1010

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XLN4"

i d1011ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1011

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C4K2"

i d1012ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1012

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8H9"

i d1013ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1013

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIQ8"

i d1014ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1014

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JMC1"

i d1015ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1015

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0MBY8"

i d1016ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1016

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EJ69"

i d1017ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1017

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THF0"

i d1018ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1018

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z310"

i d1019ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1019

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIK0"

i d102ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID102

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d1020ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1020

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C761"

i d1021ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1021

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0QT90"

i d1022ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1022

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TF95"

i d1023ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1023

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XND5"

i d1024ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1024

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PKI7"

i d1025ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1025

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LA32"

i d1026ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1026

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XM98"

i d1027ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1027

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZXA5"

i d1028ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1028

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PHI9"

i d1029ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1029

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XP76"

i d103ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID103

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d1030ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1030

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8P2"

i d1031ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1031

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFG9"

i d1032ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1032

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNU0"

i d1033ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1033

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XN68"

i d1034ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1034

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EIU5"

i d1035ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1035

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LAH8"

i d1036ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1036

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZYB8"

i d1037ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1037

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XLN4"

i d1038ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1038

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C4K2"

i d1039ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1039

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8H9"

i d104ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID104

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d1040ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1040

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIQ8"

i d1041ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1041

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JMC1"

i d1042ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1042

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0MBY8"

i d1043ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1043

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EJ69"

i d1044ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1044

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THF0"

i d1045ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1045

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z310"

i d1046ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1046

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIK0"

i d1047ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1047

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C761"

i d1048ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1048

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0QT90"

i d1049ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1049

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TF95"

i d105ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID105

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d1050ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1050

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XND5"

i d1051ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1051

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PKI7"

i d1052ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1052

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LA32"

i d1053ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1053

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XM98"

i d1054ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1054

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZXA5"

i d1055ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1055

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PHI9"

i d1056ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1056

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XP76"

i d1057ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1057

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8P2"

i d1058ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1058

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFG9"

i d1059ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1059

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNU0"

i d106ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID106

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d1060ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1060

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XN68"

i d1061ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1061

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EIU5"

i d1062ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1062

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LAH8"

i d1063ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1063

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZYB8"

i d1064ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1064

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XLN4"

i d1065ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1065

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C4K2"

i d1066ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1066

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8H9"

i d1067ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1067

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JMC1"

i d1068ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1068

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0MBY8"

i d1069ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1069

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z310"

i d107ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID107

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d1070ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1070

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C761"

i d1071ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1071

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0QT90"

i d1072ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1072

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TF95"

i d1073ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1073

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PKI7"

i d1074ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1074

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XM98"

i d1075ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1075

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZXA5"

i d1076ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1076

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XP76"

i d1077ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1077

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8P2"

i d1078ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1078

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFG9"

i d1079ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1079

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNU0"

i d108ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID108

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d1080ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1080

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XN68"

i d1081ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1081

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LAH8"

i d1082ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1082

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZYB8"

i d1083ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1083

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XLN4"

i d1084ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1084

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C4K2"

i d1085ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1085

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6F8Z994"

i d1086ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1086

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1THN6"

i d1087ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1087

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8H9"

i d1088ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1088

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIQ8"

i d1089ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1089

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JMC1"

i d109ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID109

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d1090ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1090

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0MBY8"

i d1091ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1091

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EJ69"

i d1092ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1092

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THF0"

i d1093ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1093

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z310"

i d1094ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1094

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIK0"

i d1095ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1095

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C761"

i d1096ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1096

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0QT90"

i d1097ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1097

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TF95"

i d1098ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1098

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XND5"

i d1099ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1099

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PKI7"

i d11ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID11

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d110ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID110

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d1100ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1100

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LA32"

i d1101ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1101

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XM98"

i d1102ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1102

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZXA5"

i d1103ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1103

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PHI9"

i d1104ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1104

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XP76"

i d1105ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1105

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8P2"

i d1106ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1106

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFG9"

i d1107ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1107

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNU0"

i d1108ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1108

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XN68"

i d1109ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1109

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EIU5"

i d111ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID111

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d1110ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1110

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LAH8"

i d1111ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1111

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZYB8"

i d1112ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1112

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XLN4"

i d1113ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1113

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C4K2"

i d1114ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1114

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1XPS2"

i d1115ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1115

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0C680"

i d1116ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1116

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1Z3H4"

i d1117ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1117

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1TJR7"

i d1118ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1118

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0C6J2"

i d1119ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1119

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L673"

i d112ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID112

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d1120ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1120

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1XM00"

i d1121ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1121

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0QTK2"

i d1122ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1122

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6G7KRD9"

i d1123ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1123

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0C4M2"

i d1124ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1124

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0JMD6"

i d1125ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1125

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8H9"

i d1126ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1126

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JMC1"

i d1127ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1127

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0MBY8"

i d1128ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1128

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z310"

i d1129ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1129

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C761"

i d113ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID113

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d1130ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1130

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0QT90"

i d1131ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1131

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TF95"

i d1132ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1132

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PKI7"

i d1133ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1133

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XM98"

i d1134ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1134

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZXA5"

i d1135ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1135

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XP76"

i d1136ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1136

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8P2"

i d1137ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1137

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFG9"

i d1138ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1138

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNU0"

i d1139ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1139

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XN68"

i d114ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID114

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d1140ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1140

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LAH8"

i d1141ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1141

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZYB8"

i d1142ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1142

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XLN4"

i d1143ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1143

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C4K2"

i d1144ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1144

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4Z4"

i d1145ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1145

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0QUB7"

i d1146ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1146

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4Z4"

i d1147ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1147

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6F8Z994"

i d1148ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1148

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0QUB7"

i d1149ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1149

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1THN6"

i d115ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID115

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d1150ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1150

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M9QCD0"

i d1151ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1151

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6H2EI78"

i d1152ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1152

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4N2N5"

i d1153ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1153

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4N9B1"

i d1154ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1154

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M8F5V8"

i d1155ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1155

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4NF71"

i d1156ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1156

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VT90"

i d1157ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1157

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M9TUQ1"

i d1158ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1158

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4N6S0"

i d1159ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1159

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N1WI29"

i d116ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID116

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d1160ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1160

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N1WNH3"

i d1161ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1161

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VR93"

i d1162ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1162

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4MYI3"

i d1163ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1163

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4NHQ1"

i d1164ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1164

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4ENN1"

i d1165ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1165

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VU49"

i d1166ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1166

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6H2L7P8"

i d1167ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1167

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M5KAW5"

i d1168ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1168

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4N341"

i d1169ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1169

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6H1PQX1"

i d117ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID117

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d1170ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1170

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4N0V5"

i d1171ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1171

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4N1V1"

i d1172ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1172

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N1NCJ1"

i d1173ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1173

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1XPS2"

i d1174ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1174

belongs to
Gene c
has facts
hasName dp "E"
produce protein dp "A0A6M4BBQ0"

i d1175ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1175

belongs to
Gene c
has facts
hasName dp "E"
produce protein dp "A0A6M3VWL1"

i d1176ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1176

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6G7KRD9"

i d1177ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1177

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0C680"

i d1178ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1178

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1Z3H4"

i d1179ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1179

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0C4M2"

i d118ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID118

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d1180ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1180

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1TJR7"

i d1181ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1181

belongs to
Gene c
has facts
hasName dp "E"
produce protein dp "A0A6M3WPV3"

i d1182ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1182

belongs to
Gene c
has facts
hasName dp "E"
produce protein dp "A0A6N1N1B1"

i d1183ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1183

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0JMD6"

i d1184ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1184

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0C6J2"

i d1185ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1185

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L673"

i d1186ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1186

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1XM00"

i d1187ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1187

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0QTK2"

i d1188ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1188

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1XPS2"

i d1189ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1189

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0C680"

i d119ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID119

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d1190ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1190

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1Z3H4"

i d1191ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1191

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1TJR7"

i d1192ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1192

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0C6J2"

i d1193ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1193

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L673"

i d1194ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1194

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1XM00"

i d1195ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1195

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0QTK2"

i d1196ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1196

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIQ8"

i d1197ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1197

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EJ69"

i d1198ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1198

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THF0"

i d1199ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID1199

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIK0"

i d12ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID12

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d120ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID120

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d121ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID121

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d122ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID122

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d123ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID123

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d124ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID124

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H0Z2D7"

i d125ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID125

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PHS8"

i d126ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID126

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d127ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID127

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d128ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID128

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d129ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID129

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d13ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID13

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d130ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID130

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d131ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID131

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d132ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID132

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d133ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID133

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d134ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID134

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d135ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID135

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d136ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID136

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d137ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID137

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d138ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID138

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d139ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID139

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d14ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID14

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d140ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID140

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d141ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID141

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d142ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID142

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d143ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID143

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d144ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID144

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d145ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID145

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d146ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID146

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d147ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID147

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d148ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID148

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d149ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID149

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d15ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID15

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d150ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID150

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d151ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID151

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d152ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID152

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d153ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID153

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d154ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID154

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PIK7"

i d155ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID155

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PJV4"

i d156ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID156

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d157ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID157

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d158ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID158

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d159ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID159

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d16ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID16

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d160ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID160

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d161ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID161

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d162ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID162

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d163ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID163

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d164ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID164

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d165ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID165

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d166ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID166

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d167ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID167

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d168ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID168

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d169ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID169

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d17ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID17

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d170ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID170

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d171ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID171

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d172ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID172

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d173ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID173

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d174ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID174

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d175ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID175

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d176ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID176

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d177ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID177

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H1XPU5"

i d178ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID178

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C5K7"

i d179ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID179

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H1XPU5"

i d18ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID18

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d180ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID180

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H0Z2D7"

i d181ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID181

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C5K7"

i d182ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID182

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PHS8"

i d183ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID183

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M8WMM2"

i d184ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID184

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6F8Z1D7"

i d185ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID185

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VRN9"

i d186ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID186

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M5SXN6"

i d187ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID187

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N1Q955"

i d188ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID188

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4NDY0"

i d189ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID189

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VWI0"

i d19ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID19

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d190ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID190

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M3WMJ8"

i d191ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID191

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VYM0"

i d192ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID192

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0W0N5"

i d193ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID193

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M3YR24"

i d194ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID194

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VR35"

i d195ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID195

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4ERW7"

i d196ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID196

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4NJ80"

i d197ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID197

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6H0JG71"

i d198ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID198

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M8EXU6"

i d199ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID199

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VWP2"

i d2ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID2

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C5K7"

i d20ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID20

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d200ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID200

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6G7CR90"

i d201ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID201

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M8DZ80"

i d202ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID202

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M6B8Z3"

i d203ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID203

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VQL9"

i d204ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID204

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N1WJ27"

i d205ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID205

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6H1TGT0"

i d206ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID206

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VY77"

i d207ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID207

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N0VUJ4"

i d208ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID208

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M8DPU6"

i d209ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID209

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4NDC2"

i d21ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID21

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d210ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID210

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d211ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID211

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PIK7"

i d212ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID212

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PJV4"

i d213ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID213

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d214ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID214

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d215ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID215

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d216ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID216

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d217ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID217

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d218ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID218

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d219ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID219

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d22ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID22

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d220ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID220

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d221ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID221

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d222ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID222

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d223ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID223

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d224ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID224

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d225ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID225

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d226ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID226

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d227ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID227

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d228ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID228

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d229ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID229

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d23ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID23

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d230ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID230

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d231ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID231

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d232ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID232

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d233ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID233

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d234ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID234

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d235ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID235

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d236ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID236

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d237ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID237

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d238ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID238

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d239ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID239

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d24ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID24

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d240ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID240

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d241ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID241

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d242ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID242

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d243ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID243

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d244ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID244

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d245ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID245

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d246ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID246

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d247ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID247

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d248ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID248

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d249ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID249

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d25ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID25

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d250ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID250

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d251ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID251

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d252ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID252

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d253ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID253

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d254ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID254

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d255ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID255

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d256ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID256

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d257ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID257

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d258ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID258

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d259ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID259

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d26ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID26

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d260ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID260

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d261ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID261

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d262ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID262

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d263ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID263

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d264ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID264

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d265ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID265

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d266ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID266

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d267ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID267

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d268ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID268

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H0Z2D7"

i d269ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID269

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PHS8"

i d27ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID27

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d270ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID270

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d271ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID271

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d272ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID272

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d273ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID273

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d274ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID274

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d275ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID275

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d276ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID276

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d277ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID277

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d278ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID278

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d279ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID279

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d28ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID28

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d280ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID280

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d281ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID281

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d282ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID282

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d283ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID283

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d284ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID284

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d285ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID285

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d286ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID286

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d287ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID287

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d288ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID288

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d289ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID289

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d29ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID29

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d290ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID290

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d291ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID291

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d292ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID292

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d293ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID293

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d294ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID294

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6F8Z1D7"

i d295ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID295

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6H0JG71"

i d296ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID296

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6G7CR90"

i d297ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID297

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d298ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID298

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d299ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID299

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d3ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID3

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d30ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID30

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d300ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID300

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d301ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID301

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d302ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID302

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d303ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID303

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d304ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID304

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d305ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID305

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d306ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID306

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d307ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID307

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d308ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID308

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d309ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID309

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d31ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID31

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d310ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID310

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d311ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID311

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d312ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID312

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d313ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID313

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d314ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID314

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d315ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID315

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d316ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID316

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d317ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID317

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d318ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID318

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d319ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID319

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d32ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID32

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d320ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID320

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d321ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID321

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d322ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID322

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d323ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID323

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d324ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID324

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d325ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID325

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d326ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID326

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d327ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID327

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d328ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID328

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d329ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID329

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d33ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID33

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d330ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID330

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d331ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID331

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d332ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID332

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d333ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID333

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d334ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID334

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d335ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID335

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d336ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID336

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d337ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID337

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d338ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID338

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d339ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID339

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d34ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID34

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d340ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID340

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d341ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID341

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d342ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID342

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d343ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID343

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d344ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID344

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d345ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID345

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d346ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID346

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d347ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID347

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d348ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID348

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d349ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID349

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d35ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID35

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d350ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID350

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d351ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID351

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d352ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID352

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d353ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID353

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d354ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID354

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d355ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID355

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d356ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID356

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d357ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID357

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d358ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID358

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d359ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID359

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d36ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID36

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d360ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID360

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d361ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID361

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d362ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID362

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d363ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID363

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d364ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID364

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d365ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID365

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d366ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID366

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d367ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID367

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d368ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID368

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d369ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID369

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d37ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID37

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d370ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID370

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d371ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID371

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d372ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID372

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d373ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID373

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d374ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID374

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d375ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID375

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d376ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID376

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d377ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID377

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d378ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID378

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d379ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID379

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d38ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID38

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d380ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID380

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d381ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID381

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d382ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID382

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d383ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID383

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d384ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID384

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d385ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID385

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d386ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID386

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d387ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID387

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d388ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID388

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d389ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID389

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d39ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID39

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d390ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID390

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d391ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID391

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d392ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID392

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d393ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID393

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d394ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID394

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d395ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID395

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d396ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID396

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d397ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID397

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d398ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID398

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d399ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID399

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d4ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID4

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d40ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID40

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d400ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID400

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d401ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID401

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d402ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID402

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d403ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID403

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d404ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID404

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d405ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID405

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d406ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID406

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d407ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID407

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d408ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID408

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d409ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID409

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d41ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID41

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d410ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID410

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d411ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID411

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d412ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID412

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d413ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID413

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d414ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID414

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d415ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID415

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d416ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID416

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d417ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID417

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d418ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID418

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d419ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID419

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d42ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID42

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d420ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID420

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d421ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID421

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d422ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID422

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d423ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID423

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d424ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID424

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d425ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID425

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d426ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID426

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d427ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID427

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d428ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID428

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d429ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID429

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d43ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID43

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d430ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID430

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d431ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID431

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d432ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID432

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d433ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID433

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d434ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID434

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d435ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID435

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d436ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID436

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d437ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID437

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d438ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID438

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d439ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID439

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d44ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID44

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d440ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID440

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d441ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID441

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d442ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID442

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d443ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID443

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d444ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID444

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d445ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID445

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d446ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID446

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d447ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID447

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d448ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID448

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d449ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID449

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d45ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID45

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d450ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID450

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d451ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID451

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d452ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID452

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d453ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID453

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d454ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID454

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d455ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID455

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d456ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID456

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d457ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID457

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d458ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID458

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d459ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID459

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d46ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID46

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d460ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID460

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d461ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID461

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d462ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID462

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d463ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID463

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d464ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID464

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d465ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID465

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d466ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID466

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d467ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID467

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d468ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID468

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d469ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID469

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d47ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID47

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d470ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID470

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d471ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID471

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d472ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID472

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d473ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID473

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d474ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID474

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H1XPU5"

i d475ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID475

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C5K7"

i d476ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID476

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d477ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID477

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d478ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID478

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d479ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID479

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d48ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID48

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d480ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID480

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d481ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID481

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d482ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID482

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d483ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID483

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d484ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID484

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d485ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID485

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d486ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID486

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d487ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID487

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d488ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID488

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d489ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID489

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d49ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID49

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d490ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID490

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d491ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID491

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d492ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID492

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d493ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID493

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d494ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID494

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d495ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID495

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d496ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID496

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H1XPU5"

i d497ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID497

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C5K7"

i d498ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID498

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d499ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID499

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d5ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID5

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d50ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID50

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d500ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID500

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d501ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID501

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d502ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID502

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d503ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID503

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d504ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID504

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d505ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID505

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d506ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID506

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d507ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID507

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d508ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID508

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d509ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID509

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d51ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID51

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d510ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID510

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d511ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID511

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d512ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID512

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d513ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID513

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d514ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID514

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d515ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID515

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d516ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID516

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d517ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID517

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d518ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID518

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d519ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID519

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d52ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID52

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d520ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID520

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d521ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID521

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d522ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID522

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d523ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID523

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d524ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID524

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d525ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID525

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d526ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID526

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d527ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID527

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d528ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID528

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d529ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID529

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d53ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID53

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d530ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID530

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d531ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID531

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d532ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID532

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d533ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID533

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d534ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID534

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d535ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID535

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d536ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID536

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d537ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID537

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d538ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID538

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d539ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID539

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d54ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID54

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d540ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID540

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d541ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID541

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d542ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID542

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d543ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID543

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d544ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID544

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d545ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID545

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d546ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID546

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d547ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID547

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d548ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID548

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d549ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID549

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d55ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID55

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d550ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID550

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d551ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID551

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d552ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID552

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d553ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID553

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d554ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID554

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d555ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID555

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d556ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID556

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d557ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID557

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d558ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID558

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d559ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID559

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d56ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID56

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d560ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID560

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d561ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID561

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d562ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID562

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d563ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID563

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d564ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID564

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d565ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID565

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d566ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID566

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d567ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID567

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d568ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID568

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PIK7"

i d569ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID569

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d57ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID57

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d570ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID570

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d571ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID571

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H1XPU5"

i d572ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID572

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d573ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID573

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H0Z2D7"

i d574ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID574

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d575ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID575

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d576ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID576

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d577ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID577

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d578ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID578

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C5K7"

i d579ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID579

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d58ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID58

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d580ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID580

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d581ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID581

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d582ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID582

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d583ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID583

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d584ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID584

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PHS8"

i d585ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID585

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PJV4"

i d586ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID586

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d587ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID587

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d588ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID588

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d589ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID589

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d59ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID59

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d590ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID590

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d591ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID591

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d592ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID592

belongs to
Gene c
has facts
hasName dp "ORF7b"
produce protein dp "A0A6H0C5L9"

i d593ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID593

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d594ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID594

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d595ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID595

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d596ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID596

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d597ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID597

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d598ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID598

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d599ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID599

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d6ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID6

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d60ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID60

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d600ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID600

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d601ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID601

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H1XPU5"

i d602ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID602

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C5K7"

i d603ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID603

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d604ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID604

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d605ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID605

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d606ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID606

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d607ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID607

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d608ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID608

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d609ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID609

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d61ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID61

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d610ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID610

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d611ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID611

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d612ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID612

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d613ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID613

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d614ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID614

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d615ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID615

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d616ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID616

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d617ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID617

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d618ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID618

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d619ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID619

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d62ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID62

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d620ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID620

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d621ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID621

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d622ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID622

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d623ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID623

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d624ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID624

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d625ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID625

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d626ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID626

belongs to
Gene c
has facts
hasName dp "ORF7b"
produce protein dp "A0A6H0C5L9"

i d627ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID627

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d628ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID628

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d629ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID629

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d63ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID63

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d630ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID630

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d631ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID631

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d632ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID632

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d633ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID633

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H0Z2D7"

i d634ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID634

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PHS8"

i d635ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID635

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6F8Z1D7"

i d636ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID636

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d637ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID637

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d638ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID638

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d639ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID639

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d64ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID64

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d640ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID640

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d641ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID641

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d642ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID642

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d643ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID643

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d644ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID644

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d645ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID645

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d646ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID646

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d647ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID647

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6H0JG71"

i d648ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID648

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d649ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID649

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d65ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID65

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d650ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID650

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d651ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID651

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6G7CR90"

i d652ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID652

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d653ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID653

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d654ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID654

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d655ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID655

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d656ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID656

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d657ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID657

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d658ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID658

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H0Z2D7"

i d659ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID659

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PHS8"

i d66ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID66

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d660ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID660

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6F8Z1D7"

i d661ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID661

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6H0JG71"

i d662ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID662

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6G7CR90"

i d663ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID663

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PIK7"

i d664ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID664

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H1XPU5"

i d665ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID665

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H0Z2D7"

i d666ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID666

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C5K7"

i d667ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID667

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PHS8"

i d668ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID668

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PJV4"

i d669ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID669

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d67ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID67

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d670ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID670

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d671ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID671

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d672ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID672

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d673ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID673

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d674ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID674

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d675ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID675

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d676ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID676

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d677ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID677

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d678ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID678

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d679ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID679

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d68ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID68

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d680ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID680

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d681ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID681

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d682ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID682

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d683ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID683

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d684ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID684

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d685ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID685

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d686ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID686

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d687ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID687

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d688ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID688

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d689ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID689

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d69ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID69

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d690ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID690

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d691ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID691

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d692ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID692

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d693ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID693

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d694ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID694

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d695ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID695

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d696ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID696

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L6I0"

i d697ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID697

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PIK7"

i d698ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID698

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H1PJV4"

i d699ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID699

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H1PLX6"

i d7ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID7

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d70ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID70

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d700ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID700

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H2L683"

i d701ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID701

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0M9Z2"

i d702ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID702

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4H2"

i d703ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID703

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d704ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID704

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d705ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID705

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d706ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID706

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d707ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID707

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d708ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID708

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d709ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID709

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d71ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID71

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d710ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID710

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d711ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID711

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d712ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID712

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d713ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID713

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d714ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID714

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d715ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID715

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d716ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID716

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d717ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID717

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d718ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID718

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d719ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID719

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d72ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID72

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d720ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID720

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d721ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID721

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d722ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID722

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d723ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID723

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d724ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID724

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d725ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID725

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d726ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID726

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d727ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID727

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d728ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID728

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d729ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID729

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d73ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID73

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d730ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID730

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d731ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID731

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d732ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID732

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d733ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID733

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d734ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID734

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d735ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID735

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d736ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID736

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d737ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID737

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d738ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID738

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d739ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID739

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d74ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID74

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d740ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID740

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d741ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID741

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d742ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID742

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d743ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID743

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d744ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID744

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d745ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID745

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PN56"

i d746ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID746

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d747ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID747

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d748ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID748

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d749ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID749

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d75ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID75

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6G9ZX30"

i d750ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID750

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d751ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID751

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d752ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID752

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d753ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID753

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d754ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID754

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d755ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID755

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d756ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID756

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0JP42"

i d757ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID757

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d758ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID758

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d759ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID759

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d76ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID76

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJZ2"

i d760ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID760

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d761ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID761

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d762ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID762

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d763ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID763

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0M9Z2"

i d764ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID764

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4H2"

i d765ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID765

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PN56"

i d766ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID766

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0M9Z2"

i d767ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID767

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4H2"

i d768ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID768

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M8FB13"

i d769ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID769

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M8DYW3"

i d77ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID77

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6C0QEN3"

i d770ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID770

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6N1NRR0"

i d771ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID771

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M4N2W7"

i d772ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID772

belongs to
Gene c
has facts
hasName dp "N"
produce protein dp "A0A6M8WFV2"

i d773ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID773

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d774ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID774

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0JP42"

i d775ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID775

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d776ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID776

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d777ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID777

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d778ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID778

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d779ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID779

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d78ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID78

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THT0"

i d780ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID780

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d781ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID781

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d782ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID782

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d783ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID783

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d784ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID784

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d785ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID785

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d786ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID786

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d787ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID787

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d788ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID788

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0JP42"

i d789ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID789

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d79ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID79

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZX45"

i d790ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID790

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d791ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID791

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d792ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID792

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d793ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID793

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d794ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID794

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d795ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID795

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PN56"

i d796ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID796

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d797ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID797

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d798ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID798

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d799ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID799

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d8ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID8

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d80ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID80

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PJL6"

i d800ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID800

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d801ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID801

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d802ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID802

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d803ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID803

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d804ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID804

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d805ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID805

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d806ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID806

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d807ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID807

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d808ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID808

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d809ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID809

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d81ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID81

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EFF6"

i d810ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID810

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d811ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID811

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d812ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID812

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d813ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID813

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d814ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID814

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d815ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID815

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d816ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID816

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d817ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID817

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d818ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID818

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d819ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID819

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d82ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID82

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PN84"

i d820ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID820

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d821ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID821

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d822ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID822

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d823ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID823

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d824ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID824

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d825ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID825

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d826ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID826

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d827ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID827

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d828ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID828

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d829ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID829

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d83ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID83

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFJ7"

i d830ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID830

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d831ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID831

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d832ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID832

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d833ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID833

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d834ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID834

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d835ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID835

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d836ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID836

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d837ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID837

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d838ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID838

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d839ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID839

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d84ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID84

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d840ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID840

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d841ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID841

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d842ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID842

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d843ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID843

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d844ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID844

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d845ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID845

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d846ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID846

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d847ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID847

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d848ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID848

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d849ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID849

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d85ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID85

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2S5"

i d850ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID850

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d851ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID851

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d852ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID852

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d853ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID853

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d854ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID854

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d855ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID855

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d856ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID856

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d857ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID857

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d858ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID858

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d859ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID859

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d86ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID86

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNK2"

i d860ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID860

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d861ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID861

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d862ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID862

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d863ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID863

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0M9Z2"

i d864ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID864

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4H2"

i d865ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID865

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d866ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID866

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d867ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID867

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d868ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID868

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d869ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID869

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d87ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID87

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIG6"

i d870ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID870

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d871ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID871

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d872ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID872

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0M9Z2"

i d873ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID873

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4H2"

i d874ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID874

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d875ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID875

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d876ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID876

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d877ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID877

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d878ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID878

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d879ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID879

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d88ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID88

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2V2"

i d880ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID880

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d881ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID881

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d882ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID882

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d883ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID883

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d884ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID884

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d885ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID885

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d886ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID886

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d887ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID887

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d888ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID888

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d889ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID889

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d89ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID89

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGU7"

i d890ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID890

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d891ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID891

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d892ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID892

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d893ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID893

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d894ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID894

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d895ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID895

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d896ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID896

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d897ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID897

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d898ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID898

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d899ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID899

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d9ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID9

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFP8"

i d90ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID90

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8B6"

i d900ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID900

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d901ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID901

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PN56"

i d902ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID902

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d903ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID903

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d904ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID904

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d905ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID905

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0M9Z2"

i d906ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID906

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d907ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID907

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d908ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID908

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d909ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID909

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d91ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID91

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XPF6"

i d910ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID910

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4H2"

i d911ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID911

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0JP42"

i d912ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID912

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d913ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID913

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d914ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID914

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d915ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID915

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d916ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID916

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0M9Z2"

i d917ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID917

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d918ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID918

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4H2"

i d919ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID919

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d92ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID92

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d920ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID920

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d921ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID921

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d922ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID922

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d923ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID923

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d924ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID924

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d925ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID925

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d926ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID926

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d927ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID927

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d928ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID928

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d929ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID929

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d93ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID93

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G7K2F6"

i d930ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID930

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PN56"

i d931ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID931

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d932ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID932

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d933ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID933

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d934ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID934

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d935ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID935

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d936ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID936

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d937ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID937

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d938ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID938

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PN56"

i d939ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID939

belongs to
Gene c
has facts
hasName dp "ORF7a"
produce protein dp "A0A6H1PN56"

i d94ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID94

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6B9WIK4"

i d940ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID940

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0M9Z2"

i d941ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID941

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4H2"

i d942ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID942

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0JP42"

i d943ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID943

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PK90"

i d944ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID944

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EGI5"

i d945ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID945

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z4X5"

i d946ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID946

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCT9"

i d947ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID947

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C5F7"

i d948ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID948

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C599"

i d949ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID949

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9KDH5"

i d95ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID95

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LCV8"

i d950ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID950

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PMN4"

i d951ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID951

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PLK8"

i d952ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID952

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JN75"

i d953ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID953

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d954ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID954

belongs to
Gene c
has facts
hasName dp "S"
produce protein dp "A0A6H0JNQ1"

i d955ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID955

belongs to
Gene c
has facts
hasName dp "M"
produce protein dp "A0A6H0JP42"

i d956ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID956

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0C4Z4"

i d957ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID957

belongs to
Gene c
has facts
hasName dp "ORF3a"
produce protein dp "A0A6H0QUB7"

i d958ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID958

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8H9"

i d959ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID959

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIQ8"

i d96ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID96

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JNE9"

i d960ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID960

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JMC1"

i d961ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID961

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0MBY8"

i d962ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID962

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EJ69"

i d963ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID963

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THF0"

i d964ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID964

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z310"

i d965ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID965

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIK0"

i d966ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID966

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C761"

i d967ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID967

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0QT90"

i d968ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID968

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TF95"

i d969ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID969

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XND5"

i d97ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID97

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PL25"

i d970ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID970

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PKI7"

i d971ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID971

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LA32"

i d972ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID972

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XM98"

i d973ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID973

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZXA5"

i d974ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID974

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PHI9"

i d975ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID975

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XP76"

i d976ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID976

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8P2"

i d977ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID977

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TFG9"

i d978ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID978

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XNU0"

i d979ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID979

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XN68"

i d98ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID98

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C6K8"

i d980ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID980

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EIU5"

i d981ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID981

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LAH8"

i d982ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID982

belongs to
Gene c
has facts
hasName dp "orf1ab"
produce protein dp "A0A6G9ZYB8"

i d983ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID983

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XLN4"

i d984ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID984

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C4K2"

i d985ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID985

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2L8H9"

i d986ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID986

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIQ8"

i d987ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID987

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0JMC1"

i d988ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID988

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0MBY8"

i d989ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID989

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2EJ69"

i d99ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID99

belongs to
Gene c
has facts
hasName dp "ORF1a"
produce protein dp "A0A6H0C2P8"

i d990ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID990

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1THF0"

i d991ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID991

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1Z310"

i d992ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID992

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PIK0"

i d993ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID993

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0C761"

i d994ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID994

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H0QT90"

i d995ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID995

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1TF95"

i d996ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID996

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XND5"

i d997ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID997

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1PKI7"

i d998ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID998

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H2LA32"

i d999ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ID999

belongs to
Gene c
has facts
hasName dp "ORF1ab"
produce protein dp "A0A6H1XM98"

o r g s i d1ni back to ToC or Named Individual ToC

IRI: https://w3id.org/def/COV#ORGSID1

belongs to
Genome c
Virus c
has facts
hasLink dp "https://github.com/shevelp/COVSJI/blob/main/genome.fasta"
hasName dp "SARSCOV2"

Legend back to ToC

c: Classes
op: Object Properties
dp: Data Properties
ni: Named Individuals